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ABSTRACT 
 
Physical inactivity and adiposity are independent risk factors for several chronic 
conditions including coronary heart disease. Activity and adiposity also modulate 
psychophysiological responses to psychosocial stress. Since heightened 
cardiovascular and inflammatory responses to mental stress predict cardiovascular 
risk, these two factors may influence cardiovascular risk through modulation of 
autonomic reactivity to stress. However, experimental evidence to support this 
hypothesis is scarce. 
 
The aim of this project is to investigate the associations between physical activity, 
adiposity, mental stress and mood and physiological reactivity using naturalistic and 
controlled laboratory methods. Study one examined the association between self-
reported physical activity participation, diurnal cortisol rhythm and mood symptoms in 
everyday life. Study two used an experimental design to examine the effect of 
physical activity on mood symptoms and on cardiovascular and inflammatory 
responses to acute mental stress. Exercise withdrawal was used as a model of 
physical inactivity to induce mood disturbances in healthy, active participants. 
Several stress-induced markers relevant in cardiovascular disease were examined 
including pro-inflammatory factors and cortisol. 
 
Study three examined the effect of adiposity on physiological responses to acute 
mental stress and mood. Weight loss was experimentally induced through caloric 
restriction in overweight or obese women. Responses to acute stress were 
compared before and after weight loss. Cardiovascular and inflammatory responses 
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to acute stress were evaluated to establish whether adiposity is associated with a 
heightened or blunted response. 
 
The combination of studies presented in this thesis provides insight into the complex 
relationships that links behavioural factors such as physical activity with mood and 
stress. An understanding of the mechanisms involved in the association between 
adiposity, physical activity and cardiovascular risk is invaluable in informing 
preventive strategies and health related programmes.  
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CHAPTER 1: LITERATURE REVIEW 
 
 
In this review the aetiology and disease process of coronary heart disease (CHD) 
will be briefly described. In addition, the main risk factors including traditional and 
psychosocial factors will be discussed. I will then summarise observational research 
on the role of stress and inflammatory processes in cardiovascular disease (CVD) 
and cardiovascular (CV) risk factors. This chapter will then discuss the evidence for 
an association of physical activity with mood and stress and its relevance in CVD 
with particular attention to the inflammatory pathways involved.  
This chapter will also address the literature relating obesity and adiposity with 
inflammation and CVD, and summarise studies addressing the association between 
adiposity and stress-induced autonomic and inflammatory responses. I will draw on 
observational and experimental research, and identify the gaps this PhD project sets 
out to address.  
 
1.1 Cardiovascular Disease 
 
CVD is the leading cause of death in developed countries accounting for 35 per 
cent of deaths each year. Coronary heart disease, or ischemic heart disease (IHD), 
and stroke are the most common form of CVD accounting for nearly 28 per cent of 
deaths in men and 25 per cent in women in the United Kingdom (UK) in 2008 (BHF). 
Mortality due to CVD in the year 2008 was 191,000 nearly half of whom were for 
CHD. Death rates in the UK have been falling but are higher compared to other 
Western European country. The prevalence of CHD in the most recent national 
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survey (2008) was estimated to be 2.7 million. The total economic cost of CVD in the 
UK in 2006 was estimated to be about 30 billion pounds per year. This cost is mainly 
derived from health care costs, loss of productivity and outpatient care (Luengo-
Fernandez, Leal, Gray, Petersen, & Rayner, 2006). In addition to an economic cost, 
CVD has a profound negative impact on quality of life and often leads to 
psychological impairments including psychological distress, depression and cardiac 
fatalism in sufferers, but also in family members who in the majority of cases act as 
carers. 
 
1.2 Standard Risk Factors. 
 
The term risk factors was first used half a century ago in a publication from the 
Framingham study (Kannel, Dawber, & Kagan, 1961). Standard, or traditional, CV 
risk factors include modifiable factors such as hypertension, dyslipidemia, cigarette 
smoking, diabetes mellitus, obesity and physical inactivity, and non-modifiable ones 
such as age, male gender and family history of CVD. Traditional risk factors may 
explain less than half of total CVD mortality (Greenland et al., 2003; Hackam & 
Anand, 2003; Pasternak et al., 2003) prompting the need to identify other factors or 
markers that may be causally related to CVD or to the development of cardiac risk 
factors. In recent years the role of systemic, low-level inflammation in the 
development and progression of CHD (Libby, Ridker, & Hansson, 2011; Dandona, 
Aljada, & Bandyopadhyay, 2004) has received increase attention and will be 
reviewed in this chapter. 
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1.3 Psychosocial Factors. 
 
1.3.1 Psychosocial Stress and CVD.  
 
It is well established that psychosocial and behavioural factors are aetiologically 
important in the development and course of CVD and related metabolic disorders. 
Behavioural and lifestyle risk factors for CVD include excess weight and obesity, 
cigarette smoking, lack of physical activity and sedentary lifestyle and a diet rich in 
fat and lacking in fruit and vegetables. Evidence has emerged for associations of 
psychosocial characteristics such as low socioeconomic status (SES), negative 
affect, depression and anxiety, major negative life events, chronic stress at work and 
chronic strain and cardiovascular morbidity and mortality (Yusuf et al., 2011; 
Dimsdale, 2008; Rosengren et al., 2004; Frasure-Smith & Lesperance, 2010; 
Brotman, Golden, & Wittstein, 2007; Rozanski, Blumenthal, Davidson, Saab, & 
Kubzansky, 2005). Therefore, it has been estimated that psychosocial factors may 
explain about half of the risk for CVD. 
Psychosocial, stress-related risk factors in CVD can be divided into affective, 
personality related and sociodemographic factors. Affective factors include 
depression, anxiety, burnout and negative wellbeing. Personality factors include 
traits such as neuroticism, anger proneness, pessimism and hostility, while 
sociodemographic include low social position, lack of social support or lack of a 
social network, negative life events and work stress. These factors may therefore 
influence CHD directly, indirectly, or impact on prognosis in patients with established 
cardiovascular disease (Rozanski et al., 2005). For example, stress may impact CV 
healthy through its direct effect on vascular mechanisms such as blood pressure, 
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insulin sensitivity or endothelial function. An indirect effect of stress may be the 
impact of psychosocial stress such as low social support or work stress for instance 
on established CV risk factors including smoking, poor diet habits or sleep problems 
(Steptoe & Kivimaki, 2012). In acute coronary patients, acute episode of stress such 
as intense anger or physical exertion may act as a trigger to initiate further cardiac 
events such as a myocardial infarction or cardiac death. Likewise, survivors of acute 
CV events may deal or cope poorly with stress related events and as a result impact 
negatively on quality of life or other factors such as return to work. In addition, 
several psychosocial risk factors do not occur in isolation but often co-exist in the 
same individual. As an example, depression or work stress are more prevalent in 
individuals of low SES (Wamala, Mittleman, Schenck-Gustafsson, & Orth-Gomer, 
1999).  
A great deal of research has examined the association of depressive symptoms 
and mood with cardiovascular outcomes. The strongest evidence to date is from two 
meta-analysis of prospective epidemiological studies showing that the relative risk 
for future CHD attributable to depression was 1.81 (95% CI 1.53 – 2.15) (Nicholson, 
Kuper, & Hemingway, 2006), and 1.34 (95% CI 1.17 – 1.54) for risk of future stroke 
(Dong, Zhang, Tong, & Qin, 2012). Depression is also important as a prognostic 
factor in individuals with CHD. A meta-analysis has shown that depression is 
associated with nearly double the risk of death (OR 1.78 95% CI 1.12 – 2.83) in 
patients with CHD (Barth, Schumacher, & Herrmann-Lingen, 2004). Interestingly, 
somatic symptom of depression including fatigue, bodily pain, sleep problems and 
poor appetite have been shown to predict cardiovascular mortality (Bekke-Hansen, 
Trockel, Burg, & Taylor, 2012) twelve months after an acute coronary event 
independently of the cognitive dimension of depression. This suggests that the 
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depression phenotype characterized by somatic or affective symptoms may be 
particularly damaging or toxic. This phenotype closely resembles a cluster of 
symptoms termed sickness behaviour in which inflammatory and immune factors are 
involved. Depression also conferred a higher risk of death or of a secondary event in 
heart failure patients (risk ration 2.1, 95% CI 1.7 – 2.6) (Rutledge, Reis, Linke, 
Greenberg, & Mills, 2006).  
Work stress defined as a combination of high employee’s effort and low reward 
or low control over the work environment coupled with high psychological demand is 
also a predictor of CHD risk. A meta-analysis of prospective observational studies 
has found a fifty per cent excess risk for CHD among workers with work stress 
operationalized as low reward – high effort, high demand – low control as well as 
perceived organisational injustice at work (Kivimaki et al., 2006). High job demands 
and lack of social support at work were also found to be risk factors for ischemic 
heart disease in men only (Eller et al., 2009).  
Low social position or SES operationalized as low income, low educational 
attainment or occupational position has been found to be strongly related to CHD 
risk (Van Rossum, Shipley, Van De Mheen, Grobbee, & Marmot, 2000; Marmot et 
al., 1991). The most compelling evidence has shown that low SES was associated 
with risk of CHD mortality conferring an increased relative risk of between 1.3 to 2.0 
(Stringhini et al., 2010; Albert, Glynn, Buring, & Ridker, 2006). Low social position 
and other behavioural and psychosocial factors contribute to CHD through bio-
behavioural and psychobiological pathways. Stress activates autonomic responses 
that may become maladaptive if heightened or sustained. Therefore, it is important to 
understand the mechanism that mediate or moderate the association between 
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factors such as depression or physical activity and cardiovascular risk factors. In 
order to achieve this, several observational and experimental methods are available.   
 
1.3.2 Methods of Investigation. 
 
In order to understand the role of stress and other psychosocial factors in 
cardiovascular disease, different methodologies of investigation need to be applied. I 
will briefly outline three study methodologies in this section: The observational 
epidemiological method, the naturalistic, ambulatory monitoring method, and the 
laboratory mental stress model. I will also outline studies that have used ambulatory 
monitoring and mental stress testing to investigate association of psychosocial and 
behavioural factors with CV risk factors as these two methods have been employed 
in the thesis. 
 
1.3.2.1 Epidemiological Studies. 
 
The observational epidemiological method is used to investigate the contribution 
of several psychosocial factors to the development and course of CVD at the 
population level. Typically, a cohort free of CVD or other diseases under 
investigation (the outcomes) is selected and the sociodemographic, clinical and 
psychosocial variables of interest (the exposure) are measured from questionnaires, 
interviews or medical screening at baseline. The cohort is followed up over time so 
that the outcome of interest (e.g CV events or mortality) can be measured and 
evaluated at different points in time. In this way, the association between exposure 
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and outcomes can be evaluated using statistical techniques such as multilevel 
modelling, or multivariate analysis. These techniques allow to estimate the size of 
the association between several psychosocial factors alone or in combination, as 
well allowing adjustment for factor that covary with  the disease under investigation, 
the exposure or both. The main advantage of this method is that it provides robust 
data on the association between stress and future CV risk factors such as 
hypertension, lipids or inflammatory activity as well as hard outcomes such as death. 
The contribution of psychosocial factors to CV morbidity and mortality can therefore 
be evaluated. In addition, with this method investigators are able to construct 
theoretical models of underlying biological pathways that may mediate these 
associations. However, the main disadvantage of the epidemiological method is that 
the assessment of the exposure factor may not be particularly sophisticated and 
relies mainly on questionnaires. Furthermore, this method is subject to bias since 
causality cannot be established. Despite these limitations the epidemiological 
method can provide rich and robust data on the association between stress and CV 
outcomes. 
 
1.3.2.2 Naturalistic Studies. 
 
This method of investigation is also called ecological and involves the sampling 
of several affective, behavioural, biological or physiological variables over several 
days. The range of measures that can be sampled in this kind of studies include 
saliva for the assessment of hormones or enzyme such as cortisol, corticotrophin 
realising factor, alpha amylase or various catecholamine metabolites that are 
relevant in CV disease. Other measures include the assessment of autonomic 
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function such as blood pressure, heart rate and heart rate variability over the day 
and night, objective recording of daily levels of physical activity using accelerometer 
devices, and several affective measures such as momentary stress, fatigue or mood 
that can be aggregated over a day or more. Many of the instruments used in this 
kind of research are not or minimally intrusive therefore allowing to capture the 
dynamic of the physiological or behavioural response in everyday life. 
Accelerometers such as the ActiGraph for example are tiny devices that are worn 
around the waist or on the wrist and provide rich information on the dynamic and 
frequency of physical activity. The sampling of saliva throughout the day is a stress 
free and easy method that can be implemented by the participant as he or she goes 
about their normal life without having to visit a laboratory or undergo potentially 
stressful procedure such as blood sampling. In this way, more detailed measures of 
an individual CV risk can be obtained that would not otherwise be possible in an 
epidemiological study. Various methods can be applied to analyse the rich data 
provided by this naturalistic methods. For example, in this thesis I will use saliva 
samples to index the diurnal cortisol profile and examine whether this profile is 
different in individuals who are more or less physically active. In the second study I 
will use data derived from an accelerometer wore over four weeks to index the 
degree to which participants have reduced their exercise regime. In this way an 
objective check of compliance with the intervention protocol can be established.  
A meta-analysis has shown that ambulatory blood pressure recording obtained 
over a 24 hour period was associated with mortality from cardiovascular causes 
(Conen & Bamberg, 2008). This suggests that information collected in everyday life 
can provide added value to the measure obtained in the clinic or in population 
studies. However, this method has also some limitations. The main problem is that 
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the range of measures that can be obtained without burdening the participants is still 
limited. In addition, some behavioural activities including smoking or eating and 
drinking may affect the biological samples under investigation and confound the 
results. A further limitation of this technique is that participants may change their 
behaviour during the monitoring period or limit their activities due to awareness of 
being monitored or because they feel uneasy with the equipment or the sampling 
protocol. If this is the case what would be supposed to represent a typical or ordinary 
day or week might not be such but may be biased by participants’ behaviour. Despite 
these limitations, the naturalistic method adds important information that may not be 
obtained in the laboratory or in population survey. 
 
 
 
1.3.2.3 Mental Stress Testing. 
 
The last method I describe that is used to investigate the association of stress 
and other psychosocial factors on cardiovascular risk factors is psychophysiological 
mental stress testing. It involves monitoring and recording psychobiological 
responses to various behavioural challenges in a control setting using assessment 
tools such as continuous heart and blood pressure monitoring, blood and saliva 
samples and other physiological parameters. This design allows for the assessment 
of various inflammatory, cardiovascular and neuroendocrine responses following the 
administration of acute stress tasks under tightly controlled conditions. In this way 
the dynamic of this autonomic response can be measured and related to the various 
psychosocial factors under investigation. For example, the blood pressure or cortisol 
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reactivity to a public speaking scenario may be indexed as the change in systolic or 
diastolic pressure from baseline values and compared between a sedentary and a 
physically active group. If one is interested in the link between depression and 
inflammatory responses to acute stress, the inflammatory marker under investigation 
may be compared between different groups categorised by their depression status. 
Investigators employing the mental stress model may also be interested in 
investigating effects rather than associations that requires an experimental 
manipulation. For example, affective states such as anger, depression or positive 
affect may be induced in the laboratory before having participants perform mental 
stress tasks. Their responses can then be compared against a control group so that 
it may be possible to evaluate the effect of anger or other factors on autonomic 
responses. 
This method has the advantage that greater control over confounding factors 
and standardization of protocols can be achieved that would not normally be 
possible in the other two methods outline above. In addition, sophisticated biological 
measures can be obtained during stress testing including repeated blood sampling, 
detailed hemodynamic and neuroendocrine responses, endothelial dysfunction and 
catecholamine activity. Importantly, blood samples obtained in the laboratory before 
and after mental challenge can also be used for further immunological challenges 
(i.e ex-vivo) in order to measures immune tissue sensitivity or inflammatory inhibition 
that may be relevant in the association of stress with CVD risk.  
Typically, a mental stress protocol involves a period of rest in which the subject 
is sitting comfortably on an armchair in order to establish baseline or resting 
physiological. Instrumentation of monitoring equipment is normally carried out to 
ensure proper calibration and functioning of equipment such as cardiovascular 
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monitors and indwelling cannula for repeated blood sampling. After the baseline 
values have been obtained subjects are given stressors that may range from 
cognitive tasks such as the Stroop word interference, or hand-eye attention 
coordination tasks such as the mirror drawing, or socially evaluative tasks such as 
public speaking or the Trier Social Stress Test depending on the protocol and on the 
type or response under investigation. Immediately after the stressors further samples 
are usually obtained. Depending upon the protocol participants will be required to 
rest for several minutes after the stress tasks so that more biological sample can be 
obtained. This post-stress period is termed recovery time and is important for several 
reasons that will be discussed in more detailed later. The main reason is that some 
physiological responses to stress can be detected in blood or saliva several minutes 
after stimulation. For example, cortisol levels tend to rise between ten and twenty 
minutes after stress while pro-inflammatory markers continue to increase for up to 
two hours after mental stress.  
Therefore, a typical stress session may take between two to four hours although 
some protocol can be longer, and require an experimenter and a research nurse or 
research assistant trained in blood processing techniques. The main limitation of 
using this methodology is that the task used to elicit the various responses an 
investigator is interested in may not be representative of stressors or challenges 
found in everyday life. For example, tasks such as the Stroop interference might be 
criticized for not representing a typical scenario for the average person. Furthermore, 
only a fair range of short-term biological responses can be recorded in the laboratory 
setting. This indicates that factors such as chronic stress exposure rather than acute 
stress may result in different autonomic responses that can be difficult to account for. 
However, despite some criticism, mental stress testing remains a valid and popular 
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method to investigate and evaluate the contribution of stress response to CVD risk 
factors. Two of the studies presented in this thesis involve mental stress testing. 
 
1.4 Pathophysiology of CHD 
 
Atherosclerosis is the process that underlies CHD. This is the progressive 
thickening of the walls of the coronary arteries due to the accumulation of lipids, 
macrophages, platelets, smooth muscle cells and various haemostatic factors into 
the lining of the vessel that eventually leads to narrowing of the vessel lumen and 
impaired blood flow to the heart muscle. Central to the process of atherosclerosis is 
the inflammation of the wall of blood vessels and the endothelium with subsequent 
accumulation of lipid rich debris derived from dead cells that form the necrotic core of 
the atherosclerotic plaque. Inflammatory signalling mechanisms in the endothelium 
are thought to translate the effect of several risk factors for CVD. The inflammatory 
process leads to build-up of toxic materials in the arteries that supply blood to the 
heart (Ross, 1999).  
The atherosclerotic process is initiated in the artery wall by various enzymes 
including 15-lipoxygenase (15-LO) and inducible nitric oxide synthase (i-NOS) which 
promote the oxidation of low-density-lipoprotein (LDL). Oxidized LDL (Ox-LDL) in 
turn is responsible for the proliferation of pro-inflammatory cytokines and acute 
phase reactant including C-reactive protein (CRP), fibrinogen, Interleukin-6 (IL-6), 
interleukin-1 beta (IL-1β) and Tumour necrosis factor alpha (TNF-α). These factors 
promote vascular and endothelial dysfunction by regulating the expression of 
adhesion molecules and formation of foam cells in the endothelium. This metabolic 
activity leads to the proliferation of smooth muscle cells and consequent release of 
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fibrous elements that covers the atherosclerotic plaque (Bhagwagar, Hafizi, & 
Cowen, 2005). When this fibrous cap eventually fractures, it releases pro-coagulant 
materials that may trigger thrombosis (Libby et al., 2011; Hansson, 2005).  
 
 
 
 
Figure 1.1 illustrates the stages involved in the development of atherosclerotic 
lesions. It can be seen in part (b) of figure 1.1 that the early stage of endothelial 
dysfunction involves permeability of the endothelium and recruitment of monocytes 
and T cells which undergo maturation into macrophages and, through the uptake of 
lipids, eventually form foam cells. Part (c) of figure 1.1 illustrates how the initial stage 
of lesion formation initiates. The migration of smooth muscle cells (SMC) to the site 
Fig.-1.1 Stages of atherosclerotic lesion development (Adap ted from Libby et al,  2011)  
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of the lesion is stimulated by cytokines and platelet derived growth factors released 
mainly by the now activated macrophages and T cells. Therefore, the migration of 
leucocytes, the formation of foam cells and the migration of SMC and lipids 
accumulation represents a central process in atherosclerosis development that 
develops through the years (Gratchev, Sobenin, Orekhov, & Kzhyshkowska, 2012).  
The thickened wall of the artery hosting the atherosclerotic plaque undergoes 
arterial remodelling, that is a process of changing and adapting of the lumen of the 
vessel which allows the blood to flow. The final stage of plaque development and 
thrombus formation is shown in part (D) of figure 1.1. The accumulation of debris in 
the arterial wall lesion leads to a chronic inflammatory process that contributes to a 
narrowing of the lumen (stenosis). Eventually, the plaque is weakened by the 
accumulation of lipids and macrophages leading to its rupture. Plaque rupture 
involves the release of a fibrous cap with platelet aggregation and humoral 
coagulation to the site and the formation of a thrombus. The thrombus will impede 
the blood flow in the lumen of the vessel causing tissue ischemia and myocardial 
infarction. However, the thrombus may also detach from its original site becoming an 
embolus and block the flow of blood at a different site (Hansson & Hermansson, 
2011).  
Several risk factors for atherosclerosis are involved in this process, which 
generally take years to develop and may not present until in advanced stages. As an 
example, hypertension is thought to increase tension in the artery wall that results in 
impaired endothelial function and formation of an aneurysm. 
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1.5 Role of Inflammation in CVD 
 
As it can be seen from the previous section, inflammation is a central part in the 
atherosclerotic process. For several years the accepted wisdom was that the passive 
accumulation of lipids and cholesterol into the arterial walls was responsible for 
atherosclerosis. However, it is now understood that atherosclerosis is a chronic 
inflammatory disease involving an interaction of lipid accumulation, vascular injury 
and specific inflammatory responses (Anogeianaki et al., 2011; Ross, 1999).  
In recent years increasing effort has been devoted to investigating the role of 
systemic, low-level inflammation in the development and progression of 
atherosclerosis and CHD, and cardiovascular risk factors including the metabolic 
syndrome and diabetes (Sutherland, McKinley, & Eckel, 2004; Yudkin et al., 2004; 
Dandona, Aljada, & Bandyopadhyay, 2004; Libby et al., 2011). Systemic, low-level 
inflammation is defined as a two to four fold level increase in circulating pro and anti-
inflammatory agents including cytokines and chemokines, and acute-phase 
reactants such as CRP and fibrinogen (Bruunsgaard & Pedersen, 2003). Cytokines 
are inflammatory polypeptides produced by the immune system that are involved in 
controlling local and neuroendocrine activities, and regulate immune and metabolic 
functions (see Figure-1.2). 
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It can be seen from Figure 1.2 that inflammatory cytokines are involved in several  
metabolic and vascular processes that are relevant in CVD. Inflammatory agents 
operate through bi-directional channels of communication – the immune system and 
the central nervous system (CNS) – and release inflammatory protein, neutrophils, 
natural killer cells and other factors involved in the pathophysiology of CVD and in 
cardiovascular mortality (Reuben et al., 2002; Hansson, 2005; Tedgui & Mallat, 
2006).  
CRP is an acute-phase protein produced by the liver which has been associated 
with the initial stages of atherosclerosis as well as the later stage. It induces 
expression of endothelial adhesion molecule cells, recruits inflammatory cells into 
Fig-1.2 Pro-Inflammatory cytokines interact with the metabolic, vascular and endocrine 
system (Adapted from: Bruunsgaard, 2005). 
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the artery wall and promotes plaque instability and eventually thrombosis (Li & Fang, 
2004). CRP has emerged as a robust predictor of future CVD events due, among 
other factors, to its presence together with foam cells in atherosclerotic lesions. In a 
prospective study of over a thousand healthy men, it was demonstrated that the 
baseline level of plasma CRP was a strong predictor of risk of first myocardial 
infarction and ischemic stroke. Crucially, the reduction of risk of a first myocardial 
infarction associated with the use of an anti-inflammatory agent (aspirin) was related 
to CRP levels (Ridker, Cushman, Stampfer, Tracy, & Hennekens, 1997).  
A recent meta-analysis offered evidence that CRP measured with a high 
sensitivity assay is a strong, independent predictor of mortality from cardiovascular 
causes (Kaptoge, Di Angelantonio, & Lowe, 2010). However, the causal association 
between CRP levels and CVD is still controversial (Kuper, Nicholson, Kivimaki et al, 
2009), and genotype studies do not seem to support a causal link (Zacho et al., 
2008). For example, it has been shown that although CRP levels independently 
predicts risk of CHD the causal association of CRP genotypes with CHD has not 
been established (Elliott et al., 2009). Therefore, CRP is considered to be an 
important marker of CV related outcomes rather than being causally related.  
Inflammatory cytokines such as IL-6, tumour necrosis factor alpha (TNFα) and 
IL-1β are involved in the hepatic stimulation and production of CRP. IL-6 is produced 
peripherally by the skeletal muscle and the adipose tissue but crucially also in the 
vasculature by leukocytes and the endothelium (Rus, Vlaicu, & Niculescu, 1996; 
Mihara, Hashizume, Yoshida, Suzuki, & Shiina, 2012). It is implicated in the 
regulation of metabolic changes and the repair of damaged tissues (Papanicolaou, 
Wilder, Manolagas, & Chrousos, 1998). Some evidence also shows that IL-6 is a 
robust modulator of fat metabolism and has an augmenting effect on lipolysis and fat 
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oxidation (Van Hall et al., 2003). This suggests a central role of the inflammatory 
marker IL-6 in obesity and chronic disorders associated with obesity such as CHD, 
the metabolic syndrome and type 2 diabetes.  
There is evidence for an association between plasma levels of IL-6 and CVD. 
For example, plasma IL-6 has been shown to be as strong a predictor as some of 
the major established risk factors in healthy older individuals (Danesh et al., 2008) 
conferring a 2.14 increased risk (95% CI 1.45 – 3.15). A nested case-control study in 
a population with stable CHD it was found that an increase of 1 pg/ml in plasma IL-6 
was associated with a 1.70 increased relative odds of developing a myocardial 
infarction or sudden cardiovascular death (Fisman et al., 2006). Most importantly, a 
recent Mendelian randomisation analysis has offered robust evidence to support a 
causal role of IL-6 in CHD making this cytokine a likely target for intervention 
(Swerdlow et al, 2012). 
TNF-α is a potent pro-inflammatory cytokine produced mainly by macrophages 
that mediates local inflammatory and acute-phase responses. It is mainly present in 
atherosclerotic lesions and is responsible for inducing the expression of adhesion 
molecules such as intracellular adhesion molecule-1 (ICAM-1) in the vascular 
smooth muscle cells which contribute to plaque rupture and thrombosis (Couffinhal 
et al., 1993). TNF-α plays a central role in obesity, type 2 diabetes and the metabolic 
syndrome (Donath & Shoelson, 2011; Bruunsgaard & Pedersen, 2003), and elevated 
circulating levels of this inflammatory marker independently predicts risk of 
myocardial infarction and the severity of carotid artery atherosclerosis in healthy men 
(Wilund, 2007; Skoog et al., 2002). A large, prospective study of the incidence of 
cardiovascular events in healthy, older individuals has demonstrated an association 
between plasma TNF-α and CHD over a mean follow-up time of 3.6 years. The 
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relative risk (RR) per TNF-α standard deviation increase was 1.22 (95% CI 1.04 – 
1.43) after adjustment for traditional risk factors (Cesari et al., 2003). There was also 
an association between TNFα and congestive heart failure (RR 1.59, 95% CI 1.30 – 
1.95). 
Therefore, inflammatory markers, cytokines and acute phase reactant are all 
involved in mediating cardiovascular risk. However, there is still some doubt 
regarding the causal association (Danesh & Pepys, 2009), and it has been 
suggested that some inflammatory agents such as CRP may be an intermediate 
marker that contributes to CVD via other mechanisms. Since psychosocial stress is 
associated with inflammation and with CVD, the next section will review evidence for 
a link between stress and inflammatory markers. 
 
1.6 Stress and Inflammation  
 
Although factors such as genetic influences are also known to influence 
inflammation and CVD risk, stress and psychosocial factors are important in 
inflammatory conditions and therefore CVD risk. In the previous sections I have 
outlined the methodology used to investigate the associations between stress and 
CV risk and in here the focus is on controlled laboratory studies since this method is 
used in the thesis. However, firstly I will briefly summarise some of the evidence from 
population studies showing association of psychosocial stress with inflammatory 
factors. Population studies are useful because of the large number of participants 
that allow statistical adjustment for several factors including ethnicity, gender and 
lifestyle characteristic that may confound the association of inflammation with stress.  
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Chronic psychological stress such as depressive symptoms, loneliness and 
caring for a relative with dementia seems to be associated with a low-grade 
inflammatory state (Hañnsel, Hong, Camara, & von Kanel, 2010). In a meta-analysis, 
depression was positively associated with CRP, IL-6 and IL-1 (Howren, Lamkin, & 
Suls, 2009) with body mass index (BMI) playing a moderating role. There is a wealth 
of research on depression and inflammation (Miller, Maletic, & Raison, 2009; 
Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008) suggesting that inflammation 
may be an important biological event in the development of stress-related disorders.  
However, other psychosocial stress factors are also important.  
A consistent finding seems to indicate that low SES individuals have raised 
plasma level of CRP and fibrinogen which are independent of factors that are also 
associated with both inflammation and stress including blood pressure, smoking and 
socio-demographics characteristics (Nazmi & Victora, 2007; Brunner et al., 1996). 
The clotting inflammatory factor fibrinogen was also associated with psychological 
distress in a large representative sample independent of socio-demographic and 
lifestyle factors but no association was found for CRP (Goldman-Mellor, Brydon, & 
Steptoe, 2010).  
Stress at work has not been found to be consistently associated with 
inflammatory markers. For example, one study reported a negative, independent 
association between fibrinogen and job control in men (Clays et al., 2005) but no 
association was found between CRP and work stress. Therefore, population studies 
seem to offer inconsistent evidence to support an association between stress and 
inflammation. More prospective studies testing whether inflammatory factors 
contribute to the association between stress and CVD will be able to address this 
issue.   
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1.6.1 Mental Stress Testing and Inflammatory Responses.  
 
 It has been suggested that chronic psychosocial stress is associated with 
chronic inflammatory responses that are relevant in CVD risk (Black, 2002). Mental 
stress testing allows for the evaluation of inflammatory responses under controlled 
conditions that can then be related to several psychosocial and stress 
characteristics.  
 
 
 
 
Fig-1.3 The effect of acute mental stress on IL-6 (A) and IL-1β (B) inflammatory 
responses. Includes healthy and clinical population. Adapted from Steptoe, 
Hamer & Chida (2007) 
A 
B 
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A meta-analysis of the effect of acute psychological stress on peripheral 
inflammatory markers has shown that acute mental stress in the laboratory induced 
transient elevation in IL-6 and IL-1β and only marginally in CRP (Steptoe, Hamer, & 
Chida, 2007). This effect of acute stress on IL-6 and IL-1β is illustrated in figure 1.3. 
The quantitative review noted that there was great overall variation between studies 
in the stressor tasks employed, blood sampling technique, and crucially the 
biochemical assay technique used to analyse inflammatory markers from plasma. 
The authors concluded that following acute psychological stress there is a modest 
increase in some inflammatory markers and highlighted methodological issues 
including the small sample size of most studies, the limited pool of markers 
examined and heterogeneity in the stress protocols.  
There has been no prospective study examining whether inflammatory 
responses to mental stress predict the development of CVD or risk factors such as 
hypertension. However, one study has found that heightened IL-6 and fibrinogen 
responses to two stress tasks were positively associated with a three year increase 
in ambulatory blood pressure that was independent of confounding factors including 
smoking, BMI and ambulatory blood pressure at the time of stress testing (Brydon & 
Steptoe, 2005). Additionally, the fibrinogen and TNFα but not IL-6 stress responses 
were associated with reductions in the degree of arterial distensibility (a measure of 
carotid artery stiffness) measured at the three year follow-up independently of 
covariates including resting CRP, lipids and blood pressure (Ellins et al., 2008).  
Therefore, although correlational, these studies suggest that inflammatory responses 
to acute psychosocial stress may predispose to an increase in CVD risk through 
alteration in hemodynamic and inflammatory functions and changes in the structure 
of the artery wall. 
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1.7 Neuroendocrine Factors in CHD. 
 
Research on the contribution of neuroendocrine factors in CHD has mainly 
focussed on the HPA axis end product hormone cortisol. Briefly, the HPA axis links 
the hypothalamus in the brain to the adrenal glands situated near the kidneys. The 
axis initiates communication from the brain to the periphery via the release of the 
corticotrophin releasing factor (CRF) and adrenocorticotrophin (ACTH) hormones. 
These hormones stimulate the release of the glucocorticoid hormone cortisol from 
the adrenal glands whose role is to prepare the organism for mental or physical 
activities that require substantial energy expenditure. Cortisol has vital metabolic 
functions including stimulation of the cardiovascular system and suppression of the 
inflammatory response. A highly adaptive negative feedback loop system signals 
back to the brain to inhibit further release of CRF and ACTH hormones and 
ultimately inhibit further production and release of cortisol.  
In physiologically normal conditions, cortisol has a marked and reliable circadian 
rhythm characterised by high levels upon awakening that peak between 30 to 40 
minutes post-awakening (cortisol awakening response [CAR]) followed by a steady 
decline thereafter reaching a trough in the late evening (illustrated in Figure 1.4).  
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Acute and chronic psychosocial stress can impair or dysregulate this adaptive 
diurnal rhythm resulting in an impaired feedback signalling system, dysregulated 
HPA axis activity and heightened cortisol levels. The strongest evidence to date 
supporting a role for impaired diurnal cortisol rhythm in CV outcomes comes from a 
longitudinal study of over 4000 individuals (Kumari, Shipley, Stafford, & Kivimaki, 
2011). The authors found that a cortisol pattern characterized by a flatter diurnal 
decline with higher evening levels was an independent predictor of cardiovascular 
mortality during a six years follow-up.  
Indeed, several aspects of the cortisol diurnal profile are associated with 
psychosocial stress factors. A meta-analysis of studies that examined the 
association between psychosocial factors and the CAR (Chida & Steptoe, 2009) 
Fig-1.4 The cortisol diurnal cycle in 542 healthy men and women from the Whitehall 
II longitudinal cohort adapted from (O'Donnell, Badrick, Kumari, & Steptoe, 
2008).  
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concluded that the dimensions that were most reliably associated with a heightened 
CAR were work stress and life stress. However, other psychosocial factors such as 
fatigue and burnout were related to a reduced CAR, whereas there was evidence for 
an association of both heightened and reduced CAR for depression. Depression and 
depressive symptoms measured with the Center for Epidemiological Study 
Depression Scale (CES-D) have been recently related to a flatter decline in diurnal 
cortisol in a relatively large sample of women independently of several covariates 
including age, BMI, SES and health behaviours (Knight, Avery, Janssen, & Powell, 
2010).  
A recent meta-analysis of depression and HPA axis function reported that 
depression is associated with hyperactivity of the axis resulting in higher cortisol 
levels compared to non-depressed individuals (Stetler & Miller, 2011). The authors 
argued that the results of their meta-analysis support a model wherein dysregulation 
of the HPA axis links depression with an increased risk for chronic illness such as 
diabetes and CHD. Indeed, a large cross-sectional study of cortisol and 
atherosclerosis plaques in an elderly population reported an independent association 
between total cortisol exposure during the day and the number of plaques present in 
the carotid arteries (Dekker et al., 2008). Therefore, HPA axis dysfunction and 
impairment in the diurnal cortisol profile is an important pathway contributing to the 
association between stress and psychosocial factors with CV risk factors and 
mortality.    
The HPA axis is also responsive to mental stress induced in the laboratory. It 
has been shown that social evaluative stressors such as speaking in front of others 
or the Trier Social Stress Test induce robust cortisol increases (Dickerson & 
Kemeny, 2004) that alters the normal downward cortisol slope (see Figure 1.4). 
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However, stressors characterized by cognitive or non-motivational challenges are 
generally modestly associated with cortisol responses. Evidence is beginning to 
emerge for an association between cortisol responses to psychological stress 
induced in the laboratory and the development of CHD risk factors. In a cross-
sectional analysis, Hamer and colleagues demonstrated that healthy individuals who 
responded with a small cortisol increase to two mild mental stress tasks had a 
greater degree of coronary artery calcification measured by electron beam computed 
tomography (Hamer, O'Donnell, Lahiri, & Steptoe, 2010). Crucially, the cortisol 
responses were also associated with the progression of coronary artery calcification 
three years later independently of several covariates including BMI, SES, resting 
cortisol and blood pressure (Hamer, Endrighi, Venuraju, Lahiri, & Steptoe, 2012).  
Therefore, acute stressors that disrupt the adaptive cortisol diurnal rhythm if 
sustained or repeated over time may increase CV risk. These studies provide some 
evidence that psychosocial stress induced under controlled conditions influence CVD 
risk through HPA axis dysregulation and cortisol release. 
 
2 Physical Activity, CVD and Stress. 
 
 
2.1 Physical Activity and CVD. 
 
Physical activity has recognised, far-reaching beneficial effects on the 
cardiovascular system as well as on psychological wellbeing. Physical activity is 
associated with reduced risk of CVD risk factors and mortality (Ahmed, Blaha, Nasir, 
Rivera, & Blumenthal, 2012; Szostak & Laurant, 2011), and this relationship persists 
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after traditional, biological cardiovascular risk factors such as blood pressure and 
lipids are taken into account (Bijnen et al., 1998).  
In a recent analysis of data from the Scottish Health Survey prospective cohort 
study, individuals who did not take part in at least 30 minutes of moderate physical 
activity a day had a 53 per cent increased risk of a cardiovascular event 
independently of traditional risk factors including smoking and hypertension (Hamer, 
Molloy, & Stamatakis, 2008). Results from prospective cohort studies have shown a 
strong association between levels of physical activity and cardiovascular risk. In one 
large epidemiological study Tanasescu and colleagues (Tanasescu et al., 2002) 
reported that various physical activities such as running, weight training and walking 
were each associated with a large reduction in the incidence of coronary heart 
disease independent of traditional risk factors. For example, that study showed that 
in men running at least a hour per week was associated with a risk reduction for 
CHD of 42 per cent (RR 0.58 95% CI 0.44 – 0.77) compared with men who did not 
run.  
In the McArthur studies of successful aging, a longitudinal cohort of older men 
and women, the combined effect of a high allostatic load score (a cumulative cluster 
of CV related risk factors) and low physical fitness at baseline were strong predictors 
of incidence cardiovascular disease and cognitive decline several years later 
(Seeman, Singer, Rowe, Horwitz, & Mcewen, 1997). Recently, a prospective study of 
more than 10,000 adults with a mean follow-up of 13 years (Reddigan, Ardern, 
Riddell, & Kuk, 2011) has shown that taking part in physical activity that is of light or 
moderate intensity (assessed by self-report) was associated with lower risk of CVD 
mortality. Interestingly, this association was independent of traditional and metabolic 
risk factors including hypertension, lipids and inflammation. 
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A major weakness in this area is the reliance on self-report physical activity data. 
Self-report requires individuals to recall their usual level of activity so that people can 
generally be categorised into non-active or moderately and vigorously active. This is 
a limitation because physical activity and sedentary time is somewhat arbitrary and 
there is no consensus about the optimal cut-off point that define intensity levels 
(Pate, O'Neill, & Lobelo, 2008). Indeed, concordance between self-report and 
objective level of physical activity is low (Prince et al., 2008). Therefore, in order to 
examine the contribution of exercise and physical activity to CVD risk factors and 
mortality with greater precision, objective measures of physical activity participation 
are becoming increasingly important. Accelerometers devices such as the ActiGraph 
or the Gravity Estimator of Normal Everyday Activity (GENEA) watch that measure 
body movements in term of acceleration and use algorithms to estimate the intensity 
of physical activity over time are being increasingly used (Chen & Bassett, 2005; 
Butte, Ekelund, & Westerterp, 2012).  
For example, in a cross-sectional analysis of a representative sample of adults 
there was an association between objectively recorded moderate to vigorous 
physical activity and better self-rated physical health which is a predictor of morbidity 
and mortality (Hamer & Stamatakis, 2010). In a prospective study of over 4,000 
adolescent boys and girls objective physical activity level at age 12 was strongly 
associated with reduced fat mass measured by dual emission absorptiometry 
(Riddoch et al., 2009). The authors were able to show that an extra 15 minutes of 
moderate to vigorous physical activity each day was associated with 20 per cent 
lower fat mass in boys. This suggests that objective measures of physical activity 
behaviour have greater power to detect changes in important CV risk factors. 
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2.2 Physical Activity and Inflammation. 
 
Midway through this chapter I discussed the role of inflammatory factors and 
psychosocial stress in CVD risk factors. Physical activity is a strong stimulus for the 
production and release of pro and anti-inflammatory cytokines and immune 
regulatory cells. Following an acute bout of exercise, cells in the skeletal muscle 
tissue and to a lesser degree the adipose tissues release the cytokine IL-6 into the 
circulation (Febbraio & Pedersen, 2002). This stimulates the production of the anti-
inflammatory cytokines IL-1ra, sTNF-r, IL-10 and, to a lesser extent, the acute phase 
reactant CRP. The release of pro-inflammatory markers such as TNF-α and IL-1 is 
not stimulated by acute exercise (Pedersen, Ostrowski, Rohde, & Bruunsgaard, 
1998; Pedersen, 2011). During this acute bout there is an actual increase in free 
radicals (oxidative stress) which is due to the sharp increase in oxygen consumption. 
The increase in free radicals was thought to promote LDL oxidation in the artery wall 
and contribute to atherosclerosis. However, ox-LDL produced following acute 
exercise is promptly processed by the liver in a different fashion compared to the ox-
LDL present in the vascular artery and does not promote inflammation or contribute 
to atherosclerosis (Van Berkel, De Rijke, & Kruijt, 1991; Wilund, 2007).  
The inflammatory factors released during exercise originate from working 
skeletal muscles exerting specific endocrine effects on several signalling pathways 
including the glycogen/p38 MAPK (Pedersen, 2011). In contrast, the inflammatory 
markers that are released during psychosocial stress are thought to be dependent 
upon the activation of the signalling transcription pathway Nuclear Factor kB 
(Bierhaus et al., 2003; Brydon et al., 2005). The differential activation of relevant 
pathways by stress and physical activity suggests that inflammatory markers such as 
IL-6 may be of central importance in explaining the association between physical 
47 
 
activity, stress and CVD risk factors. Indeed, several observational prospective 
studies have shown associations between physical activity and lower plasma level of 
inflammatory markers including CRP (Kasapis & Thompson, 2005), IL-6 and TNF-α 
(Panagiotakos, Pitsavos, Chrysohoou, Kavouras, & Stefanadis, 2005; Bruunsgaard, 
2005; Hamer, 2007; Cesari et al., 2003). Hence, attenuated circulating levels of 
these inflammatory markers may be atheroprotective through various mechanisms. 
Crucially though, through regulation of lipid production and activation or 
enhancement of several antioxidant enzymes, in particular e-NOS in the plasma, 
muscles and in the vascular wall (Van Hall et al., 2003; Vollaard, Shearman, & 
Cooper, 2005), which all contribute to an anti-inflammatory environment.  
Results from the few randomized exercise intervention trials that have been 
conducted however have been less consistent in finding reductions in inflammatory 
markers after physical activity interventions. Hence, there is only partial support for 
the hypothesis that regular physical activity is associated with lower levels of 
inflammatory markers (Ahmed, Blaha, Nasir, Rivera, & Blumenthal, 2012; Beavers, 
Brinkley, & Nicklas, 2010). It has been suggested that some of the inconsistencies 
may be explained, among other factors, by the effect of exercise on changes in fat 
mass as an inflammatory source, the lack of objective measurement of protocol 
adherence and the poor methodological qualities of some studies (Beavers et al., 
2010; Hamer & O'Donovan, 2010). 
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2.3 Physical Activity and Stress-Related Processes. 
 
2.3.1 Physical Activity and Mood. 
 
Physical activity may also be relevant in several mental health outcomes 
including depression. This section reviews the evidence for an association of 
physical activity with mood, focussing particularly on studies in everyday life. A meta-
analysis of prospective cohort studies has quantified the association (illustrated in 
Figure 1.5) between baseline physical activity and risk of depression during an 
average follow-up of 9 years (Hamer & Chida, 2008). 
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Participants included over 73,000 healthy, non-depressed men and women. The 
pooled odds ratio for the risk of depression in physically active compared to 
sedentary individual was 0.78 (95% CI 0.71 – 0.86). Therefore, engaging in regular 
physical activity seems to be protective against future depression. A large population 
study reported an hazard ratio for the risk of depression in women with low level of 
physical activity of 1.80 (95% CI 1.29 – 2.51) compared to women with a high level 
of physical activity (Mikkelsen et al., 2010). Interestingly, there were no significant 
associations in men. Although the effect sizes included in the meta-analysis (Hamer 
Fig-1.5 Effect sizes showing the prospective association between physical activity and 
risk of depression (adapted from Hamer & Chida, 2008).   
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& Chida, 2008) were adjusted for confounding factors such as social position, health 
behaviours and smoking, several limitations remains in this area. The main 
methodological issue is the self-report nature of questionnaire measure used to 
gather data on depressive symptoms and on physical activity levels. In addition to 
the well-known problems shared by self-report data such as memory bias or the 
concurrent effect of a current mood state on the recalling of past mood, symptoms of 
depression may also cause reporting bias. For example, some individuals may be 
more likely to under- or over-report frequency of physical activity or sedentary time.  
Few studies have examined the relationship of objectively assessed physical 
activity with depression either measured by questionnaire or by ecological 
momentary assessment or both. One large population study (Vallance et al., 2011) 
found that the level of moderate to vigorous physical activity (MVPA) measured with 
an accelerometer was associated with decreased odds of depression in a linear 
fashion (64 per cent reduced odds for depression in the most active compared to 
least active group). One study investigated the associations between objective time 
spent engaging in MVPA over a seven day period and daily ratings of mood in a 
small sample of healthy women (Poole et al., 2011). There was a moderate positive 
association between daily positive mood and objective MVPA. Importantly, MVPA 
was also negatively associated with mood measured by questionnaire (CES-D).  
Overall, physical activity seems to be protective of future depression especially 
in women. There are however methodological limitations in interpreting self-report 
data. In study one I will investigate the relationship between self-report, habitual 
physical activity participation and mood measured by questionnaire as well as daily 
rating of general stress which may be an important precursor of mood disturbance. 
In study two I will use objective recording of physical activity over a four week period 
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to establish whether a causal association between mood symptoms and activity 
levels exists.   
   
2.3.2 PA and psychophysiological responses  
 
Tsatsoulis and colleagues (Tsatsoulis & Fountoulakis, 2006) have argued that 
there is evidence from animal models and human observational studies that poor 
levels of physical activity contributes to a dysregulated and inefficient adaptive stress 
response with sustained autonomic activity. This, in turn, results in an increase in 
cardiovascular risk and in the development of cardio metabolic risk factors. Indeed, it 
was demonstrated in a meta-analysis (Chida & Steptoe, 2010) that greater 
cardiovascular reactivity to, and impaired recovery from, psychological stress 
induced in the laboratory was associated with the development of important CHD 
risk factors including hypertension.  
Physical activity may also act by inhibiting or modulate acute responses to stress 
challenges that if sustained over-time have negative effect on CV risk factors. This 
section reviews studies that have examined the association between physical activity 
and autonomic or inflammatory stress responses. Two fairly recent meta-analysis 
(Forcier et al., 2006; Jackson & Dishman, 2006) have also attempted a quantitative 
review of published studies examining the associations between physical fitness and 
cardiovascular responses. Jackson and colleagues review (Jackson & Dishman, 
2006) concluded that fitness was related to improved recovery from mental stress 
only in the better quality studies reviewed. Forcier and colleagues instead (Forcier et 
al., 2006) concluded that higher fitness was related  to attenuated systolic blood 
pressure and heart rate reactivity to mental stress. However, there were no 
52 
 
associations between cardiovascular recovery to stress and fitness. The limitation 
with these reviews is that they examined the effect of fitness rather than the levels of 
physical activity on stress reactivity. Most of the studies included were also based on 
non-objective measure of adherence to an exercise intervention. Furthermore, the 
outcomes under investigation were restricted to cardiovascular responses as there is 
at present a paucity of research examining the effect of physical activity or exercise 
on inflammatory and immune responses to stress.      
The studies summarised in table 1.1 include cross-sectional as well as 
intervention studies that examined the effect of physical activity or fitness on stress-
induced psychophysiological reactivity. About half of the studies were randomised 
exercise interventions, and only one cross-sectional study had inflammatory 
responses as an outcome. 
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Ref 
 
Design Sample 
Physical activity 
measure 
Stressor Outcome 
 
PA/fitness effect on 
reactivity/recovery 
 
 
Albright et al, 
1992 
 
24w RCT 
 
83 healthy 
 
Aerobic ex vs control 
 
MA 
 
HR, BP 
 
No 
Blumenthal et 
al, 1990 
 
12w RCT 37 type A Aerobic ex vs strength 
training 
15m MA BP, HR, RPP, 
ADE, NAD 
Yes BP, HR, RPP, 
Blumenthal et 
al, 2005 
16w RCT 134 IHD Aerobic ex vs usual 
care 
5m mirror + 5m 
speech 
LVEF, WMA, 
FMD, HRV, BS 
Yes (LVEF, FMD, BS) 
No (WMA, HRV) 
Bond et al, 
2008 
8w Non-
RCT 
32 healthy Aerobic vs control 5m Stroop, 4m CPT BS, HR, AC, BP Yes 
Boutcher et 
al,1998 
C-S 30 healthy Trained vs untrained 5m MA + 5m Stroop HRV Yes (Stroop) 
Degeus et al, 
1993 
16w QExp 62 healthy Aerobic ex vs wait list 
control 
2m CPT, + 2*10m 
RT 
TPR, HR, BP, CO No 
Finkenzeller, et 
al, 2011 
 
 
12w non-
RCT 
34 healthy Skiing ex vs control 4*4m cognitive 
stress 
HRV, SCL No 
Table-1.1 Summary of studies that examined the effect of physical activity or fitness on stress-induced psychophysiological responses. 
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Hamer & 
Steptoe, 2007 
 
C-S 
 
207 healthy 
 
HR cycle ergometer 
 
5m Stroop + 5m 
mirror 
 
IL-6, TNFα, IL-1ra, 
HRV 
 
Yes: IL-6, TNFα HRV 
Palatini et al, 
2010 
C-S 119 
hypertensive 
Active vs sedentary 
(hypert) vs control 
6m speech BP, HR Yes (BP) 
Poole et al, 
2011 
C-S 40 healthy Objective 7d PA 5m speech + 5m 
mirror 
Cort, HR, BP No 
Ray & Carter, 
2010 
8w RCT 23 healthy Aerobic ex. Vs 
sedentary control 
5m MA MSNA, RVR No 
Rimmele et al, 
2007 
C-S 44 healthy Trained vs untrained TSST Cort, HR Yes 
Rimmele et al, 
2009 
C-S 92 healthy Elite vs amateur vs 
untrained 
TSST Cort, HR Yes 
Sloan et al, 
2011 
12w RCT 149 healthy Aerobic vs strength 5m MA+ 5m Stroop 
+ 5m speech 
BP, HR, RRV No 
Spalding et al, 
2000 
C-S 20 healthy Trained vs untrained 2.5m Stroop, 2.5m 
MA, 2.5m problem 
solving 
 
HP, RSA 
No 
 
PA physical activity, RCT randomized controlled trial, C-S cross-sectional, MSNA muscle sympathetic nerve activity, RVR renal vascular, RRV 
responses, TSST Trier Social Stress Test, HR heart rate, Cort cortisol, HRV heart rate variability, RRV RR interval variability, IHD stable ischemic heart 
disease, BS baroreflex sensitivity, LVEF left ventricular ejection fraction, WMA wall motion abnormalities, FMD flow-mediated dilation, CPT cold pressor 
test, TPT total peripheral resistance, CO cardiac output, QExp quasi experimental, RT reaction time, MA mental arithmetic, HP heart period, respiratory 
sinus arrhythmia, RPP rate pressure product, ADE adrenalin, NAD noradrenalin, PA physical activity, AC arterial compliance 
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Overall, no firm conclusions can be drawn from the studies listed in table 1.1, 
and there seems to be a lack of experimental studies that use objective physical 
activity measures and inflammatory outcomes. Due to these methodological 
shortcomings the study described in chapter four was designed to experimentally 
manipulate the level of physical activity and examine the effect of on inflammatory, 
neuroendocrine and cardiovascular stress responsivity. 
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3 Adiposity, Inflammation and CVD. 
 
 
3.1 Adiposity in CVD 
 
Obesity and excess adiposity are important risk factors for CVD and associated 
co-morbidities including atherosclerosis, type 2 diabetes and the metabolic 
syndrome (Weyer, Foley, Bogardus, Tataranni, & Pratley, 2000). In a pooled study of 
over one and a half million adults, overweight and obesity defined as a BMI greater 
than 25 was associated with all-cause mortality independently of age, physical 
activity, education and marital status (De Gonzalez et al., 2010). It has been 
estimated that the association between obesity and risk of mortality for 
cardiovascular causes is about 40 per cent (hazard ratio 1.41, 95% CI 1.37 – 1.45) 
higher for a five unit increase in BMI above the 22.5 – 25 range (Prospective, 2009).  
The adipose tissue is an active endocrine organ secreting and activating several 
immune and adaptive inflammatory cells (Rocha & Libby, 2009). It has been shown 
that adiposity correlates with several pro-inflammatory markers in peripheral blood 
including IL-6, CRP, TNFα, IL-1β, RANTES and leptin which are also referred to as 
adipokines (Mohamed-Ali, Pinkney, & Coppack, 1998; Vozarova et al., 2001; Visser, 
Bouter, McQuillan, Wener, & Harris, 1999). Therefore, serum adipokine levels are 
raised in humans with excess adiposity especially central, visceral fat (Madani et al., 
2009; Fried, Bunkin, & Greenberg, 1998). This systemic inflammatory state of 
metabolic tissues is associated with insulin resistance, metabolic dysfunctions such 
as the metabolic syndrome (Lorenzo, Williams, Hunt, & Haffner, 2007) and ultimately 
contributes to cardiovascular disease (Gregor & Hotamisligil, 2011).  
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Weight loss studies have generally shown reductions in basal levels of vascular 
inflammatory markers including CRP, IL-6, TNFα and increases in the anti-
inflammatory marker adiponectin with a weight loss of at least six to ten per cent of 
initial body weight (Forsythe, Wallace, & Livingstone, 2008; Selvin, Paynter, & 
Erlinger, 2007). This suggests that weight loss is able to improve the low grade 
inflammatory state associated with obesity. It has been suggested that significant 
weight loss is not necessary in order to improve the metabolic derailment seen in 
obesity. Several changes in risk factors including insulin sensitivity, hemodynamic 
and inflammatory markers can be observed after initiation of moderate physical 
activity and healthy eating with minimal or not weight loss (Ross & Bradshaw, 2009).  
 
 
3.2 Leptin.  
 
Several inflammatory markers have already been reviewed in this chapter. 
However, the hormone adipokines leptin is relevant in study three of this thesis. 
Leptin is mainly secreted by cells of the adipose tissue in proportion to the amount of 
body fat present. It is implicated in appetite regulation through its direct effect on 
receptors in the hypothalamus, and energy expenditure. In obese individuals leptin 
levels are elevated suggesting that the cells targeted by this hormone become 
resistant to the effect of leptin. There is some evidence suggesting that leptin is 
associated with atherosclerosis and CHD risk (Oral et al., 2002; Wallace et al., 2001) 
possibly via its effect on central mechanisms such as blood pressure and on the 
vascular endothelium (Hou & Luo, 2011).  
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Leptin may also be involved in orchestrating the cytokine response to stress. In a 
cross-sectional study women with higher resting levels of leptin were characterized 
by greater stress-induced increases in pro-inflammatory IL-6 (Brydon et al., 2008a). 
This finding suggests that the adipose tissue may be an important source of stress 
responsive cytokines activation and provide a link between stress, inflammatory 
responses and cardiovascular risk factors. 
 
3.3 Adiposity, Stress and Inflammation.  
 
Stress has been linked to the development of adiposity and visceral obesity 
(Karalis et al., 2009). Low-grade inflammatory responses in obesity activate the HPA 
axis and the central and peripheral components of the central nervous system 
(Chrousos & Gold, 1992; Hotamisligil & Erbay, 2008). This results in the release of 
several hormones and immune cells that contribute to a chronic inflammatory state 
and therefore to increased cardiovascular risk (Purnell et al., 2009). Therefore, 
psychosocial stress may be a causal or predisposing factor in the development of 
adiposity and obesity. A recent meta-analysis of longitudinal studies examining the 
association between chronic stress exposure and adiposity (Wardle, Chida, Gibson, 
Whitaker, & Steptoe, 2011) reported a small effect size (r = 0.014, 95% C = 0.002 – 
0.025). The authors concluded that although an association between stress such as 
job stress, caregiving and life stress was observed, there was considerable variability 
across studies suggesting that moderators of this association are likely to play an 
important role.   
Cardiovascular and inflammatory activation in response to acute or chronic 
stress exposure might partly explain the link between adiposity and increased CVD 
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risk. Several cross-sectional and a few longitudinal studies have examined the 
association between obesity and psychophysiological responses to mental stress in 
the laboratory. These studies are summarised in table 1.2.  
In cross-sectional studies, greater adiposity (waist circumference or waist to hip 
ratio) and BMI have been linked to greater inflammatory responses to mental stress. 
For example, the obesity related hormone leptin and IL-1ra responses to mental 
stress were found to be more pronounced in women with greater central obesity 
(Brydon et al., 2008b). Cross-sectional studies have generally found positive 
associations between obesity and cardiovascular and cortisol responses to mental 
stress but only a few cross-sectional studies have examined inflammatory responses 
in obesity. However, the largest prospective study to date showed that an attenuated 
heart rate response to mental stress at baseline was independently associated with 
an increased risk of becoming obese five year later (Carroll, Phillips, & Der, 2008).  
Therefore, it is unclear whether obesity and adiposity are associated with a 
heightened or attenuated autonomic response to stress. Previous work in this area 
has been mainly observational highlighting the need for more experimental studies 
that systematically manipulate adiposity levels. Such studies may be able to 
elucidate whether reactivity to mental stress is one of the mechanisms linking 
adiposity to CVD risk factors, and to clarify the direction of the association. This 
issue will be addressed in chapter five by testing a group of overweight or obese 
women before and after weight loss. In this way it will be possible to examine the 
effect of adiposity on inflammatory and cardiovascular responses to stress.     
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Ref 
 
Design Sample 
Obesity/adiposity 
measure 
Stressor Outcome 
 
Obesity/adiposity 
effect on 
reactivity/recovery 
 
 
Agapitov et al, 
2002 
 
C-S 
 
46 healthy 
 
BMI (Obese vs matched 
lean) 
 
4m MA 
 
BP, HR, FBF, SBF 
 
Yes (SBF, FBF) 
Benson et al, 
2009 
C-S 39 healthy BMI (obese vs non-
obese) 
10m speech ACTH, Cort, IL-6, 
HR, BP 
Yes (cort, HR, BP) 
Brydon et al, 
2008a  
C-S 94 healthy Leptin 5m speech + 5m 
mirror 
IL-6, HR, HRV, 
PEP 
Yes (women only) 
Brydon et al, 
2008b 
C-S 67 healthy Fat mass, WC 
(continuous) 
5m Stroop + 5m 
speech 
BP, HR, IL6, 
IL1ra, leptin, Cort 
Yes (leptin, IL1ra, BP) 
 
 
Carroll et al, 
2008 
C-S & 
Long. 
1647 (C-S) 
1272 (Long.) 
BMI, WHR, 3m MA BP, HR Yes (HR-neg C-S & 
Long.) 
Davis et al, 
1999 
C-S 24 healthy WHR (Central vs 
peripheral obesity) 
5m Speech + 2m 
CPT 
BP, HR, CO, TPR Yes (BPreact, TPR 
higher, CO lower in 
central adiposity 
group) 
Epel et al, 
2000 
C-S 59 healthy WHR (low WHR vs high 
WHR) 
15m (speech, MA, 
cognitive tasks) 
Cort, Yes 
Table-1.2 Summary of studies that examined the associations of adiposity or obesity on stress-induced psychophysiological responses. 
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Georgiades et 
al, 2000 
 
24w RCT 
Weight loss 
 
99 
high/normal 
HT 
 
(exercise vs weight loss 
vs control) 
 
5m speech + 3m 
anger recall + 3m 
mirror + 2m CP 
 
BP 
 
No 
Kuniyoshi et al, 
2003 
C-S 35 healthy BMI (obese vs matched 
lean) 
4m Stroop + 2m 
CPT 
MSNA, FVR, BP, 
HR 
Yes (MSNA) 
Moyer et al, 
1994 
C-S 41 healthy WHR (low vs high) 15m MA Cort Yes 
Ribeiro et al, 
2005 
RCT 39 healthy (diet + exercise vs diet 
only) 
5m Stroop BP, HR, FBF No 
Seematter, et 
al, 2000 
C-S 19 healthy BMI, fat mass (obese vs 
lean) 
5m MA + 5m Stroop IS Yes 
Steptoe & 
Wardle, 2005 
C-S & 
Long. 
225 healthy BMI, WHR (continuous) 5m Stroop + 5m 
mirror 
BP, HR, CO, TPR (C-S) yes (BP, CO) 
(Long.) yes (BP, CO) 
Therrien et al, 
2010 
 
C-S 82 healthy BMI, WC (lean vs 
obese vs reduce obese) 
TSST Cort Yes (neg in men only) 
FBF forearm blood flow, SBF skin blood flow, BMI body mass index, WHR waist-hip ratio, CPT cold pressure test, TPR total peripheral 
resistance, IS insulin sensitivity, HT hypertension, WC waist circumference, Long. Longitudinal, PEP cardiac pre-ejection period, TSST Trier 
Social Stress Test, 
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CHAPTER 2: AIMS, HYPOTHESES AND RESEARCH 
STRATEGY 
 
2.1 Aims 
 
The association between physical activity, adiposity, and inflammatory stress 
responses has gained little attention and therefore forms the focus of this PhD 
thesis. This project also examines the effect of physical activity and weight loss on 
mood symptoms. A further aim is to explore the associations between diurnal cortisol 
level, regular physical activity and daily level of stress using ambulatory methods.  
At present, there is little experimental evidence regarding the effect of physical 
activity on pro-inflammatory reactivity and on the effect of adiposity on 
cardiovascular and inflammatory reactivity.  
This PhD project experimentally investigates whether reduction in adiposity, 
achieved through caloric restriction, and reduction in physical activity levels achieved 
through exercise withdrawal, results in attenuated or improved responses to 
standardized mental stress. Heightened and sustained autonomic activation to 
behavioural stress under controlled conditions has been found to predict several 
cardiac risk factors. Therefore, by experimentally manipulating physical activity and 
adiposity levels one is able to examine the pathways through which these factors 
influence or protect against autonomic and inflammatory dysregulation. 
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2.2 Research Strategy and Methodology 
 
In order to achieve the aims of this PhD project, I firstly carried out an analysis of 
data from a cross-sectional study and then set up and implemented two 
experimental controlled studies of acute psychophysiological stress testing. Study 1 
is a cross-sectional investigation of self-reported physical activity participation, daily 
stress and mood, and the diurnal cortisol in a sample of working women. The data 
used in this analysis are from the Day-Tracker study which was conducted by the 
UCL Psychobiology Group between 2007 and 2008. I was involved extensively in the 
data collection process for this study.  
Study two is a randomized cross-over study conducted with physically active 
participants using an exercise withdrawal paradigm (EWP) and objectively recorded 
physical activity levels. Study 3 is a non-randomized study of overweight or obese 
women tested in the psychophysiology stress lab at baseline and again after a 9 
weeks weight loss intervention designed to modify adiposity. I planned, set up and 
implemented these two laboratory studies.  
Psychophysiological stress testing involves the induction of psychological and 
biological responses in a controlled setting by means of validated, standard 
psychosocial stimuli such as public speaking, the Stroop colour-word interference 
paradigm, the mirror tracing task or similar protocols. These responses to laboratory 
stress are considered to be an index of the individual’s stress reactivity, and are 
usually monitored for a period of time depending on the protocol used and the 
biomarkers under analysis. In addition to the reactivity index of any stress protocol, 
the rate at which psychobiological markers (i.e. blood pressure or heart rate) return 
to baseline levels after stimulation, termed recovery, is also of great interest. This is 
because evidence suggests that impaired stress recovery may be an indication of 
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sustained allostatic load and therefore detrimental to health in the long term 
(McEwen & Seeman, 1999; Chida & Steptoe, 2010; Mcewen, 1998).  
The two experimental psychophysiology studies involve the evaluation of 
cardiovascular, cortisol and pro-inflammatory cytokine IL-6 responses to mental 
stress under controlled conditions. The cross-sectional study involves the evaluation 
of the diurnal cortisol cycle in relation to habitual levels of physical activity.  
 
 
2.3 Psychophysiology Stress Protocol. 
 
A detailed description of the protocol will be provided under the methods section 
of each individual study, so in here only a general outline is provided. I planned to 
use two stress stimuli to induce psychobiological responses: a simulated public 
speaking task and a mirror drawing task. These stimuli have been used previously 
by our group and others and have been found to induce robust, reliable and 
reproducible stress responses. These tasks have been chosen because they do not 
require anyone other than the experimenter to be administered, unlike stress 
protocols such as the Trier Social Stress Test, and are of a relatively short duration.  
The autonomic and immune parameters that are measured under stress-induced 
conditions include blood pressure, heart rate and heart rate variability, the 
noradrenalin metabolite 3-Methoxy-4-hydroxyphenylglycol (MHPG), the inflammatory 
marker C-reactive protein (CRP), the pro-inflammatory cytokine interleukin-6 (IL-6), 
the inflammatory hormone leptin, and the marker of hypothalamic pituitary adrenal 
axis (HPAa) cortisol. Figure 2.1 below gives an overview of the laboratory session 
protocol.  
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2.4 Study 1: Physical Activity, Daily Stress and Mood, and 
Cortisol. 
 
This study explored the cross-sectional association between self-reported levels 
of physical activity participation and daily rating of stress and general mood 
symptoms. In addition, the diurnal cortisol rhythm in relation to frequency of physical 
activity was also examined. It is possible that the beneficial health effects of physical 
30 min Baseline Rest Period 
•Calibration of Equipments. 
•Questionnaires. 
•Cardiovascular, saliva and blood samples. 
•Subjective appraisal.   
Two 5-minute Stressors 
 
•Cardiovasacular and saliva samples. 
•Subjective appraisal.  
 
20 min post-stress: Recovery 1 
 
•Cardiovascular and saliva samples. 
•Subjective appraisal. 
 
45 min post-stress: Recovery 2 
 
•Cardiovascular, saliva and blood samples. 
•Subjective appraisal. 
 
Fig-2.1 Overview of Psychophysiological Stress Testing Protocol . 
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activity are in part mediated through improved HPA axis regulation but very little 
work has examined the activity of the hormone cortisol in relation to physical activity 
levels in a naturalistic sample.  
The method of investigation for study one is ecological momentary assessment 
of general stress level during a working day and a leisure day as well as 
questionnaire ratings of mood and physical activity participation. Seven saliva 
samples obtained over a working day and again over a non-working day (leisure 
day) were used to estimate the diurnal profile of cortisol secretion which is an index 
of the HPA axis activity.  
 
 
2.4.1 Hypotheses for Study 1: 
 
I. Higher levels of physical activity will be associated with lower level of stress and 
mood symptoms.  
There will be group differences in rating of general daily stress and questionnaire 
measure of depressive symptoms between participants categorized into three 
levels of self-reported, habitual medium and vigorous physical activity (MVPA) 
participation: (1) No MVPA, (2) Little/some MVPA, and (3) Frequent MVPA. 
 
II. Higher levels of physical activity will be associated with an attenuated cortisol 
diurnal profile.  
The following components of the cortisol diurnal profile: (1) mean evening 
concentrations, (2) cortisol awakening response (CAR), (3) total day cortisol 
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exposure (AUC), and (4) slope of cortisol decline through the day will differ 
between the MVPA participation groups. 
 
2.5 Study 2: Physical Activity Withdrawal and Stress Study 
(PAWS). 
 
If study one demonstrated a cross-sectional association between physical 
activity and mood symptoms in an ecological setting, the second study uses an 
experimental method to establish a causal association between physical activity and 
mood. In addition, the PAWS study examined the effect of physical activity on 
psychobiological responses to laboratory induced mental stress. A physical activity 
withdrawal paradigm was employed as an experimental model of physical inactivity 
in a cross-over, randomised, single-blind, controlled manner.  
There are several advantages in using a physical activity withdrawal model 
rather than a formal active exercise induction trial, and therefore the strengths and 
weaknesses of this experimental model will be reviewed in greater details in the next 
chapters. Briefly, the manpower needed and the logistical and organisational costs 
required are reduced, because formal exercise supervision is not required. 
Moreover, a physical activity withdrawal approach overcomes the notorious 
problems of participant drop-out and poor adherence to protocol in exercise training 
studies.  
Habitually active and physically fit individuals were assigned to two weeks of 
physical activity maintenance (control condition) or two weeks of physical activity 
withdrawal in a randomized, cross-over manner. Objectively measured physical 
activity levels over the four weeks duration of the study as well as self-report 
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assessment of mood symptoms were used to index the outcome of the intervention.  
This time period was chosen because previous work by our group and others has 
shown that two weeks of forced physical activity withdrawal is a robust and reliable 
method to induce mood disturbances in healthy, regular exercisers.  
I examined psychobiological responses to the standard stress protocol relevant 
in cardiovascular disease risk before and after physical activity withdrawal. These 
psychobiological responses that were obtained in the psychophysiology laboratory 
include cardiovascular parameters (systolic and diastolic blood pressure, heart rate 
and heart rate variability, and total peripheral resistance); the neuroendocrine marker 
cortisol and MHPG; the inflammatory marker CRP and IL-6; and subjective stress 
appraisal ratings.   
 
 
2.5.1 Hypotheses for Study 2:  
 
I. Physical activity withdrawal will be associated with mood disturbances. 
a) A two week abstinence from regular physical activity compared to a two week 
maintenance of physical activity will cause significant changes in negative mood 
symptoms measured by questionnaire. 
b) The amount of objectively assessed change in physical activity will be positively 
and linearly associated with the mood disturbances following exercise 
withdrawal. 
c) The change in mood following physical activity withdrawal will be associated with 
changes in resting concentration levels of the inflammatory markers IL-6 and 
CRP. 
69 
 
II. Physical activity withdrawal will be associated with autonomic responses to stress. 
a) Cardiovascular, inflammatory and neuroendocrine reactivity to mental stress will 
be higher, and recovery slower, following the two weeks of physical activity 
withdrawal compared to physical activity maintenance. 
b) Subjective stress ratings will be higher, and stress task appraisal less 
favourable, following exercise withdrawal compared to exercise maintenance. 
 
2.6 Study 3: Weight Loss and Stress Responses Study (WLSR). 
 
This study examined the effect of adiposity on psychobiological responses to 
laboratory induced acute stress. Furthermore, mood changes following weight loss 
were also examined. I experimentally manipulated adiposity levels by inducing 
weight loss using a calorie restriction method with partial meal replacement and 
weekly support meetings. The weight loss intervention part of this study had been 
planned and implemented by the Diet Group in the UCL Health Behaviour Research 
Centre (HBRC). The participants were tested in the psychophysiology laboratory at 
baseline (before weight loss) and at follow-up (after weight loss) and the biological 
responses were compared. These psychobiological responses included the 
measures obtained in study two but with the exclusion of heart rate variability and 
cortisol. In addition, the adiposity-related biomarker leptin was assessed.   
Overweight or obese, but otherwise healthy, women were recruited through 
advertisement in the local press for a study investigating the effect of adiposity and 
immune responses to stress. The total duration of the trial from study entry to the 
follow-up laboratory session was nine weeks. The weight loss intervention followed a 
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partial meal replacement method plus weekly nutritional advice and was designed by 
dieticians and Health Psychologists at the HBRC. This method aimed to achieve a 
400 – 600 calorie deficit of calculated daily energy requirement. It was anticipated 
that this calorie deficit would induce an average weight loss of between 3 to 5 kg at 
three to six months follow-up. It was decided to use this method because standard 
behavioural counselling about nutrition does not produce substantial weight loss in 
the majority of participants.  
The choice of this method was broadly based on a meta-analysis of weight loss 
clinical trials (Franz et al., 2007). As illustrated in figure 2.2, the meal replacement 
strategy was found to result in a mean weight loss of 6.7 Kg at 12 months follow-up. 
Importantly, the meal replacement method when compared to diet alone was found 
to result in significantly more weight loss at 12 months. The article also reported that 
the average attrition rate across the studies reviewed was 29 per cent at the one 
year follow-up.  
 
 
 
71 
 
 
 
 
 
 
2.6.1 Hypotheses for Study 3: 
 
I. Weight loss will be associated with improvements in resting levels of inflammatory 
markers (CRP, IL-6 and leptin) and lipids.  
 
II. Weight loss will be associated with attenuated autonomic responses to acute 
mental stress. 
a) Participants’ cardiovascular and inflammatory responses to stress will be 
lower after weight loss compared to responses before weight loss, and the 
magnitude of this response will correlate with changes in adiposity measures. 
Fig-2.2. Systematic review of weight loss clinical trials (adapted from Franz et al,  2007)  
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b) Reductions in leptin following weight loss will be correlated with stress-
induced inflammatory and cardiovascular responses. 
 
III. Weight loss will be associated with improvements in depressive symptoms which 
will be mediated though changes in adiposity or inflammatory markers.    
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CHAPTER 3: PHYSICAL ACTIVITY, DIURNAL CORTISOL 
AND MOOD 
 
 
3.1 Introduction 
 
Regular physical activity has been consistently associated with morbidity and 
mortality and improved mental health and wellbeing (O'Donovan et al., 2010; Penedo 
& Dahn, 2005). The mechanism linking physical activity with health and wellbeing is 
important for several main reasons. Firstly, there is convincing evidence for an 
association between physical inactivity and depressive symptoms in healthy 
individuals (Strawbridge, Deleger, Roberts, & Kaplan, 2002) and in clinical samples 
(Krogh, Nordentoft, Sterne, & Lawlor, 2011). Depression is also associated with the 
development of cardiovascular disease risk factors (Nicholson, Kuper, & 
Hemingway, 2006; Hamer, Kivimaki, Lahiri, Marmot, & Steptoe, 2010; Knol et al., 
2006), and mortality (Hamer, Bates, & Mishra, 2011; Moussavi et al., 2007).  
Secondly, positive psychological wellbeing is an important outcome in itself not 
only for improving quality of life in general, but also because evidence point to 
wellbeing and positive affect as being independently associated with health 
outcomes (Chida & Steptoe, 2008). Therefore, elucidating the pathways through 
which regular physical activity exerts its beneficial effects is crucial, but at present 
these mechanisms remain poorly understood. Physical activity might exert its 
beneficial effects on mental health and cardiovascular function through shared 
mechanisms although little research has examined this. 
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Sub-clinical depressive symptoms are more prevalent in the general population 
than clinically diagnosed depression and have also been recognised as a strong risk 
factor for the development of major depression (Cuijpers & Smit, 2004). A recent 
large scale study of older women concluded that mild to moderate levels of 
depressive symptoms are strongly associated with poor psychological and physical 
functioning and accelerated cognitive decline (Vahia et al., 2010). Depressive 
symptoms measured longitudinally have also been shown to be predictive of 
coronary atherosclerosis in men independently of traditional risk factors (Hamer, 
Kivimaki, Lahiri, Marmot, & Steptoe, 2010). Therefore, convincing evidence suggests 
that depressive symptoms are associated with various health related outcomes.  
Although some evidence suggests that cortisol hyper-secretion may be an 
important physiological component in depression, the association between 
depression and cortisol diurnal levels is inconsistent. Some studies have reported 
heightened cortisol in response to waking in patients with depression compared to 
healthy controls (Bhagwagar, Hafizi, & Cowen, 2005), and in healthy individuals 
reporting higher level of depressive symptoms (Pruessner, Hellhammer, Pruessner, 
& Lupien, 2003), but others have also reported a blunted response (Huber, Issa, 
Schik, & Wolf, 2006).  
The discrepancy could be due to the different types of depression that have been 
investigated and the different instruments used to assess depressive symptoms. 
Depression is a heterogeneous diagnostic category which is often comorbid with 
other conditions. In addition, other factors such as chronic stress, use of anti-
depressant and other medications, and behavioural and lifestyle factors are likely to 
confound the associations.  
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Other aspects of the cortisol diurnal cycle may also be relevant in depression. A 
recent meta-analytic review (Stetler & Miller, 2011) of the association of depression 
and HPA axis activity that included more than 18.000 individuals has found that the 
overall difference in cortisol concentration between depressed and non-depressed 
participants was more pronounced in the afternoon and smaller in the morning. This 
suggests that HPA axis dysregulation in depression may be observed in the entire 
diurnal cortisol cycle. The diurnal cycle of cortisol secretion is a well-documented 
phenomenon. In response to waking, and up to half an hour post-awakening, cortisol 
levels rise by an average of 50 to 160 per cent (Clow, Thorn, Evans, & Hucklebridge, 
2004; Fries, Dettenborn, & Kirschbaum, 2009) in most healthy people. This 
phenomenon is called the cortisol awakening response (CAR). This is followed by a 
steady decline throughout the rest of the day that culminates in a trough at around 
midnight. Cortisol levels then rise again steadily through the early hours of the 
morning until the cycle is repeated. However, this diurnal rhythm is affected by 
several psychosocial and behavioural factors (Kirschbaum, 1994; Polk, Cohen, 
Doyle, Skoner, & Kirschbaum, 2005).  
Chronic stress and stress-related factors have been more consistently associated 
with a heightened CAR (Chida & Steptoe, 2009). Since psychological stress is a 
strong risk factor for the development of depressive symptoms, an impaired or 
hyperactive HPA-axis might be an important mechanism. This is even more 
important in light of recent findings that HPA-axis dysregulation and high cortisol 
levels have been prospectively linked to cardiovascular disease mortality among 
depressed patients (Jokinen & Nordstrom, 2009) and healthy individuals (Kumari, 
Shipley, Stafford, & Kivimaki, 2011; Vogelzangs et al., 2010). Additionally, recent 
work has shown associations of the diurnal cortisol rhythm with the development of 
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cardiovascular risk factors (Reynolds et al., 2010). For example, in a large study of 
healthy, middle age adults (Matthews, Schwartz, Cohen, & Seeman, 2006), a flatter 
cortisol slope was associated with a greater presence of coronary artery calcification, 
an objective marker of atherosclerotic lesions which is a strong predictor of future 
cardiovascular events. In another study total daily cortisol exposure indexed as the 
area under the cortisol curve (Cort-AUC) was independently associated with a 
greater number of plaques of the carotid arteries (Dekker et al., 2008).  
HPA-axis hyperactivity might also be relevant in response to challenge. Acute 
stress triggers a cascade of events that leads to the release of cortisol from the 
adrenal medulla into the blood stream. Cortisol has robust cardio-metabolic effects 
and it is thought that repeated stress-induced activation of the hypothalamic adrenal 
axis due to psychosocial stress or environmental demands leads to the development 
of cardiovascular risk factors. Our group has recently shown that heightened cortisol 
responses to mental stress predicted risk of having coronary calcium among healthy, 
older participants as well as being associated with higher calcium score among 
individuals with detectable coronary calcification (Hamer, O'Donnell, Lahiri, & 
Steptoe, 2010). Therefore, the associations between the HPA-axis and cortisol 
activity with risk factors can be observed in naturalistic settings as well as in 
controlled laboratory studies. This indicates that chronic activation of the axis in 
response to mental stress and the cortisol diurnal rhythm are important pathways in 
mediating these adverse effects.  
The association between regular exercise and HPA axis function is at present 
unclear. Controlled studies in animals have shown that running exercise improved 
the glucocorticoid response during stress by facilitating hormonal habituation to 
repeated stress exposure when compared to a sedentary control group (Sasse et al., 
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2008; Droste, Chandramohan, Hill, Linthorst, & Reul, 2007). In humans, it has been 
shown that the age related increase in stress-induced cortisol is attenuated in the 
more physically fit, older women (Traustadottir, Bosch, & Matt, 2005). Rimmele and 
colleagues (Rimmele et al., 2007) have also reported that professionally trained men 
had lower cortisol responses to stress compared to sedentary men, a finding that 
was replicated in a similar study comparing elite sportsmen to non-professionally 
trained individuals (Rimmele et al., 2009). However, one study showed that an acute 
bout of exercise is associated with a marked increase in plasma and salivary cortisol 
and greater monocytes sensitivity to glucocorticoids in endurance trained men 
(Duclos, Gouarne, & Bonnemaison, 2003) possibly suggesting that this increased 
glucocorticoid sensitivity acts to prevent a sustained, post-exercise inflammatory 
response. 
Taken together these findings provide some preliminary evidence that the 
beneficial effects of physical activity may be mediated in part through improved HPA-
axis control and regulation. Since the HPA axis is implicated in several physical and 
mental health outcomes, and that this pathway is sensitive to psychosocial and 
behavioural factors, it is important to investigate these associations further. Indeed 
the few studies that have attempted to address the issue were conducted in animals 
or mainly compared elite or amateur athletes with sedentary individuals. Although 
relevant, these studies are somewhat limited by the fact they miss out important 
aspects of the diurnal cycle of cortisol activity, the small sample sizes employed and 
the use of elite or well-trained participants, rather than the general population, that 
may reduce the generalizability of results. Furthermore, the association of regular 
physical activity with mood and the diurnal cortisol rhythm in women has received 
little attention. Women generally report more psychological distress and depression 
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than men (Kuehner, 2003; Silverstein, 2002) suggesting that this population may be 
more at risk of the adverse effects of poor mental health due to greater exposure to 
stress. 
 
 
3.2 Hypotheses.  
  
Therefore, the present study aims to investigate the associations of habitual 
physical activity, depressive symptoms and daily levels of stress, with the diurnal 
cortisol rhythm over a working and a weekend day in a large sample of office based 
female workers in full-time employment from two industrial European cities.  
 
It was hypothesized that: 
 
III. Higher levels of physical activity will be associated with lower level of stress and 
mood symptoms.  
There will be group differences in rating of general daily stress and 
questionnaire measure of depressive symptoms between participants 
categorized into three levels of self-reported, habitual medium to vigorous 
physical activity (MVPA) participation: (1) No MVPA, (2) Little/some MVPA, and 
(3) Frequent MVPA. 
 
IV. Higher levels of physical activity will be associated with an attenuated cortisol 
diurnal profile.  
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The following components of the cortisol diurnal profile: (1) mean evening 
concentrations, (2) cortisol awakening response (CAR), (3) total day cortisol 
exposure (AUC), and (4) slope of cortisol decline through the day will differ 
between the MVPA participation groups. 
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3.3 Methods 
 
 
3.3.1 Study Design: Day-Tracker Study. 
 
The Day-Tracker was a cross-sectional, ambulatory investigation of bio-
behavioural factors and daily emotion regulation, involving the administration of a 
psychosocial questionnaire plus momentary ecological assessment of stress during 
a working day and a weekend day. In addition, saliva samples for the quantification 
of free cortisol were obtained over twenty-four hours during the two assessment 
days. It was designed to investigate the relationship between psychological well-
being and biological function in everyday life using a cross-national design, so data 
were collected from comparable samples of working women in London, Budapest 
and Amsterdam.  Results from the study have been published in various articles over 
the last two years (Dockray et al., 2010; Dockray & Steptoe, 2011; Jackowska, 
Dockray, Hendrickx, & Steptoe, 2011). This chapter reports analyses of data from 
the London and Budapest samples.  
 
3.3.2 Study Sample. 
 
A convenience sample of 388 healthy, full-time employed office-based women 
was recruited between April 2007 and April 2008 at University College London (UCL) 
and Semmelweis University in Budapest (Hungary). Exclusion criteria were: use of 
regular medication (except contraceptive pill), chronic illnesses such as coronary 
heart disease, cancer and diabetes, depression and related mental health 
impairments. Participants were screened over the telephone to determine eligibility 
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and scheduled to attend a research laboratory visit prior to commencing the working 
day monitoring period and again prior to the weekend period. The order in which 
participants commenced the study was counterbalanced so that roughly half of the 
participants started with the working day and half with the weekend day monitoring 
period. 
 
3.3.3 Materials. 
 
3.3.3.1 Self-Report Physical Activity: 
 
Habitual physical activity (PA) was assessed by asking participants the frequency 
with which they engage in activities that are mildly, moderately, and vigorously 
energetic. Respondents rated the extent of their involvements in such activities on a 
scale ranging from hardly ever/never to three or more times a week. This scale was 
adapted from the Whitehall II longitudinal cohort study (Marmot & Brunner, 2005; 
Singh-Manoux, Hillsdon, Brunner, & Marmot, 2005), where it was shown that PA 
participation was strongly related to cognitive performance. Given the importance of 
moderate and vigorous physical activity (MVPA) for health (O'Donovan et al., 2010), 
participants were categorized into three physical activity groups: No MVPA (n = 48); 
Little/some MVPA (1d/ week, n = 144) and Frequent MVPA (≥ 2d /week, n = 196). 
These cut points were chosen according to the distribution of responses. 
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3.3.3.2 Mood and Daily Stress: 
 
Mood and daily stress were measured in two ways. Firstly, participants were 
administered the Centre for Epidemiologic Studies Depression Scale (CES-D, 
(Radloff, 1977). The CES-D is a 20 item self-report scale that measures depressive 
symptoms in the general population by asking respondents how often they have felt 
or behaved in a certain way over the past week. The psychometric properties of the 
CES-D have been reviewed in a large sample of women in which the single 
depression dimension factor was found to fit the data well giving further support to 
the use of a single continuous score (Knight, Williams, McGee, & Olaman, 1997). 
Higher scores denote more depressed mood and cut-off values for categorical 
assessment have also been validated. In this study the continuous score system was 
used. Cronbach’s alpha in this sample was 0.88. 
Ecological Momentary Assessment (EMA) ratings of stress and the perception of 
being or feeling in control were recorded by the participant on 6 occasions during the 
working day and the leisure day. From these ratings a single measure called daily 
stress was calculated by converting the scores into standardized Z-score and 
averaging them. These ratings were obtained using a paper diary at the same time 
as the saliva sampling and consisted of a Likert scale ranging from 1 (not at all) to 5 
(very much) in response to the following statement: In the last 30 minutes how much 
did you feel (-in control?, -stressed?). The control scale was reverse scored before 
further analysis. EMA measurement techniques aim to overcome the problems 
associated with questionnaires measures such as recall bias and the influence of 
current states on trait assessment (Shiffman, Stone, & Hufford, 2008).  
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3.3.3.3 Cortisol Sampling Technique: 
 
Saliva was sampled on seven occasions during the working day and the 
weekend day using Salivettes® (Sarstedt, Leicester UK). At the research laboratory 
visit participants were provided with a sample collection kit made up of the saliva 
sampling diary and seven Salivettes. Participants were instructed to place the cotton 
swab in their mouth and chew gently for two minutes before returning the swab into 
the salivette container. They were asked to take a sample at the following times: [s.1] 
17:00, [s.2] bedtime, [s.3] waking time, [s.4] 30 minutes after waking, [s.5] 10:00, 
[s.6] midday and [s.7] 15:00 in order to capture the cortisol diurnal cycle. Samples 
were to be kept in the participant’s refrigerator until returned to the research team 
laboratory a few days later and stored in a clinical -80 degree Celsius freezer until 
analysis. 
 
3.3.3.4 Sampling Diary: 
 
The sampling diary served two main purposes: to monitor adherence to the 
saliva sampling protocol and as a memory jogger for the EMA ratings of stress and 
perception of control during the study days (described above). Each time a saliva 
sample was due to be collected, participants noted the clock time of actual sampling 
along with ‘yes’ or ‘no’ responses to the following statement: in the last 30 minutes 
before sample collection did you?: brush your teeth, drink caffeinated drinks, take 
medications, eat a meal, drink alcohol, exercise, smoke; and subsequently the EMA 
ratings were made. Participants were instructed not to exercise, eat or drink or brush 
their teeth for half an hour before saliva collection. In addition, they were asked not 
to take any anti-inflammatory medication or pain killers for the duration of the study. 
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3.3.4 Procedure. 
 
The procedure is summarised in figure 3.1 below, and is the same for the 
working and weekend day. For the working day monitoring period, participants were 
required to attend the lab between Monday and Thursday at about 16:00 so that they 
could start the study at 17:00 which is when the first saliva sample was due. For the 
weekend day monitoring period instead, participants were required to attend on a 
Friday at 16:00. The study then terminated at 3 pm the following day. The starting 
day (weekend or workday) was counterbalanced among participants and the 
maximum lag between the two research days was 2 weeks and the minimum three 
days. Participants returned questionnaires and saliva samples using a pre-paid 
padded envelope. 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 pm 
Cortisol 1 
 
EMA 1 
 
 
Bedtime 
Cortisol 2 
 
EMA 2 
 
Wake up 
Cortisol 3 
 
 
Wake + 30 
Cortisol 4 
 
EMA 3 
10 am 
Cortisol 5 
 
EMA 4 
12 pm 
Cortisol 6 
 
EMA 5 
3 pm 
Cortisol 7 
 
EMA 6 
Lab visit 
 
-Questionnaire 
-Anthropometrics 
 
End of monitoring 
period 
Figure-3.1 Flowchart illustrating the Day-Tracker study 
procedure. 
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3.3.5 Analytical Statistical Approach 
 
Firstly, I compared the English and Hungarian sample on the between-subject 
factor habitual physical activity and the outcome variables diurnal cortisol, CES-D 
and daily stress using one-way ANOVA and Chi square. Then, I sought to establish 
whether differences in the diurnal cortisol cycle were present between the working 
and leisure days by using repeated measures ANOVA. The cortisol variables 
examined were: CAR (calculated as the mean difference between the waking and 
the waking + 30 minute samples), Cort-AUC (total cortisol output during the day 
calculated using the trapezoid formula as described in (Pruessner, Kirschbaum, 
Meinlschmid, & Hellhammer, 2003), Cort-Slope (the slope of cortisol decline from 
waking through the last 3 pm sample calculated by statistically regressing the raw 
cortisol values on the time of day that the samples were collected).  
The MVPA variable was used as the between-subject factor in the analyses 
involving the mood symptoms scores obtained by questionnaire (CES-D) and daily 
stress rating by aggregating EMA ratings. In this analysis the covariates were 
country (UK and Hungary), age and BMI. The association of habitual PA with cortisol 
was examined on the cortisol variables: CAR, Cort-AUC, Cort-Slope calculated as 
described above plus Cort-Ev (evening levels of cortisol calculated by averaging the 
last 2 samples). In this analysis the covariates where country, age, BMI, smoking 
and awakening time (for the CAR). Significance p values for linear trend and 
adjusted means ± standard error of the mean (SEM) are presented. In cases where 
the ANCOVA test was significant, LSD-adjusted test for multiple comparisons was 
used to examine post-hoc differences between MVPA groups. 
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3.4 Results 
 
 
3.4.1 Sample Descriptive. 
 
Table 3.1 shows the socio-demographic characteristics of the sample. 
Participants were full-time office based workers recruited in London and in Budapest. 
The mean BMI appears to be in the normal range and the mean depression score is 
lower than the cut-off value of 16 which is indicative of mild depressive 
symptomatology (Zich, Attkisson, & Greenfield, 1990). Table 3.1 suggests a 
relatively well-educated, healthy sample with few smokers with a great proportion of 
participants engaging in frequent physical activity.   
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Variable 
 
 
Mean ± SD 
 
Age (years) 35.71 ± 10.17 
BMI (kg/m
2
) 23.82 ± 4.37 
CES-D 11.88 ± 8.86 
Variable 
 
N (%) 
 
 
Education 
Less than degree 
Degree or higher 
 
 
146 (36.7) 
252 (63.3) 
Income (£) 
< 35 K 
≥ 35 – 70 K 
> 70 K 
 
123 (31.9) 
159 (41.3) 
103 (26.8) 
 
 
Smoking 
Never 
Former 
Current 
 
 
 
249 (63.4) 
81 (20.6) 
63 (16) 
 
Alcohol 
Non-drinker 
Drinker 
 
 
40 (10) 
358 (89.3) 
 
Moderate & Vigorous Physical 
Activity (MVPA) 
No 
Little – Some 
Frequent 
 
 
 
 
48 (12.4) 
144 (37.1) 
196 (50.5) 
 
 
 
 
Table-3.1: Descriptive Characteristic of the Study Sample (n = 388) 
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Table 3.2 reports the mean cortisol concentration and sampling time for the two 
study days. Overall, compliance with the scheduled sampling protocol was 
reasonable good, however, it has been shown in previous studies that in order to 
accurately determine the cortisol diurnal rhythm, and especially the CAR, 
participants who did not comply with the sampling protocol at the specified time 
should be excluded (DeSantis, Adam, Mendelsohn, & Doane, 2010; Dockray, 
Bhattacharyya, Molloy, & Steptoe, 2008). Therefore, I excluded from further analysis 
involving cortisol participants who delayed the waking sample for more than 10 
minutes. In this way, the sample size for the working day was 326 and for the leisure 
day 314.  
 
 
 
 
Sampling  
time  
Work day n = 326 Leisure day n = 314 
Sample time ± SD 
(hh:mm) 
mean ± SD  
(nmol/l) 
Sample time ± SD  
(hh:mm) 
mean ± SD  
(nmol/l) 
1 (5pm) 17.40 ± 1.23 4.51 ± 3.98 17.14 ± 1.39 4.45 ± 2.66 
2 (Bedtime) 22.70 ± 1.05 3.34 ± 4.30 23.15 ± 1.48 3.43 ± 4.21 
3 (Waking) 06.51 ± 1.02 15.70 ± 8.34 7.56 ± 1.36 13.99 ± 7.49 
4 (Wake+30) 07.13 ± 1.08 22.60 ± 12.54 8.19 ± 1.37 18.25 ± 9.29 
5 (10 am) 10.14 ± 0.31 9.39 ± 6.33 10.25 ± 0.61 10.48 ± 7.02 
6 (12 pm) 12.15 ± 0.36 6.99 ± 4.60 12.22 ± 0.61 7.38 ± 4.62 
7 (3 pm) 15.21 ± 0.61 6.50 ± 4.25 15.23 ± 0.53 6.33 ± 3.92 
 
 
 
 
Table-3.2 Mean cortisol concentration and sampling time over the two study days 
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3.4.2 Cohort Differences. 
 
Participants from London and Budapest did not differ in regard to CES-D 
depression score (F 1, 397 = 0.34, p = 0.56) and BMI (F 1, 386 = 1.50, p = 0.22). 
However, the Hungarian sample was slightly older (M age = 37.6 ± 10.69 years vs. 
33.83 ± 9.28, p = <0.001) and reported less EMA assessed daily stress ratings in 
both the work-day (M = 3.81 ± 1.19 vs. 4.21 ± 1.20, p = 0.001) and the leisure-day 
(M = 3.48 ± 1.23 vs. 3.96 ± 1.10, p = <0.001). 
Work-day Cort-Ev levels (F 1, 336 = 0.67, p = 0.41), leisure-day Cort-Ev levels (F 1, 
335 = 2.72, p = 0.10), and leisure-day CAR (F 1, 335 = 0.01, p = 0.91) did not differ 
between the 2 groups. Work-day Cort-AUC (M = 6892.14 ± 2992 nmol/l/min vs. 
1354.98 ± 582, p = <0.001) and leisure-day Cort-AUC (M = 4918.96 ± 2150 
nmol/l/min vs. 1098.16 ± 424, p = <0.001) were significantly higher in the Hungarian 
sample. Work-day CAR (M = 8.91 ± 12.21 nmol/l vs. 6.45 ± 9.22 nmol/l, p = 0.04) 
was also greater in the Hungarian sample. 
A greater proportion of individuals in the English sample reported to engage in 
frequent MVPA (56.6% vs. 43.4%, p = 0.006). Therefore, in further analyses country 
sample will be added as a covariate.  
 
3.4.3 Work Day vs. Weekend Day Cortisol Profile 
 
Analysis of covariance was carried out in order to determine whether there were 
differences between the work-day and the leisure-day in the following diurnal cortisol 
variables: CAR, Cort-AUC and Cort-Slope. The CAR was adjusted for awakening 
time due to the fact that participants woke at different times in the two sampling days 
and therefore the absolute waking cortisol level might be different. This was 
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achieved by subtracting the waking leisure-day time from the waking working-day 
time. The obtained value, which represents the absolute waking difference 
expressed in minutes, was subsequently entered as a covariate into a repeated 
measure ANCOVA model. Figure 3.2 depicts the 24 hours cortisol diurnal profile in 
the two sampling days. 
 
 
 
 
 
 
 
 
Results showed no main effect of CAR (F 1, 315 = 0.04, p = 0.83) but a significant 
CAR by waking time interaction (F 1, 315 = 71.57, p = <0.001) and a CAR by country 
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Figure-3.2 Un-adjusted 24h Salivary Cortisol Means in the two Study Days. Bars 
are standard error of the mean work-day n=326 –  leisure-day n=314.  
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interaction (F 1, 315 = 5.26, p = 0.02). Waking time and country sample adjusted CAR 
means (±SEM) were 7.62 ± 0.57 nmol/l and 4.46 ± 0.49 nmol/l for the work-day and 
leisure-day respectively. This indicates that when taking into account country sample 
differences in awaking time there was no significant difference in CAR levels 
between the work-day and the leisure-day.  
The main effect of Cort-AUC was significant (F 1, 316 = 24.35, p = <0.001) and 
there was a significant interaction effect of Cort-AUC with country sample (F 1, 316 = 
78.48, p = <0.001). Therefore, adjusting for country sample the Cort-AUC was 
greater in the work-day (M = 4150.42 ± 120.61 nmol/l/min) compared to the leisure-
day (M = 2983.35 ± 81.36 nmol/l/min). 
There was no main effect of Cort-Slope (F 1, 329 = 0.02, p = 0.87) nor an interaction 
with country sample (F 1, 329 = 0.17, p = 0.67) indicating no significant difference in 
the slope of cortisol decline between the work-day and the leisure-day. 
Given that some differences in the cortisol diurnal rhythm in the two sampling 
days were observed, further analyses involving cortisol will be carried out separately 
for the work-day and the leisure-day.  
 
 
3.4.4 Habitual Physical Activity and Mood Symptoms. 
 
Analysis of covariance was carried out with MVPA groups as the between-subject 
factor and depression score (CES-D) as dependent variable while age, BMI and 
country sample were entered as covariates. A significant linear trend was apparent 
for the CES-D (p = 0.02), whereas age (p = 0.94), BMI (p = 0.68) and sample country 
(p = 0.71) were not significant covariates. The adjusted CES-D mean scores (±SEM) 
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were 14.36 (1.31), 11.96 (0.73) and 10.91 (0.64) for the no MVPA, little/some MVPA 
and frequent MVPA respectively. This association is shown in figure 3.3 below. 
 
 
 
 
 
3.4.5 Habitual Physical Activity and Daily Stress (working day): 
 
A total daily stress score was derived from the six aggregate EMA ratings of 
stress and perception of control for the whole day period during the work-day and the 
leisure-day. These measures reflect momentary feelings of stress rather than global 
mood as in the questionnaire measure (CES-D). The daily stress score was obtained 
by converting the score of each construct to a standardized z-score and then 
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Figure-3.3 Associations of Habitual Physical Activity and CES -D Depression Score 
Adjusted for Age, BMI and Country Sample Error Bars are Standard Error of 
the Means 
. 
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averaging the two standardized scores (the feeling in control scale was reverse 
scored prior to standardization).  
Daily stress correlated moderately with the CES-D (r = 0.36, p = <0.001) 
suggesting a certain degree of independence between the two measures. In order to 
test whether MVPA is associated with daily stress, ANOVA models for the work-day 
and leisure-day were run with the three MVPA groups as the between-subject factor 
and daily total stress score as the dependent measure adjusting for country sample.  
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Figure-3.4 Physical Activity and EMA Aggregate Ratings of Daily Stress During the 
Work-day 
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There was a significant linear association of daily stress with MVPA (p = 0.03) and 
there was also a near-significant quadratic trend (p = 0.06). The adjusted mean (± 
SEM) for the no MVPA group was 4.38 ± 0.17, for the little/some MVPA was 3.91 ± 
0.1, and for the frequent MVPA was 3.97 ± 0.08 (shown if figure 3.4).  
Post-hoc LSD adjusted analyses indicated that compared to the no MVPA, the 
little/some (p = 0.02) and frequent MVPA group (p = 0.03) rated significantly less 
daily stress. This indicates that after adjusting for differences in stress ratings 
between countries, daily stress measured during a work-day was lower in the more 
active group.  
 
3.4.6 Habitual Physical Activity and Daily Stress (leisure day): 
 
In the leisure day the correlation between total daily stress and CES-D depression 
was (r = 0.39, p = <0.001) suggesting again a good degree of independence. The 
adjusted daily stress mean scores for each MVPA group are shown in Figure 3.5.  
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The linear trend was not statistically significant (p = 0.23). The mean scores 
(±SEM) were 3.86 (0.17), 3.78 (0.1) and 3.63 (0.08) in the no, little/some and 
frequent MVPA group respectively. This indicates that taking into account differences 
in country sample there were no significant differences in daily momentary measures 
of stress during the leisure-day between the physical activity groups. 
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Figure-3.5 Physical Activity and EMA Aggregate Ratings of Daily Stress During the 
Leisure-day 
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3.4.7 Habitual Physical Activity and Diurnal Cortisol (working day)  
 
Figure 3.6 shows the 24 hours salivary cortisol profile according to the frequency 
of habitual physical activity in participants who fully complied with the saliva sampling 
protocol (n = 326). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evening cortisol levels (Cort-Ev) were examined by averaging the concentration of  
the two evening samples (5 pm and bedtime) to provide a mean evening value that 
was used as the dependent variable with age, BMI, smoking status and country 
sample as covariates. The ANCOVA models (F 2, 303 = 2.94, p = 0.055) showed that 
age (p = 0.45), BMI (p = 0.20), smoking (p = 0.68) and country sample (p = 0.41) did 
Figure-3.6 Unadjusted 24h Cortisol Means for the Work -day According to Self-report 
MVPA Participation. 
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not influence Cort-Ev levels. There was a significant linear trend (p = 0.02) 
suggesting higher Cort-Ev in the least active group. Adjusted Cort-Ev means (±SEM) 
were 5.41 (0.63) nmol/l, 3.76 (0.32) and 3.79 (0.28) in the no MVPA, little/some and 
frequent MVPA group respectively.  
Post-hoc comparisons indicated that the group difference in Cort-Ev was 
significant between the no MVPA and the little/some and frequent MVPA (p = 0.02). 
Since figure 3.6 suggests that it may be the bedtime sample that is driving the effect 
of MVPA on Cort-Ev, the analysis was repeated using the bedtime cortisol sample 
instead of the average of the bedtime and 5pm samples. As in the previous analysis 
none of the covariates were significant. The linear trend was confirmed (p = 0.03) but 
there was also a quadratic trend (p = 0.04). Post-hoc comparisons indicated that 
compared to the no MVPA group, the difference in bedtime cortisol was greater in 
the little/some MVPA group (p = 0.01) than the frequent MVPA group.  
 
The CAR is the net increase in cortisol concentration after waking and it was 
calculated as the mean difference between the waking and waking + 30 minutes 
sample (Chida & Steptoe, 2009). The covariates for the CAR included waking time. 
Age (p = 0.93), BMI (p = 0.23), smoking (p= 0.54) and waking time (p = 0.64) were 
not significantly associated with the CAR but sample country was marginally 
associated (p = 0.06) as noted in the previous section (3.4.2). There was no 
significant linear trend for MVPA groups and CAR (p = 0.12) and the adjusted means 
(±SEM) were 11.11 (2.09) nmol/l, 7.40 (1.02) and 7.59 (0.9) in the no, little/some and 
frequent MVPA group respectively. 
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The Cort-AUC was calculated using the trapezoid formula (Pruessner, 
Kirschbaum, Meinlschmid, & Hellhammer, 2003). Age (p = 0.52) and smoking (p = 
0.38) were not significant covariates, but BMI (p = 0.01) and country sample were (p 
= 0.001). There was a significant linear (p = 0.05) and quadratic trend (p = 0.02). The 
adjusted Cort-AUC means (±SEM) were 4985.05 (370.48) nmol/l/min in the no 
MVPA group, 3966.38 (190.43) in the little/some MVPA and 4188.58 (165.91) in the 
frequent MVPA group. Post-hoc analyses showed a significant lower Cort-AUC in 
the frequent MVPA group (p = 0.05), and in the little/some MVPA group (p = 0.01) 
compared to the no MVPA group.  
 
Finally, the Cort-Slope from waking through 15:00 was examined. A steeper slope 
is indicative of an improved cortisol decline. Age (p = 0.001) and country sample (p = 
0.04) were significant covariates whereas BMI (p = 0.35) and smoking (p = 0.73) 
were not. There was no significant linear association between physical activity 
groups and Cort-Slope (p = 0.85). The adjusted Cort-Slope means (±SEM) were 
0.016 (0.002) nmol/l/min, 0.017 (0.001) and 0.016 (0.001) in the no, little/some, and 
frequent MVPA groups respectively. 
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3.4.8 Habitual Physical Activity and Diurnal Cortisol (leisure day)  
 
Figure 3.7 shows the 24 hours salivary cortisol profile according to the frequency 
of habitual physical activity in participants who fully complied with the saliva sampling 
protocol (n = 314). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis for Cort-Ev levels showed that none of the covariates were statistically 
significant: Age (p = 0.17), BMI (p = 0.36), smoking (p = 0.55) and country sample (p 
= 0.11). Cort-Ev was not linearly related to MVPA groups (p = 0.27). The adjusted 
means (±SEM) were 4.12 (0.41) nmol/l in the no MVPA group, 4.12 (0.23) in the 
little/some MVPA group, and 3.61 (0.2) in the frequent MVPA group. 
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Figure-3.7 Unadjusted 24h Cortisol means in the Leisure -day According to Self-
report MVPA participation. 
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For the leisure-day CAR age (p = 0.24), BMI (p = 0.93), smoking (p = 0.09) and 
sample country (p = 0.55) were not significant covariates but waking time was (p = 
0.008). There was no association between MVPA group and CAR (p = 0.52), and the 
adjusted CAR means (±SEM) were 6.33 (1.51) nmol/l, 4.24 (0.87) and 5.24 (0.75) in 
the no MVPA, little/some and frequent MVPA group respectively. 
 
For the leisure-day cort-AUC, age (p = 0.03) and sample country (p = 0.001) were 
significant covariates whereas BMI (p = 0.9) and smoking were not (p = 0.96). There 
was a non-significant trend towards a linear association of MVPA groups with Cort-
AUC (p = 0.09). The adjusted means (±SEM) were 3481.24 (260.28) nmol/l/min in 
the no MVPA group, 3057.67 (148.77) in the little/some MVPA group, and 2995.36 
(128.04) in the frequent MVPA group.    
 
Finally, the Cort-Slope from waking through 15:00 was examined and none of the 
covariates were significant: Age (p = 0.21), BMI (p = 0.71), smoking (p = 0.13) and 
sample country (p = 0.63). There was no linear association between MVPA groups 
and Cort-Slope (p = 0.26). The adjusted means (±SEM) were 0.019 (0.003) 
nmol/l/min, 0.016 (0.001) and 0.016 (0.001) in the no MVPA, little/some and frequent 
MVPA groups respectively. 
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3.5 Discussion 
 
The aim of this chapter was to explore the associations of habitual, self-reported 
levels of physical activity with mood symptoms and daily stress, and the cortisol 
diurnal cycle in a relatively large sample of office based workers. It was hypothesized 
that levels of physical activity would be linearly associated with mood measured by 
questionnaire, daily stress quantified with momentary techniques, and the diurnal 
cycle of cortisol secretion. Daily stress ratings and cortisol levels were assessed over 
a working day and a weekend day because there are likely to be differences in the 
cortisol dynamics and subjective level of stress between these two days (Kunz-
Ebrecht, Kirschbaum, Marmot, & Steptoe, 2004; Schlotz, Hellhammer, Schulz, & 
Stone, 2004). Therefore, in order to explore the associations between physical 
activity, daily stress and the cortisol diurnal cycle it is important to capture a typical 
working day as well as a non-working, leisure day.  
The study sample consisted of working women recruited from London and 
Budapest who were asked to rate subjective stress levels and feeling of control 
several times through the study days, and collect saliva samples at the same time of 
the ratings. There were between country differences in regard to age, daily stress, 
and cortisol indexes. The Hungarian sample was older and reported slightly less 
EMA daily stress but greater cortisol output. In contrast, the English sample reported 
engaging in MVPA more frequently. Given the observed differences in several of the 
outcome variables the analyses were further adjusted for sampling country.  
I sought to establish whether there were differences in the diurnal cycle of 
cortisol between the working and the leisure day. After adjusting for awakening time 
and country sample, there was no work – leisure day difference in the CAR. 
However, the whole day cortisol secretion indexed by the area under the curve was 
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greater during the working day independent of country sample whereas the slope of 
cortisol decline did not differ. Previous work has generally shown that the CAR is 
more pronounced during a working day compared to a leisure day (Kunz-Ebrecht et 
al., 2004; Schlotz et al., 2004; Thorn, Hucklebridge, Evans, & Clow, 2006) 
independent of awakening time. In this study after controlling for country sample and 
difference in awakening time there was no working day – leisure day difference in 
CAR levels. A significant difference was nonetheless apparent in whole day cortisol 
production with greater levels during the working day.    
Physical activity was assessed with an adapted scale used in the Whitehall II 
study that represents habitual engagement in activities and sports that require mild, 
moderate and vigorous energy expenditure. In line with the hypotheses, mood 
symptoms measured with the CES-D were inversely related to physical activity. 
Women who reported frequently participating in various forms of moderate and 
vigorous physical activity had a lower CES-D score than those reporting no MVPA, 
independently of age, BMI and country sample. These findings add to the physical 
activity and mental health literature (Stephens, 1988; Penedo & Dahn, 2005; Hamer, 
Stamatakis, & Steptoe, 2009) by showing that in a sample of women from two 
different European cities the frequency of weekly participation in physical activities 
and/or sport is associated with lower depressive symptoms scores in a linear 
fashion.  
These differences were small and outside the cut-off points suggested for clinical 
or major depressive disorders. Nonetheless, it has been shown that even depressive 
symptoms at the sub-clinical level not only predict clinical depression but are also 
associated with worse health outcomes in older women (Vahia et al., 2010). 
Moreover, female office based workers such as those in this sample might be more 
103 
 
exposed to the risk of developing depression and low level physical activity than non-
office based workers due to the high amount of time spent sitting (Teychenne, Ball, & 
Salmon, 2010).  
I also examined daily levels of stress in relation to physical activity using 
aggregate scores of repeated ratings over 24 hours during the working day and 
leisure day. The subjective perception of stress and control may be important not 
only because chronic stress exposure is predictive of the development of depression 
(Alfonso, Frasch, & Flugge, 2005; Kasen, Chen, Sneed, & Cohen, 2010) but also 
because the appraisal of events or situations as stressful or demanding does, in turn, 
activate the coping strategies one will employ to deal with the situation. These 
coping strategies might be adaptive or maladaptive and have a long-term impact on 
health. The results showed that there was a moderate correlation of momentary 
stress with depression measured by questionnaire suggesting that although the two 
dimensions are related they have a large degree of independence. As predicted, 
during the work-day the group with the least physical activity participation rated 
higher daily stress compared to the other two groups. Importantly, this difference 
was independent of country sample since it was reported earlier that the London 
based sample rated greater daily stress than their Budapest counterpart.  
This finding was not replicated in the leisure day. The reason for this is likely to 
be that perception of stress was lower in the leisure day compared to the working 
day and therefore the narrow variation reduced the power to find significant 
associations. Steptoe and colleagues found no difference in stress appraisals 
measured with EMA over 12 days between exercise and non-exercise days in a 
small sample of moderately active men and women (Steptoe, Kimbell, & Basford, 
1998). However, participants reported more positive mood on the exercise compared 
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to non-exercise days. The reason for this discrepancy is likely to be attributable to 
the different methodology used.  
Indeed, the differences in daily stress rating and questionnaire measure of 
depression between the physical activity groups in this study were small, and one 
may question the significance or the meaning of this finding. However, small 
differences in subjective appraisals such those found in this sample should not be 
dismissed or underestimated for several reasons. If a participant’s rating represents 
a typical day, then, in the long-term, stress or lack of control may have negative 
health consequences. This notion may be in keeping with the allostatic load model of 
health and disease which suggest that sustained exposure to uncontrollable stress 
contributes to a disturbed or poor regulated homeostatic balance leading to 
vulnerability do disease.  
An unexpected but interesting finding of this study was that the daily cortisol 
output indexed as the AUC was greater in the Hungarian participants in both 
sampling days compared to their English counterparts. This was in spite of slightly 
lower daily stress assessed by aggregating momentary assessment ratings only (but 
no differences in self-report mood symptoms). However, the physical activity effect 
observed in the total daily and evening levels of cortisol was independent of between 
sample differences in cortisol. Nevertheless, this finding might have important 
implications and needs to be interpreted. It may be that Hungarian participants 
experience slightly less day to day stress but perhaps more chronic stress or 
negative life events, which was not measured, and this may then result in sustained 
HPA axis activation with consequent greater daily cortisol exposure. An alternative 
explanation may be that since the Hungarian sample reported engaging in physical 
activity less frequently than the English sample, cortisol output may be elevated as a 
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result. Research on cross-cultural differences in HPA axis activity and cortisol levels 
is scarce so that at this stage it may only be possible to speculate what the reason 
for the difference in cortisol AUC might be. Nevertheless, this finding may suggest 
that diurnal cortisol exposure and momentary stress measure may not necessarily 
be positively related or that at least the association may be confounded by cross-
cultural factors.    
It was argued in the introduction that the beneficial effects of regular physical 
activity may act through HPA axis regulation. For example, cross-sectional studies 
have shown lower cortisol reactivity to mental stress in elite athletes and trained 
individuals compared to non-trained individuals and amateur sportsmen (Rimmele et 
al., 2007; Rimmele et al., 2009). In naturalistic settings no study has yet examined 
whether physical activity is associated with the diurnal cortisol profile. Results for the 
working day showed that evening cortisol level (cort-ev) was higher in the lowest 
MVPA group compared to the two other groups after adjusting for age, BMI and 
smoking. However, other parameters such as total cortisol output (cort-AUC) and the 
diurnal slope decline (cort-slope) were not significantly associated with physical 
activity. Only the linear trend of CAR and MVPA approached statistical significance.  
In the leisure day none of the cortisol parameters examined was statistically 
associated with physical activity even though the associations were in the predicted 
direction. Only evening cortisol values approached significance level in this case (p = 
0.07) so that the most active group again showed the lowest mean values.   
These findings suggest that regular physical activity is associated with lower 
evening cortisol during the work-day and only marginally in the weekend. This is 
interesting because previous work has shown that perceived momentary stress is 
rated higher, and control and happiness lower, during the work-day compared to the 
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weekend day (Kunz-Ebrecht, Kirschbaum, Marmot, & Steptoe, 2004; Schlotz, 
Hellhammer, Schulz, & Stone, 2004) possibly pointing to a link between regular 
physical activity, cortisol and work-day stress. Lower evening cortisol might therefore 
be a biological pathway that partly mediates the benefits of regular physical activity 
but there is currently only little evidence to support this notion. The largest 
prospective study of cortisol and cardiovascular mortality to date (Kumari et al., 
2011) has shown that the slope of cortisol decline (flatter) but not the CAR or the 
mean diurnal output predicted an increased risk of cardiovascular mortality. 
Importantly, the flatter cortisol slope was driven by higher evening levels.  
It is important to note that the non-significant associations observed for the other 
cortisol parameters, especially the CAR, warrant further investigation. It may be that 
the study was not sufficiently powered to find small associations between cortisol 
and physical activity, or that evening levels of cortisol are more important. Further 
investigation will benefit from the use of objective measures of physical activity over 
repeated days so that the association between the cortisol profile and daily level of 
physical activity can be quantified with greater precision. 
Another significant aspect of cortisol homeostasis is the stress-induced cortisol 
increase in response to psychosocial demands that may occur in everyday life. This 
response is largely adaptive but if sustained can have negative consequences 
(Mcewen, 2008; Mcewen, 2004). Regular physical activity may also act by buffering 
the stress induced cortisol response, but no experimental study has so far examined 
this issue. Therefore, I decided to carry out a study in which physical activity levels 
will be experimentally manipulated so that its effect on cardiovascular, inflammatory 
and endocrine responses to standardized mental stress can be assessed and 
evaluated (see chapter four). 
107 
 
Strengths of this study include the use of a large sample with similar 
characteristics in terms of work environment, the assessment of cortisol over two 
days and the use of ecological momentary assessment of daily stress as well as 
depressive symptoms by questionnaire. Weaknesses include the use of self-report 
physical activity and the lack of objective checks for the saliva sampling protocol and 
time of waking. Indeed, the use of a self-reported physical activity measure might 
have introduced bias into the analysis because many people cannot accurately recall 
their activity levels, especially types of general every day activity that are not 
structured. It is also possible that the more physically active participants exercised 
during the sampling periods that might have impacted on the diurnal cortisol pattern. 
Therefore future studies in this area should incorporate objective assessments of 
physical activity. 
In summary, this study has found that regular physical activity is associated with 
lower depressive symptoms and less daily level of self-rated stress. There was only 
partial support for an association between physical activity and HPA function. It is the 
first time that an association of physical activity with cortisol has been reported in an 
ambulatory study. Although the study has offered limited evidence linking regular 
physical activity with the HPA axis, it is important that these findings are replicated. 
Furthermore, it is necessary to investigate these associations in an experimental 
manner.   
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CHAPTER 4: PHYSICAL ACTIVITY WITHDRAWAL, 
MOOD AND AUTONOMIC RESPONSES 
 
 
4.1 INTRODUCTION 
 
Physical activity (PA) is associated with reduced mortality from coronary heart and 
vascular disease and also with better mental health (Heckman & McKelvie, 2008; 
Mora, Cook, Buring, Ridker, & Lee, 2007; Blomstrand, Bjorkelund, Ariai, Lissner, & 
Bengtsson, 2009; Deslandes et al., 2009). Lack of regular physical activity, by 
contrast, has been shown to predict the development of a myriad of modifiable 
cardiovascular risk factors and chronic disease. The autonomic nervous system 
(ANS) may be an important mediator of this association as it initiates a cascade of 
cardiovascular and inflammatory responses including acute phase proteins and 
immune functions which strive to maintain the organism’s homeostasis. Acute and 
chronic psychosocial stress disturbs this homeostatic balance with deleterious long-
term consequences (Mcewen, 1998). Regular PA may also act by buffering 
exaggerated and repeated stress-induced activation of inflammatory, cardiovascular 
and endocrine pathways that are implicated in several risk factors and health 
outcomes. 
The mechanisms underlying this protective effect are not completely understood 
but it is thought that PA exerts positive effects on physical and mental health through 
shared biological pathways. Cross-sectional studies have generally shown that fitter 
individual have lower basal concentration of inflammatory cytokines (Petersen & 
Pedersen, 2006) and an improved hemodynamic profile (Hamer, 2006). Our 
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laboratory has shown that greater physical fitness is associated with lower stress-
induced interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) responses, 
and greater heart rate variability (HRV) after adjusting for the effect of age, gender, 
body mass index (BMI), socio economic status (SES) and health behaviour (Hamer 
& Steptoe, 2007). Evidence from a meta-analysis of controlled laboratory studies has 
also demonstrated that an acute bout of exercise has a robust blunting effect on 
blood pressure reactivity to psychosocial stress  (Hamer, Taylor, & Steptoe, 2006). 
These findings, although of a cross-sectional nature, suggest that PA modulates a 
wide range of autonomic responses including important inflammatory pathways.  
Heightened responses to mental stress appear to have relevance for the 
development of a poor cardiovascular risk profile (Hamer, O'Donnell, Lahiri, & 
Steptoe, 2010). Larger inflammatory and haemostatic responses to stress have been 
related to heightened resting ambulatory blood pressure at three years follow-up 
after adjustment for age, sex, baseline blood pressure, BMI and smoking (Brydon & 
Steptoe, 2005). A meta-analysis of prospective studies (Chida & Steptoe, 2010) has 
shown small but significant positive associations of cardiovascular stress reactivity 
with incident hypertension and carotid intima-media thickness at follow up, 
suggesting that psychophysiological responses under controlled conditions have 
cardiac prognostic value in initially healthy subjects. Regular PA is also linked with 
improved psychological wellbeing (Hamer & Stamatakis, 2010; Rethorst, Wipfli, & 
Landers, 2009; Windle, Hughes, Linck, Russell, & Woods, 2010), and findings from 
exercise intervention trials suggest that structured exercise may be as effective a 
treatment as antidepressants in patients with major depression (Blumenthal et al., 
2007).  
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This is noteworthy since depression has been associated with coronary heart 
disease (CHD), cardiac risk factors and poorer CHD prognosis (Knol et al., 2006; 
Nicholson, Kuper, & Hemingway, 2006). Indeed, a recent quantitative review of the 
effect of physical activity on depressive symptoms in individuals with a chronic 
condition (Herring, Puetz, O'Connor, & Dishman, 2012) showed that exercise training 
improves depression in this population by a mean effect size of ∆ 0.3 (95% CI, 0.25-
0.36).  
At present, the relationship between physical activity, mood and stress-induced 
cardiovascular and inflammatory responses is poorly understood. In the previous 
chapter based on cross-sectional data, I reported an inverse association of habitual 
PA with depressive symptoms and daily stress, and partially with evening cortisol 
levels. The exercise intervention trial is the typical experimental design that has been 
used to examine the effect of physical activity on mood and autonomic responses to 
stress. However, exercise trials are costly and require a large amount of manpower 
in administering supervised exercise sessions. In addition, the effectiveness of the 
trial depends on several factors including type of exercise, intensity and bout 
duration, and individual responses to the intervention tend to vary greatly (Rethorst 
et al., 2009).  
A novel method to experimentally investigate these associations is the Exercise 
Withdrawal Paradigm (EWP) in which fit and habitually active individuals abstain 
from structured exercise for a period of time. An early EWP randomized study of 40 
habitual male found that two weeks withdrawal from running resulted in marked 
increases in fatigue, somatic symptoms and anxiety in the withdrawn compared to 
the running maintenance group (Morris, Steinberg, Sykes, & Salmon, 1990). A small 
study of habitual exercisers (Mondin et al., 1996) showed that mood disturbances 
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following exercise deprivation developed within 24 to 48 hours of stopping physical 
activity. However, that study was confounded by the effect of acute exercise since 
participants started exercise withdrawal shortly after their morning workout. Another 
small study reported increases in fatigue and pain and decreases in pain tolerance 
after one week exercise withdrawal in regular exercisers (Glass et al., 2004).  
Interestingly, the participants that developed these symptoms were characterised 
by lower resting cortisol and slightly lower sympathetic activity suggesting a link 
between physiological functions and mood. The authors argued that a stressor like 
exercise withdrawal causes physiological changes resulting in the development of 
somatic symptoms. These early studies have shown that somatic symptoms, pain 
and fatigue reliably develop following one week or less of abstinence from habitual 
physical activity. However, these studies have limitations such as a small sample 
size or the use of a highly selected sample, the absence of objective recording of 
physical activity, limited assessment of psychological variable and the failure to 
control for acute exercise.  
More recent work has sought to use the EWP as an experimental model of 
physical inactivity to investigate the link between exercise, mood and biological 
functions. For example, Berlin and colleagues (Berlin, Kop, & Deuster, 2006) have 
shown that negative mood and fatigue after exercise withdrawal may in part be 
explained by reductions in  cardiovascular fitness pointing to a possible link between 
mood and autonomic activation. Further analysis  found that negative mood induced 
by exercise withdrawal was related to a reduction in parasympathetic activity as 
measured by the ratio of high to low frequency heart rate variability (HRV) after 
controlling for age, gender, fitness level and weight (Weinstein, Deuster, & Kop, 
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2007). However, no significant changes in HRV were observed following exercise 
withdrawal in either group.  
Two randomized studies have used objective physical activity measures to 
investigate whether mood changes and somatic symptoms that develop after two 
weeks of exercise withdrawal were associated with changes in immune markers and 
cardiovascular parameters. This idea developed from experimental work showing 
that an inflammatory stimulus resulted in transient but reliable mood disturbances in 
healthy individuals (Wright, Strike, Brydon, & Steptoe, 2005). It is therefore plausible 
to hypothesize that the marked mood changes and depressive symptoms that 
develop after exercise withdrawal may in part be mediated by changes in pro and 
anti-inflammatory activity.  
The first study (Kop, Weinstein, Deuster, Whittaker, & Tracy, 2008) did not find an 
association of negative mood with inflammatory factors including IL-6, CRP and 
fibrinogen. In addition, resting levels of these markers did not change during exercise 
withdrawal compared to an exercise maintenance control group. The other study 
(Poole, Hamer, Wawrzyniak, & Steptoe, 2011) found lower resting plasma IL-6 levels 
after exercise withdrawal compared to exercise maintenance. This attenuation in IL-6 
level was related to increases in negative mood induced by exercise withdrawal but 
no difference in the sympathetic/parasympathetic balance of the ANS was observed 
between experimental and control groups. The authors argued that the attenuation in 
muscle derived IL-6 levels may inhibit an anti-inflammatory activity and result in 
raised pro-inflammatory markers such as CRP and TNFα. However, resting levels of 
TNF-α did not change between groups which did not support this hypothesis. 
Therefore, at present there is no support for the hypotheses that pro-inflammatory 
processes following exercise abstinence are driving the mood disturbances. 
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 The association between physical activity, health and inflammatory factors 
appears to be complex. During acute exercise, IL-6 released from the skeletal 
muscle prevents a sustained pro-inflammatory response mainly by inhibiting TNF-α 
IL-1β release and promoting IL-10 and IL-1ra anti-inflammatory proliferation 
(Pedersen & Febbraio, 2008; Pedersen, 2011). Since regular exercise is associated 
with lower systemic levels of inflammatory markers, this transient increase in 
cytokines and myokines is considered to be anti-inflammatory. Therefore, it is 
conceivable to speculate that following exercise withdrawal lower levels of IL-6 may 
indicate a switch towards a pro-inflammatory state. However, a small prospective 
study of middle aged, sedentary men found that IL-6 levels decreased significantly 
after a 12 week exercise intervention but returned to pre-exercise levels after two 
weeks of detraining (Thompson et al., 2010).  
Another small study found that a week of exercise withdrawal in active, older men 
did not alter basal levels of CRP, IL-6 and TNF-α, but neither did a week of active 
exercise intervention in previously sedentary, older men (Lund, Hurst, Tyrrell, & 
Thompson, 2011). These inconsistencies are likely to be attributable to the different 
populations studied (i.e sedentary vs. active), the protocol adopted (withdrawal vs 
active exercise) and the time line duration of the intervention. In addition, the source 
of cytokine release may play an important part in accounting for the different results. 
Muscle derived IL-6 is likely to be anti-inflammatory and therefore decrease after 
exercise withdrawal whereas adipose tissue derived IL-6 is pro-inflammatory and 
may therefore increase following exercise withdrawal (Petersen & Pedersen, 2005). 
Unfortunately, it is difficult to investigate the source of cytokine release in humans 
without quite invasive techniques such as muscle biopsy. Nonetheless, the studies 
reviewed above have shown that the EWP is a robust model to experimentally 
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induce mood disturbances and investigate the links between PA, mood and 
physiological processes.  
Another reason for the lack of significant differences in inflammatory markers or 
associations with mood using the EWP may be that in relatively young and healthy 
participants, and under un-stimulated conditions, these associations are difficult to 
detect. If the immune system is stimulated through acute mental stress for instance, 
an effect of physical activity withdrawal on autonomic or inflammatory responses 
may be detected. Indeed, evidence shows that acute mental stress activates a 
transcription factor (Bierhaus et al., 2003) resulting in pro-inflammatory and 
autonomic responses (Steptoe, Hamer, & Chida, 2007) that are reproducible over 
time (Hamer, Gibson, Vuononvirta, Williams, & Steptoe, 2006; von Kannel, Kudielka, 
Preckel, Hanebuth, & Fischer, 2006). Therefore, using an EWP it may be possible to 
experimentally examine whether changes in inflammatory markers or autonomic 
responses are present in response to acute mental stress and whether physical 
activity buffers exaggerated autonomic and inflammatory responses. 
No study has so far investigated the effect of PA on stress-induced 
cardiovascular, inflammatory and endocrine responses using an EWP. This 
experimental design will help tease out the causal mechanisms involved in the 
previously reported cross-sectional associations of PA with autonomic responses to 
mental stress. In addition, since cross-sectional and self-report data on PA and 
mood are open to biases, this design will provide experimental evidence on the 
direction of the association between PA and mood observed in the previous chapter. 
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4.2 Hypotheses  
 
The aim of this study is to experimentally reduce daily physical activity levels in 
order to examine the effect on mood and inflammatory, cardiovascular and 
neuroendocrine responses to standardized acute laboratory stress. The hypotheses 
of the study have been reported in chapter two but are repeated here:  
 
1) Two weeks of forced PA withdrawal will result in significant negative mood 
changes and fatigue like symptoms compared to a control phase of two weeks 
PA maintenance. 
a. Mood change will be associated with changes in objectively measured physical 
activity. 
b. Negative mood following PA withdrawal will be associated with changes in basal 
peripheral concentration of the inflammatory cytokines IL-6 and CRP. 
 
2)  There will be differences in psychophysiological reactivity to, and recovery from, 
standardized mental stress within the PA withdrawal and PA maintenance phase.  
a. Cardiovascular, inflammatory and endocrine reactivity to mental stress will be 
higher and recovery slower following the two weeks of PA withdrawal compared 
to the two weeks PA maintenance. 
b. Subjective stress ratings will be higher, and stress task appraisal less 
favourable, following PA withdrawal compared to PA maintenance. 
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4.3 METHODS 
 
 
4.3.1 Study Design: The Physical Activity Withdrawal & Stress Study 
 
The Physical Activity Withdrawal and Stress Study (PAWS) is a randomized, 
cross-over, single blind, controlled intervention based on the EWP that has been 
described previously. The total duration of the intervention was four weeks. Study 
participants were required to attend the research laboratory at the beginning of the 
intervention to sign the informed consent form, undergo a fitness assessment 
(described later), complete a self-report questionnaire, receive an activity monitor, 
and finally be randomly allocated to the experimental condition (withdraw from all 
forms of PA and exercise) or control condition (maintain all forms of PA and exercise 
currently performed).  
All participants switched (cross-over) group after having completed the first two 
weeks of the condition they were originally randomized to. Study participants 
attended the research laboratory a second time two weeks after randomisation, and 
a third time approximately four weeks after randomisation. In these two research 
visits, a validated psychophysiological stress test (outlined in the procedure section) 
was administered and stress-induced psychobiological responses measured. Figure 
4.1 below gives an overview of the study design.      
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4.3.2 Study Sample and Recruitment. 
 
I recruited 51 fit, habitually active healthy men and women aged between 18 and 
35 years from the student population at University College London (UCL), the 
University of London Union and various fitness centres in the UCL Bloomsbury 
catchment area. Volunteers were approached between February 2008 and 
Fig-4.1The Physical Activity & Stress Study: Overview of Experimental Design.  
VISIT 1 
 Randomization 
PA  
Maintenance 
PA  
Maintenance 
VISIT 3 
 Stress Protocol  
PA  
Withdrawal 
VISIT 2 
 Stress Protocol 
PA  
Withdrawal  
Time 0 
+ 2 Weeks 
+ 4 Weeks 
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September 2009 through intercollegiate emails, posters in local fitness centres and 
the UCL campus and union, and the University of London Student Union.  
Inclusion criteria were: Healthy individuals aged between 18 and 35 years, not on 
any regular medication (apart from the oral contraceptive pill), a BMI of between 19 
and 25 kg/m2, willing to wear an accelerometer for four weeks and to abstain from 
any form of PA that is of moderate, vigorous and very vigorous (MVPA) intensity  for 
two weeks. Being physically active was defined as regularly engaging in vigorous 
physical activity at least three times a week for a minimum of one hour each session 
and having maintained such level of activity for at least six months.  
Potential volunteers who expressed an interest in the trial received a standard 
email including the study information sheet (as shown in Appendix 1). Those 
individuals who met inclusion criteria and agreed to the study requirements were 
followed-up with a thorough telephone screening interview to ascertain suitability. 
Figure 4.2 below shows the recruitment selection process and response rate 
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4.3.3 Materials. 
 
This section is divided into four parts: 
I. Psychological, behavioural and fitness measures.  
II. Anthropometrics measures and physical activity manipulation.  
III. Laboratory stress protocol, cardiovascular and subjective measures.  
IV. Blood and saliva protocol and outcomes.  
Fig-4.2 Consort diagram of participants’ recruitment and response rate.  * No MVPA = 
did not satisfy minimum physical activity level criteria.  
Gym adverts &  
E-mails 
(Feb 09 – Oct 10)  
n = 220 
Agreed  
Not suitable n = 169 
-On medications n = 7 
-Illness n = 5 
-No MVPA* n = 141  
-No longer interested n = 16 
n = 51  
Eligible  
 
Attrition n = 4 
-Illness n = 1 
-Sport commitments n = 1 
-Unable to stop n = 1 
-Lost ActiGraph n = 1 
 
Completed  
n = 47 
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I. Psychological, Behavioural and Fitness Measures. 
 
At study entry (visit 1) between 09.00 AM and 12.00 PM all participants were 
required to review the information sheet, sign and date the informed consent form 
and retain a copy for their record. Participants then sat quietly on an armchair and 
completed a questionnaire made up of the following validated scales: 
 
4.3.3.1 The International Physical Activity Questionnaire.  
 
The International Physical Activity Questionnaire (IPAQ) (Craig et al., 2003) is a 
validated measure of physical activity which measures three different levels of 
activity performed in the past week: walking, moderate, and vigorous intensity 
activity. Data are computed for metabolic equivalent minutes per week (MET-min) for 
each intensity level. A total physical activity (MET-min) score is also computed by 
adding up the three categories. Validation of the IPAQ and relative MET values were 
derived from work carried out by Ainsworth and colleagues (Ainsworth et al., 2000). 
Briefly, each type of activity is characterised by a correspondent MET value which is 
then multiplied by the frequency (days and minutes) with which such activity is 
performed. The MET values used in this study were published in the original IPAQ 
validation paper (Craig et al., 2003) and are as follow: Walking = 3.3 METs, 
Moderate activity = 4.0 METs, and Vigorous activity = 8.0 METs. It has been 
suggested that when the IPAQ is used in a very active population, the continuous 
score is to be preferred over the categorical score. In this study the continuous score 
system was therefore employed. 
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4.3.3.2 The General Health Questionnaire – 28 Item (GHQ-28). 
 
The GHQ-28 (Goldberg & Hillier, 1979) is a widely used short form of the original 
60 item scale (Goldberg D.& William P., 1988). It assesses the participant’s current 
state of emotional distress as compared to his or her usual state and is therefore 
particularly sensitive to short-term changes in mood symptoms and psychological 
wellbeing. Four subscales derived by principal component analysis characterise the 
GHQ-28: somatic symptoms, anxiety/insomnia, social dysfunction, and depression.  
Validation studies have shown that the GQH-28 has good sensitivity and 
specificity when compared to a clinical interview and performs as well as the longer 
form as a screening instrument (Goldberg D.& William P., 1988). The Likert scale 
continuous score has been suggested for the four subscales (Goldberg et al., 1997). 
Additionally, the subscales may be added up to produce a total GHQ psychological 
distress score which can then be used to identify caseness by means of validated 
cut-off values. Cronbach’s-α coefficient in this sample were 0.78 at study entry, 0.9 
at PA withdrawal, and 0.85 at PA maintenance.  
 
 
4.3.3.3 The Perceived Stress Scale – 10 Item (PSS-10). 
 
The PSS-10 (Cohen, Kamarck, & Mermelstein, 1983) is a brief instrument to 
assess stress or the generalised perception of stress. It measures the degree to 
which certain events or situations in one’s life are perceived as stressful, that is, 
situations that are unpredictable and over which one has no or little control. The PSS 
builds on the person-environment model of stress appraisal in which potential 
stressful events are evaluated in relation to the individual’s ability to cope (Lazarus & 
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Folkman S, 1984). The PSS provides a continuous score of perceived stress by 
adding up responses to each item but is not validated for categorical scores.  
In this study the PSS-10 was used to monitor stress perception during the 
course of the study to ensure that any change in mood observed would not be driven 
by variation in naturally occurring stress. Data on validity are mainly from US where 
the PSS has been validated against other commonly used measures of 
psychological wellbeing, health behaviour, and life satisfaction (Cohen & Williamson, 
1988). The PSS was found to have good internal reliability and was able to 
discriminate the appraisal of stress from other measure of psychological distress 
fairly well. In this sample Cronbach’s-α was 0.82 at study entry, 0.85 at PA 
withdrawal and 0.83 at PA maintenance. 
 
 
4.3.3.4 The Profile of Mood Scales – Short Form 36 Item (POMS-SF). 
 
The POMS-SF (Shacham, 1983) is a measure of six dimensions of transient and 
distinct mood states. The subscales are: tension/anxiety, vigour/activity, 
depression/dejection, fatigue/inertia, confusion/bewilderment, and anger/hostility. A 
total negative mood score can also be computed by adding up the five negative 
mood subscales and subtracting the positive scale vigour/activity. The time reference 
used in the study is the past couple of days (prior to research sessions). The short 
form of the POMS improves from the original longer form in terms of better internal 
consistency and shorter completion time.  
The validity of the scale has been established by showing high correlations 
between the POMS short form and the original POMS. More recently, factor analytic 
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work on the POMS-SF has confirmed the six factor structure of the scale and strong 
internal consistency as well as confirming convergent and discriminatory validity 
(Baker, Denniston, Zabora, Polland, & Dudley, 2002). In this sample Cronbach’s-α 
was 0.79 at study entry, 0.84 at PA withdrawal, and 0.81 at PA maintenance. 
 
 
4.3.3.5 Cardiorespiratory Fitness Assessment. 
 
Participants completed a submaximal fitness test on a cycle ergometer bike 
(model 864, Monark, Varberg, Sweden) at study entry to estimate cardio respiratory 
fitness expressed as peak oxygen uptake (VO 2peak ml*kg
-1*min-1). Prior to starting 
the test participants were fitted with a heart monitor and then rested for 20 minutes 
before two readings of blood pressure were taken using UA-779 digital blood 
pressure monitor (A&D Instrument  LTD, Oxon, UK).  
An initial four minutes warm-up on the bike was followed by a work load increment 
of one kg (55 watts) every four minutes to reach a maximum of 220 watts workload 
at the last four minute block (twelfth to sixteenth minute). Participants were required 
to keep a constant cycling speed of 60 revolutions per minute (RPM) throughout the 
duration of the test. Subjective appraisal ratings were also taken before every 
workload increment using the Borg perceived exertion rating scale (Borg, 1998) 
which is a reasonably good estimate of heart rate reactivity during strenuous 
exercise. All participants were expected to complete the test. However, when 
perceived exertion rating reached 18 or 19 (very hard to extremely hard exertion) the 
test ended and calculation of VO 2peak was adjusted accordingly. Out of 51 subjects 
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who underwent the test 47 completed the test at the sixteenth minute whereas four 
ended the test at the twelfth minute.   
Baseline heart rate (beats-min, bpm) was calculated from the average of the last 
minute of the resting period before starting the cycling exercise. Maximum heart rate 
was defined as the average of the last sixty seconds of cycling. Maximum heart rate 
was then used was used to calculate VO 2peak value. A sex and work load adjusted 
nomogram for the calculation of maximal oxygen uptake from submaximal pulse rate 
has been used to estimate fitness (Astrand 1960). It is based on the linear 
association of heart rate with oxygen uptake (in Litres * min-1) observed on the cycle 
ergometer (Astrand & Rodahl, 1986). Briefly, the participant’s work rate expressed in 
watts is matched up with the average pulse rate during the last minute of cycling to 
give an oxygen uptake estimate (range 1.6 to 6.0 L*min-1). This value is then 
multiplied by 100 and divided by the participant’s body weight in kilograms to give an 
estimated VO2peak value (ml /min/kg).  
This measure varies greatly in the general population. Data from the Health 
Survey for England (HSE, 2008) has shown that, based on an in-house 8-min step 
test, the average cardiorespiratory fitness level of men is 36.3 ml/min/kg and 32 in 
women. A value of less than 33 ml/O2/min/kg is considered unfit according to the 
HSE. In this study a more robust test was chosen due to the nature of the sample 
that consisted of young and highly active participants free from known chronic 
conditions. 
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II. Anthropometrics Measures and Physical Activity Manipulation. 
 
4.3.3.6 Anthropometric Measures. 
 
At each visit (study entry, 2 week, and 4 week) participants’ height was measured 
by a research nurse or the principal investigator using a Stadiometer according to 
the standard protocol. Height was recorded to the nearest 0.1 centimetres. Body 
weight, fat mass, total body water and basic metabolic rate were assessed using a 
Tanita body composition analyser digital scale. Body mass index (BMI) was 
calculated as the ratio of weight in kilogram and the square of the height in meters 
(Kg/m2). 
 
 
4.3.3.7 Experimental Manipulation of Physical Activity (ActiGraph). 
 
An ActiGraph® GT1M Monitor accelerometer device (Manufacturing Technology 
Inc. 2004) was employed in order to assess the level of compliance with the study 
protocol (i.e. PA withdrawal and maintenance). Participants wore the ActiGraph 
monitor around their waist during the PA maintenance and PA withdrawal phases of 
the study. The ActiGraph is a validated instrument widely used in physical activity 
research that records movement of the body using triaxial, solid state 
accelerometers to measure human motion against the force of gravity. It records the 
intensity and duration of physical activity in counts per minutes, as well as sedentary 
time.  
The instrument has been validated to measure individual activity level, steps 
taken, energy expenditure and daily activity profile (Freedson, Melanson, & Sirard, 
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1998). The software used to analyse the raw data provided by the ActiGraph 
(MAHUffe) was developed by the MRC Epidemiology Unit at the University of 
Cambridge. The MAHUffe software processes data collected with ActiGraph 
instruments by processing raw data in predetermined intensity boundaries values to 
produce the following outcome variables: sedentary, light, moderate, vigorous and 
very vigorous activity. Average daily counts per minutes (CPM) and active wear time 
(RegTime) as well as a detailed hourly activity breakdown are also processed by the 
software.  
The intensity of the cut-off values  were chosen according to the population of 
interest and the activity of interest, but there is controversy about the optimal 
boundaries (Ward, Evenson, Vaughn, Rodgers, & Troiano, 2005). Generally, raw 
accelerometer counts may be translated into units such as MET minutes by 
employing suitable standardised equations. In this study the intensity boundaries for 
physical activity applied to the raw data were: (0-189 CPM) for sedentary behaviour; 
(190-572 CPM) for light activity; (573-2098 CPM) for moderate intensity activity; 
(2099-5898 CPM) for vigorous intensity activity and (5899 CPM) and above for very 
vigorous activity (Matthews, 2005). Participants were required to remove the monitor 
before showering or swimming and at bedtime. A minimum wear time of 10 hours/d 
was considered as valid. Any continuous 10 min periods of zero counts were 
considered as non-wear time. 
The six outcome variables obtained provide a summary score expressed in 
average minutes per day and CPM/d per day of PA during the maintenance and 
withdrawal phases of the study. The number of days and the amount of time 
participants wore the ActiGraph was also analysed in the two exercise conditions 
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since some evidence suggest that there might be a behavioural effect of being 
monitored which may impact compliance (Costa, Cropley, Griffith, & Steptoe, 1999). 
 
 
III. Laboratory Stress Protocol, Cardiovascular and Subjective Measures. 
 
4.3.3.8 Mental Stress Tasks. 
 
Two, 5-minute, standardised stress tasks which have been used previously by our 
group (Hamer & Steptoe, 2007; Brydon et al., 2008) and others were administered 
under time pressure in a random order in the two laboratory mental stress testing 
sessions. The tasks were a mirror tracing (MT) exercise and a simulated public 
speaking scenario (PS). In the MT task, participants were instructed to trace around 
the marked contour of a star with an electronic pen whilst looking at the star’s own 
reflection in a mirror. The apparatus beeps and records an error every time the 
participant comes off the marked contour. Performance is judged by the number of 
times the drawing of the star is completed, as well as the number of mistakes made 
during the drawing. Participants were told that an average person usually completes 
the drawing of the star five times in five minutes with a minimum number of mistakes. 
Standard written instructions were given to participants before commencing the task, 
and up to one minute were normally allowed for practicing.  
In the PS task participants were presented with a scenario in which they were 
either accused of stealing a purse in a large department store or threatened with 
redundancy at a company where they have been working for several years. 
Participants are allowed two minutes to prepare a speech and then three minutes to 
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talk without interruption in front of a video camera. General instructions for the 
stealing scenario required participants to pretend to be defending themselves in front 
of the store manager and the police. Instructions for the redundancy scenario instead 
required participants to argue their value and loyalty to the company’s boss or face 
being made redundant. Participants were told that their performance on the speech 
task would be recorded and rated by three experts. The experimenter would be 
standing beside the camera during the speech and prompted the participant to 
continue in case they stopped talking before the end of the 5 minute period.  
 
 
4.3.3.9 Cardiovascular Stress Responses. 
 
During the stress sessions, heart rate (HR) and heart rate variability (HRV) were 
measured continuously using an ActiHeart monitoring device (Cambridge 
Neurotechnology, UK) attached to the participants’ chest with ECG electrodes. The 
ActiHeart is a heart rate and movement monitor that is used in technical 
environments, and in resting or running conditions. Data on validity and reliability of 
the ActiHeart have been previously established and are published in (Brage, Brage, 
Franks, Ekelund, & Wareham, 2005). Autonomic nervous system activity can be 
investigated through changes in HRV which is regarded as an index of the relative 
influence of sympathetic and parasympathetic activity. The variable derived for HRV 
is the root mean square of the successive differences in interbeat intervals 
expressed in millisecond in the time domain index (rMSSD) (Task Force, 1996). The 
software used to analyse the raw data measured by the ActiHeart was the HRV 
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Analysis Software (Biomedical Signal Analysis Group, Dept. Of Applied Physics, 
University of Kuopio, Finland).  
Before using the analysis software the ActiHeart data were cleaned by 
inspecting the distribution of IBI values and outliers were replaced by mean values. 
The time points analysed during the stress session were: Baseline (the average 
recording of the last five of thirty minutes resting time) stress task 1 (5 minutes 
mean), stress task 2 (5 minutes mean), post stress recovery 1 (mean of 15-20 
minutes post-stress) and recovery 2 (mean of 40-45 minutes post-stress). 
Blood pressure was monitored continuously during the two psychophysiology 
stress sessions. The device used was a Finometer Pro (Finapres Medical System, 
Amsterdam, The Netherlands) which records beat by beat pressure using a small 
finger cuff attached to the middle finger of the non-dominant arm. Although the 
Finometer does not collect direct measures of BP, the device provides measures of 
arterial pressure based on the volume clamp method and uses Modelflow modelling 
to derive hemodynamic parameters from pressure data, which have been previously 
validated using a range of stressors (Wesseling, 1996; Wesseling, Gizdulich, & Bos, 
1996). The Finometer main unit is used to initiate calibration and to record 
participants’ characteristics (age, sex, height and weight). A height sensor 
appropriately calibrated at each session accounts for hand movement and for 
differences in pressure between the finger and the arm.  
The apparatus utilises the Beatscope® software to derive the appropriate 
variables. Systolic (SBP), diastolic (DBP) and mean arterial blood pressure (MAP) 
and cardiac output (CO) were obtained from the Finometer. Total peripheral 
resistance (TPR) was derived with the formula (TPR = MAP/CO*80). Each time point 
was marked with an event button. For each laboratory session the time point 
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analysed were: Baseline (the average recording of the last five of thirty minutes 
resting time) stress task 1 (5 minutes mean), stress task 2 (5 minutes mean), post 
stress recovery 1 (mean of 15-20 minutes post-stress) and recovery 2 (mean of 40-
45 minutes post-stress).  
 
 
4.3.3.10 Subjective Stress Responses, Task Appraisal and Engagement. 
 
 Subjective ratings of stress and anxiety were taken at five time points during the 
stress testing sessions: baseline, task 1, task 2, recovery 1 (20 minutes post-stress) 
and recovery 2 (45 minutes post-stress). In addition, task appraisal ratings were 
taken at the end of each task. Task appraisal included the perceived level of 
difficulty, involvement and controllability. All subjective ratings were measured on a 
seven point Likert scale anchored at 0 (not at all) and 7 (very). 
 
 
IV. Blood and Saliva Protocol and Outcomes. 
 
4.3.3.11 Blood Sampling Protocol. 
 
In each laboratory stress session blood was collected at the end of the baseline 
resting period and again at the end of the session (45 minutes post-stress). This 
sampling strategy was employed because previous work from our laboratory has 
suggested that inflammatory cytokines peak at 45 – 75 minutes following acute 
stress (Steptoe, Owen, Kunz-Ebrecht, & Mohamed-Ali, 2002). This time lag is 
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consistent with a hypothesis linking acute stress with de novo synthesis of cytokines. 
Blood was drawn from the antecubital vein of the forearm into EDTA coated 
vacutainers for plasma, and serum separator tubes containing a clotting gel for 
serum separation. The EDTA sample was immediately centrifuged at 1250rpm for 
ten minutes and the plasma obtained was transferred into appropriated microtubes in 
0.5ml aliquottes and frozen at -80 C. The serum tube was left to clot for thirty 
minutes at room temperature before being spun. The supernatant was then removed 
and snap frozen in 0.5ml microtubes. All blood samples were taken by the PhD 
student after training at the University College Hospital phlebotomy ward. 
 
 
4.3.3.12 Saliva Sampling Protocol. 
 
Several saliva samples were obtained for the assessment of free cortisol as an 
index of the HPA-axis response to stress, and of 3-methoxy-4-hydroxyphenylglycol 
(MHPG) which is a metabolite of central catecholamine (noradrenaline) activity and 
therefore an index of sympathetic activation. Samples were collected during the two 
laboratory stress sessions at baseline, after the stress tasks, and at 20 and 45 
minutes after stress.  Samples were snap frozen at - 80°C and assayed in duplicate 
at the Kurume University in Japan using gas chromatography mass spectrometry 
(MHPG).  
This method which is described in (Yajima, Tsuda, Yamada, & Tanaka, 2001) was 
found to have an intra-assay coefficient of variation of less than 4 per cent and to 
correlate highly with plasma levels of noradrenalin. This metabolite is therefore 
considered to be a valid marker of noradrenergic activity. Previous studies have also 
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shown robust increases in salivary MHPG in response to acute mental stressors 
(Hamer, Tanaka, Okamura, Tsuda, & Steptoe, 2007). 
Salivary free cortisol was determined using a cortisol enzyme immunoassay kit by 
Salimetrics that has range of detection of 0.083 nmol/l to 83.01 nmol/l, and intra-and 
inter-assay CV of 3.6 and 5.4% respectively. Correlation of serum cortisol with 
salivary cortisol is r = 0.91 as reported by the manufacturer.  
 
 
4.3.3.13 Inflammatory Markers. 
 
The inflammatory cytokines Interlukin-6 (IL-6) and C - reactive protein (CRP) 
which are relevant in cardiovascular and metabolic disorders were examined. 
Peripheral concentrations of these markers were determined at baseline and in 
response to stress (IL-6 only). CRP was measured only at baseline since this marker 
indexes low-grade, systemic inflammation and may therefore be more sensitive to 
short term changes in physical activity. On the other hand IL-6 is released following 
acute stress as well as during PA, and therefore IL-6 is the primary stress-induced 
inflammatory marker in this study. Blood samples were analysed in duplicate using 
high-sensitivity Enzyme-Linked Immunosorbent Assay (ELISA) kits for quantitative 
determination of analytes in serum and plasma (R&D Systems, Oxford, UK). The 
limit of detection of the IL-6 assay is 0.016 pg/ml and the mean minimum detectable 
dose is 0.039 pg/ml. For CRP the limit of detection is 0.005 ng/ml and the mean 
minimum detectable dose is 0.010 ng/ml.  
Participants with any sample that had a coefficient of variations (CV) of >10% 
were re-assayed in triplicate and the mean of the two readings with the lowest CV 
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was retained. By the end of the study each participant had 4 blood samples in total 
for IL-6 and 2 for CRP. The microplate reader used to determine the optical density 
of the ELISA plate was the Molecular Devices (UK) with software SoftMax® Pro 5 
capable of reducing the data to a linear log/log parameter and therefore produce a 
standard curve and readings according to the ELISA kit protocol requirements. All 
samples were processed and assayed by the PhD student.  
 
 
4.3.4 Procedure.  
 
At study entry the researcher reviewed the study information sheet and the study 
protocol and answered participant’s questions. The informed consent form was then 
signed and dated. All participants were seen between 09.00 AM and 12.00 PM. 
Figure 4.3 provides an overview of the study procedure adopted at each of the three 
research visits. 
 
 
 
 
 
 
 
 
 
 
Study Entry  
 
 Informed Consent 
 Anthropometrics  
(Height, BMI, Fat mass) 
 Questionnaires  
(IPAQ, GHQ-28, POMS-SF, PSS-
10) 
 CV Fitness  (Cycle Ergometer) 
 ActiGraph (2 week recording) 
 Randomization  
 
 
+ 2 Weeks 
 
 Questionnaires  
(GHQ-28, POMS-SF, PSS-10) 
 Anthropometrics 
(BMI, Fat mass)  
 Resting BP 
 Stress Protocol  
(Mirror tracing – Speech task) 
 ActiGraph (2 week recording) 
 Cross-over PA Condition 
 
+ 4 Weeks 
 
 Questionnaires  
(GHQ-28, POMS-SF, PSS-10) 
 Anthropometrics 
(BMI, Fat mass)  
 Resting BP 
 Stress Protocol  
(Mirror tracing – Speech task)  
 End of Study & Feedback 
 
Fig-4.3 Summary of Study Procedure During each Research Visit.  
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The anthropometric measures were taken using standard protocols in the 
Psychobiology Group. The ActiHeart monitor was attached to the participant’s chest, 
tested and initialised according to manufacturer’s guidelines. Participants were then 
taken to the laboratory and rested for half a hour while completing the 
questionnaires. Resting blood pressure was measured twice using a manual 
electronic sphygmomanometer. Standard instructions were read out by the 
researcher and a few minutes were allowed for the participant to familiarize 
themselves with the cycle ergometer and testing protocol before formally starting the 
test. After the fitness test was completed, the researcher explained the main features 
of the activity monitor ActiGraph and emphasised the importance of wearing the 
device every day.  
A third person blind to the study’s hypotheses provided participants with a sealed 
envelope containing the random allocation to condition letter (see Appendix 2). The 
letter explained the study condition the participant was being allocated to (PA 
withdrawal or PA maintenance) with detailed instructions of the requirements of each 
condition. In order to maximise adherence, each participant received an email, on 
average a week into the study, containing a reminder of the study requirements. 
Participants also received standard instructions prior to coming to each of the two 
stress testing sessions reminding them not to exercise, drink caffeine and alcohol or 
take anti-inflammatory medications for a minimum of 24 hours before the scheduled 
visits. 
At the two week follow-up research visit, the anthropometric measures were 
obtained according to standard protocol and participants returned the ActiGraph 
monitor containing the activity data of the previous two weeks. Psychophysiological 
testing was undertaken with the participant sitting comfortably on an armchair and 
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attached to the cardiovascular monitor devices. During the thirty minutes baseline 
resting time participants completed a short mood and stress questionnaire. At the 
end of the baseline rest period, blood and saliva samples, and subjective stress 
ratings were obtained according to protocol. The two five- minute stress tasks were 
administered in a random order with subjective stress and task appraisal rating 
obtained after each task. A saliva sample was also collected at the end of the tasks 
and participants were subsequently required to enter a 45 minutes recovery period.  
The second blood sample was obtained at the forty-fifth minute which is when 
the stress protocol ended. A new initialised ActiGraph and letter of condition 
allocation containing instructions were then given to the participant by a research 
nurse blinded to the study design. The participant was required to do the opposite 
condition to which he or she had been originally randomized and return to the 
research laboratory for a final visit in two weeks time. 
At the four week follow-up research visit the same stress testing protocol as in 
week two research visit was implemented. At the end of the session participants 
were given feedback on their fitness levels, resting blood pressure, BMI and the 
objective of the study. All participants were debriefed and given the opportunity to 
ask questions before being compensated with £60. Figure 4.4 below summarizes the 
stress protocol adopted and all the stress-induced outcome measures obtained. 
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4.3.5 Statistical Approach.   
 
The distribution of inflammatory markers, cortisol and MHPG data was inspected 
by examining the distribution and kurtosis/skewness values and where appropriate a 
log, or square root, transformation was applied to normalize the distribution. The 
data analyses strategy is as follow: Differences in objective physical activity data 
between PA conditions were used to check the experimental manipulation. This was 
achieved by computing a change score so that greater values indicate greater 
reduction in daily PA. Paired t-tests were used to test for the effect of PA withdrawal 
Fig-4.4 Summary of Stress Measure Recorded During the  Psychophysiological Stress 
Protocol.  
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on mood outcomes, and to explore any interaction term, while Pearsons correlation 
was used to explore the association of negative mood with objective PA data. 
Product-moment Pearson correlations were also used to investigate associations 
among baseline predictors.  
The main analyses involving cardiovascular, cortisol and IL-6 responses to 
stress were carried out using mix analysis of variance (ANOVA) models with gender 
as the between-subject factors and time (baseline, stress and recovery) and PA 
condition (withdrawal and maintenance) as the within-subjects factor. The 
Greenhouse-Geisser correction for degree of freedom was applied when the 
assumption of sphericity was violated. Changes in the main outcome variables 
between the conditions were calculated by subtracting the PA withdrawal values 
from the PA maintenance values (absolute change) and by calculating a proportional 
change (relative change) making adjustment where appropriate.  
Stress-induced reactivity scores were also computed as the mean difference 
between baseline and stress values while recovery scores were computed as the 
mean difference between baseline and recovery values. Secondary analyses were 
carried out using objective recording of physical activity data as an indicator of 
adherence to the study protocol in the first instance, and by using mood change 
following PA withdrawal as an index of the success of the intervention as a further 
manipulation check. Data are presented as mean (M) ± standard error of the mean 
(SEM) or standard deviation (SD) as appropriate. 
Since the design of this study is randomized cross-over, half of the participants 
were assigned to each physical activity condition first. Therefore, there is a 
possibility, though unlikely, of an order effect (reactivity might be higher in the first 
stress session). In order to check for a possible order effect, a between-subject 
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factor was added to the analysis. This factor called “order” has two levels: PA 
withdrawal first then PA maintenance; PA maintenance first then PA withdrawal.   
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4.4 RESULTS 
 
 
4.4.1 Sample Descriptive.  
 
 
 
 
 
 
 
The descriptive characteristics of the sample at study entry are summarised in 
table 4.1 above. Participants were 47 males and females who completed the study. 
As expected, males weighted more than females and had slightly higher resting 
systolic blood pressure. Female participants tended to have slightly higher resting 
BMI =Body Mass Index, Sbp =Systolic Blood Pressure, Dbp =Diastolic Blood Pressure, Hr =Resting 
Heart Rate, Hr (react) = Maximum Heart Rate During Cycling Ergometer Test, MET =Metabolic 
Equivalent of Task in Minutes per Week. 
Table-4.1 Descriptive Characteristic of Study Sample. 
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diastolic blood pressure but the difference only approached significance. The mean 
VO 2 peak values were above the general population mean (HSE, 2008) suggesting 
that the strict selection criteria had ensured the inclusion of mainly fit and active 
volunteers. As expected, VO 2peak correlated negatively with BMI (r = - 0.28, p = 
0.06), baseline heart rate (r = - 0.36, p = 0.01), perceived exertion (r = - 0.35, p = 
0.02), and resting SBP though this did not reach significance (r = - 0.23, p = 0.11).  
Self-reported levels of physical activity in the week prior to study entry suggest 
that this sample exceeded the Governmental recommendation for the minimum 
amount of physical activity for health. Recommended amount of PA is that adults 
should be active at a moderate or vigorous intensity for at least 30 minutes five days 
a week (Chief Medical Officer, 2004) and therefore achieve between 450 – 750 
MET/m/w. This is roughly equivalent to at least a two and a half hour of brisk waking 
per week. This sample achieved about 2900 MET/m/w in the week prior to study 
entry largely exceeding recommendations. This indicates that participant’s CV fitness 
level and weekly amount of time spent doing PA of moderate and greater intensity is 
well above the population average values.  
 
 
4.4.2 Experimental Manipulation.  
 
Adherence to the experimental protocol is an important and crucial part of this 
study. Therefore, an accelerometer was used to monitor the degree of participants’ 
compliance to the PA conditions. There was great variation in protocol adherence 
but overall results suggest marked differences in PA during the four week study 
protocol. One participant had missing data in the PA maintenance phase whilst one 
had missing data in the PA withdrawal phase. Firstly, I tested for a possible order 
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effect in recorded daily counts per minutes (CPM/d) in order to examine whether 
participants levels of PA was influenced by the order of condition allocation. As 
expected, there was no difference in mean CPM/d in the PA maintenance phase (F 1, 
45 = 0.02, p = 0.88) between order groups. Likewise, no differences were observed in 
CPM/d during PA withdrawal between order groups (F 1, 45 = 2.55, p = 0.12). 
Therefore, the order with which participants were allocated to the two PA conditions 
did not influence the level of recorded PA. 
 I then examined compliance with accelerometer wearing behaviour to check 
whether there were differences in the amount of time participants wore the ActiGraph 
during the study. In the PA withdrawal phase the mean ActiGraph wear time was 
11.11 ± [SD] 3.17 days (range 2 – 15 days) with an average valid recording time of 
774.67 ± [SD] 89.45 minutes/day. In the PA maintenance phase the mean ActiGraph 
wear time was 11.28 ± 2.95 days (range 4 – 16 days) with an average valid 
recording time of 797.30 ± 93.04 minutes/day. There was no statistically significant 
difference in the number of days (p = 0.79) the ActiGraph had been worn but there 
was a near significant difference in the amount of average daily wearing time 
indicating that participants wore the ActiGraph for 22 m/d (SEM = 11.97) longer 
during the PA maintenance condition compared to the PA withdrawal (t 44 = 1.85; p = 
0.07). 
Next, I examined average recorded CPM/d as the primary indicator of protocol 
adherence and the data are illustrated in table 4.2. In the whole sample (n = 45) 
there was a significant difference (128.13 CPM/d [SEM] = 27.97; t 44 = 4.58; p = 
<0.001) indicating that participants were more active during PA maintenance than 
PA withdrawal. 
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When re-running the analyses excluding participants with less than six days of 
valid ActiGraph data in either condition (n = 4) this difference remained nearly 
unchanged (125.39 CPM/d [SEM] = 30.17; t 40 = 4.16; p = <0.001). Overall, these 
data show that the manipulation of physical activity had been successful although 
there was clearly variation in the degree to which participants had decreased their 
daily activity (see Figure 4.5). Therefore, in light of this variation in compliance with 
study protocol, a secondary analysis will also be performed excluding participants 
whose daily CPM had not been reduced by at least 25 per cent compared to their PA 
maintenance period.  
 
 
PA condition 
 
n = 45 n = 41 
PA Maintenance 516.22 ± 201.75 518.83 ± 205.12 
PA Withdrawal 388.08 ± 162.50 385.01 ± 160.44 
Table-4.2 Summary of ActiGraph Recorded Physical Activity. Values are counts 
per minute per day Means ± SD 
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4.4.3 The Effect of PA Withdrawal on Mood Symptoms. 
 
The effect of the intervention on mood symptoms is summarized in table 4.3. 
Mood in the two weeks before study entry was also measured in order to monitor 
pre-existing symptoms. One-way ANOVAs revealed that there was no gender 
difference in either the subscales or the total score in the GHQ (all p ≥ 0.8), POMS (p 
range from 0.12 to 0.92) and PSS (p = 0.82) at study entry. 
 
 
 
 
Fig.-4.5 Distribution of the accelerometer CPM/d reduction from PA maintenance to PA 
withdrawal in the physical activity and stress responses study n = 45. Positive values 
show a reduction in physical activity in the withdrawal phase, thus indicative of 
successful protocol compliance.  
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Variable  Pre 
Intervention 
PA 
Withdrawal  
PA 
Maintenance P* 
GHQ Tot score 15.83 ± 5.77 20.51 ± 9.38 14.19 ± 6.72 <0.001 
Anxiety/insomnia 4.42 ± 2.54 5.76 ± 4.07 3.70 ± 2.87 0.002 
Depression 1.08 ± 2.10  1.00 ± 2.41 0.87 ± 2.25 0.77 
Somatic symptoms 3.40 ± 2.18 5.85 ± 3.89 3.29 ± 2.23 <0.001 
Social dysfunction  6.91 ± 1.99 7.89 ± 2.11 6.32 ± 1.72 <0.001 
POMS Tot score 5.70 ± 2.34 7.96 ± 3.08 5.23 ± 2.56 <0.001 
Tension/anxiety 6.51 ± 3.55 7.64 ± 4.33 5.55 ± 3.43 0.03 
Vigour/activity 13.91 ± 3.58 8.02 ± 3.88  13.94 ± 4.08 <0.001 
Depression/dejection 2.78 ± 3.68 3.68 ± 3.62 2.47 ± 3.07 0.03 
Fatigue/inertia  5.43 ± 3.02 8.25 ± 5.14 5.02 ± 4.31 <0.001 
Confusion/bewild. 5.94 ± 3.31 7.36 ± 4.15 4.95 ± 3.21  <0.001 
Anger/hostility  3.47 ± 3.87 4.85 ± 4.36  3.29 ± 3.74 0.004 
PSS Tot score 12.76 ± 5.16 14.63 ± 6.08  12.25 ± 5.28 0.01 
 
*P values for difference between PA withdrawal and maintenance.  
 
 
Likewise, there was no gender effect in the PA maintenance phase for the GHQ 
(p range from 0.21 to 0.94) and PSS (p = 0.76) but female participants scored higher 
in the anger/hostility subscale of the POMS only (4.76 ± 4.60 vs. 2.11 ± 2.35, p = 
0.01; all other p range from 0.21 to 0.60). 
In the PA withdrawal phase the GHQ did not differ by gender (p range from 0.21 
to 0.70) and neither did the PSS (p = 0.33) or the POMS (p range from 0.28 to 0.85). 
Table-4.3: The Effect of PA Withdrawal on Mood Symptoms n = 47. 
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Following the two weeks withdrawal from habitual PA participants experienced 
robust changes in mood and mood symptoms across all domains measured apart 
from the depression subscale of the GHQ. Results are as follows:  
 
In the GHQ, the total psychological distress mean ± SEM within-subjects 
comparison score (PA withdrawal – PA maintenance) was 6.32 ± 1.46 (t 46 = 4.31, p 
= <0.001).  In the tension/anxiety subscale: 2.06 ± 0.61 (t 46 = 3.37, p = 0.002); in the 
social dysfunction subscale: 1.57 ± 0.30 (t 46 = 5.18, p = <0.001); in the depression 
subscale: 0.13 ± 0.43 (t 46 = 0.29, p = 0.77); in the somatic symptoms 2.55 ± 0.60 (t 
46 = 4.25, p = <0.001).  
In the POMS, the total negative mood mean ± SEM within-subjects comparison 
score (PA withdrawal – PA maintenance) was 2.73 ± 0.52 (t 46 = 5.23, p = <0.001). In 
the tension/anxiety subscale: 2.08 ± 0.67 (t 46 = 3.11, p = 0.003); in the 
vigour/activity: - 5.91 ± 0.79 (t 46 = - 7.40, p = <0.001); in the depression/dejection 
subscale: 1.21 ± 0.54 (t 46 = 2.21, p = 0.03); in the fatigue/inertia subscale: 3.23 ± 
0.85 (t 46 = 3.82, p = <0.001); in the confusion/bewilderment subscale: 2.40 ± 0.60 (t 
46 = 3.99, p = <0.001); in the anger/hostility subscale: 1.55 ± 0.51 (t 46 = 3.03, p = 
0.004). 
In the PSS, the total perceived stress mean ± SEM within-subjects comparison 
score (PA withdrawal – PA maintenance) was 2.38 ± 0.93 (t 46 = 2.56, p = 0.01). 
 
There was no evidence of a group condition order effect in either the GHQ effect 
(F 1, 46 = 0.57, p = 0.45), the POMS effect (F 1, 46 = 0.96, p = 0.33), or the PSS (F1, 
46 = 0.19, p = 0.66). This suggests that the PA condition with which participants 
started the study had no impact on the effect of PA withdrawal on mood symptoms. 
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The mood effect analyses were re-run excluding the 4 participants who did not 
have at least six days of valid ActiGraph data (n = 4) plus the 2 participants who had 
missing data on either PA condition due to equipment malfunction. However, the 
results remained virtually unchanged suggesting that participants for whom objective 
ActiGraph data were not available (equipment failure n = 2) or not of a sufficient 
length of time (less than seven days, n = 4) were unlikely to bias the study. 
 
 
4.4.4 Mood Change and PA Withdrawal: Dose-Response. 
 
In order to investigate whether these mood disturbances were related to 
objective or self-report PA data in a dose response manner, Pearson zero-order 
correlation analysis was applied. The negative mood change score was computed as 
the mean difference between GHQ total score during PA withdrawal minus PA 
maintenance (∆GHQ) so that a greater value indicated greater mood disturbance. 
The same method was used for the POMS total mood score (∆POMS). Changes in 
objectively recorded PA were computed as the mean difference in CPM/d between 
the two PA conditions (∆CPM/d) so that higher values indicate greater reduction in 
daily recorded PA. 
Results indicated that the ∆GHQ did not correlate with self-reported MET-m/w 
at study entry (r = - .03, p = 0.83). Likewise, the ∆POMS did not correlate with MET-
m/w at study entry (r = -.15, p = .32) suggesting that the degree of negative mood 
symptoms caused by PA withdrawal cannot be explained by background level of 
physical activity reported before the study had commenced.  
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There was a positive correlation between ∆POMS and ∆CPM/d (r = .36, p = 
.02) indicating greater PA withdrawal induced negative mood in participants with 
greater reduction in daily CPM. No correlation was observed between ∆GHQ and 
∆CPM/d (r = 0.16, p = 0.29). However, the positive association between the POMS 
and CPM/d became stronger (r = 0.42, p = 0.007) when the analysis was re-run with 
the exclusion of those participants without valid ActiGraph data due to either 
equipment failure (n = 2) or poor compliance (n = 4). The correlation is illustrated in 
figure 4.6 where it can be seen that higher mood disturbance is linearly associated 
with greater reduction in daily CPM. This suggests that changes in mood can in large 
part be accounted for by changes in objectively recorded PA, especially when 
participants with poor compliance with ActiGraph wearing behaviour are excluded. 
 
4.4.5 The Effect of PA Withdrawal on Stress-Induced Cardiovascular 
Reactivity. 
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Fig-4.6 Scatterplot of the Association Between Negative Mood and Reduction in Objectively 
Recorded Physical Activity (n=41). Positive Values Represent Greater Reduction in 
Physical Activity (CPM/d) & Greater Negative Mood (POMS)  
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Participants’ anthropometric measures were recorded at study entry, two and 
four week follow-up and in order to monitor changes in BMI as well as resting level of 
heart rate and blood pressure. As revealed by within-subject ANOVAs, BMI did not 
significantly change in the 4 weeks study period (F 2, 44 = 1.48, p = 0.24) and neither 
did resting systolic blood pressure (SBP) (F 2, 43 = 1.11, p = 0.34). However, there 
was a marginally significant increase in resting heart rate (HR) in the PA withdrawal 
condition compared to the PA maintenance (66.75 ± [SEM] 1.47 bpm vs. 64.32 ± 
1.61 bpm, p = 0.057) even though the main effect of resting heart rate across the 
three repeated measures was not significant (F 2, 44 = 1.98, p = 0.15). 
The two mental stress tasks elicited significant increases in the cardiovascular 
(CV) parameters examined in both laboratory sessions. As an example, SBP 
increased during the task and returned towards baseline levels at 45 minutes post-
stress (quadratic time effect: PA maintenance F 1, 42 = 122.64, p = <0.001; PA 
withdrawal F 1, 42 = 124.87, p = <0.001). As expected, SBP responses to the mirror 
task (MT) and the public speech task (PS) were highly correlated in both conditions 
(PA maintenance r = 0.87, p = <0.001; PA withdrawal r = 0.72, p = <0.001) indicating 
that the tasks elicited comparable blood pressure responses. I therefore averaged 
the CV responses to the MT and the PS in further analyses to create a single mean 
task response value.  
The effect of PA withdrawal on stress-induced CV responses was analysed 
using mixed model ANCOVAs. In this model, the within-subject factors were PA 
conditions (withdrawal and maintenance) and time (baseline, mean stress, recovery 
1 and recovery 2), and the between-subject factor was gender. Group order effect 
was entered as a covariate in order to check whether the PA condition to which 
participants were first randomized to had an effect on the CV responses. Two 
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participants had missing data due to equipment failure whereas two participants had 
data missing on at least one time point. Therefore, the sample size for blood 
pressure reactivity was 43. Figure 4.7 summarises SBP and DBP responses in the 
two stress testing sessions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The assumption of sphericity was not met for SBP and Greenhouse-Geisser 
adjusted degrees of freedom are therefore presented. The main effect of time was 
significant (F 2.02, 78.71 = 51.37, p = <0.001) indicating a change in SBP over time but 
there was no PA condition by time interaction (F 2.36, 92.36, = 1.91, p = 0.15). The 
gender effect was not significant (F 1, 39 = 2.05, p = 0.16) and there was no evidence 
Time points 
Fig-4.7 SBP and DBP responses to mental stress in the 2 PA conditions n = 43.  
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of an order effect (F 1, 39 = 0.07, p = 0.78). These results suggest that gender and 
condition allocation order effect did not influence the SBP responses but there were 
no differences in responses between the PA withdrawal and maintenance phases. 
A similar pattern appeared for DBP. The main effect of time was significant (F 
2.04, 77.65 = 59.87, p = <0.001) indicating that SBP increased during stress returning 
closer to baseline values at 20 and 45 minutes post-stress in both stress sessions. 
However, as shown above for SBP, the PA condition by time interaction was not 
significant (F 2.53, 97.38 = 0.75, p = 0.50) suggesting that PA withdrawal did not affect 
blood pressure responses to stress. Similarly, there was no main effect of gender (F 
1. 38 = 2.33, p = 0.13) nor order effect (F 1, 38 = 0.001, p = 0.97). 
Total peripheral resistance (TPR), or systemic vascular resistance, was 
calculated with the formula (mean arterial pressure/cardiac output)*(79.9) and is 
expressed in dyn.s/cm5. TPR responses during the MT and PS were highly 
correlated in both conditions (r = 0.85, p = <0.001) therefore a mean TPR task 
response value was calculated.  
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The TPR response to stress is shown in figure 4.7. The mixed ANOVA showed a 
main effect of time (F 2.25, 87.97 = 12.38, p = <0.001) indicating that TPR changed 
throughout both mental stress sessions but there was no main effect of PA condition 
(F 1, 39 = 0.40, p = 0.53). The main effect of gender was also significant (F 1, 39 = 
10.84, p = 0.002) suggesting sex differences in TPR during the lab stress session 
but neither the time by gender (p = 0.25) nor the PA condition by time by gender (p = 
0.80) interactions were significant. There was no significant PA condition by time 
interaction (F 3, 117 = 1.85, p = 0.14) suggesting that stress-induced TPR responses 
were not affected by the PA withdrawal intervention.  
 
HR and heart rate variability (HRV) were assessed using an Acitiheart as 
described in the Method section. HR responses to the MT and PS were highly 
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Fig-4.8 TPR mental stress reactivity and recovery in the two PA 
conditions. 
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correlated in the two repeated stress sessions (r = 0.74, p = <0.001). Consequently, 
a mean task response value was computed by averaging the HR responses. As for 
the blood pressure analyses two participants were excluded due to the use of 
medications before the lab stress session and one participant had data missing due 
to equipment malfunction. Greenhouse-Geisser degree of freedoms correction is 
applied for the main effect of time only. The HR response to stress in the two stress 
testing sessions is depicted in figure 4.9. 
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Fig-4.9 Heart rate responses to mental stress in the 2 PA conditions testing n = 44 .  
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The main effects of time (F 2.07, 89.32 = 51.47, p = <0.001) was significant but the 
main effect of PA condition was not (F 1, 43 = 0.29, p = 0.59). There was a significant 
PA condition by time interaction (F 3, 129 = 3.42, p = 0.01). The gender effect was not 
significant (F 1, 43 = 0.74, p = 0.39) and there was no evidence of a condition 
allocation order effect (F 1, 43 = 1.8, p = 0.18). The interaction term was examined by 
computing a stress reactivity score (mean stress – baseline) and two stress recovery 
scores (recovery values – baseline). These values were then compared across PA 
conditions using within-subject t-tests. The HR reactivity did not differ across PA 
conditions (t 45 = - 0.24, p = 0.80). When comparing recovery scores there were no 
differences in the 15-20m values (t 45 = 1.18, p = 0.24) or in the 40 - 45m values (t 45 
= 1.3, p = 0.19). These results suggest that the lower HR values during stress 
observed in the PA maintenance phase can be largely accounted for by lower overall 
baseline values. 
 
HRV stress reactivity and recovery data are expressed in milliseconds (mss). 
The distribution of HRV data was skewed and was therefore normalized with the 
square root method. HRV responses to the speech and the mirror task were only 
moderately correlated (r = 0.42) and were therefore analysed separately. Figure 4.10 
illustrates the HRV responses in the PA withdrawal and PA maintenance stress 
testing session. 
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Mirror task: There was a main effect of time (F 1.7, 70.5 = 9.85, p = 0.001) but not 
of PA condition (F 1, 40 = 2.81, p = 0.10). The PA condition by time interaction was 
also not significant (F 2.03, 81.4 = 2.22, p = 0.11). As expected, HRV was reduced 
during mental stress but increased in the recovery phases.  
Speech task: The main effect of time was significant (F 3, 117 =19.23, p = <0.001) 
as was the main effect of PA condition (F 1, 39 = 6.59, p = 0.01). However, the PA 
condition by time interaction was not statistically significant (F 3, 117 = 0.90, p = 0.44). 
There was no main effect of gender (F 1, 37 = 0.002, p = 0.96) or condition allocation 
order effect (F 1, 37 = 1.25, p = 0.96) in the combined stress tasks. These results 
suggest that HRV responses to mental stress were not affected by PA withdrawal.  
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     Fig-4.10 Heart rate variability responses to mental stress in the 2 testing 
sessions n = 42.  
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4.4.6 The Effect of PA Withdrawal on Stress-Induced MHPG Responses. 
 
MHPG values were not normally distributed and were therefore logarithmically 
transformed but in the figure the raw data are presented. The MHPG response to 
stress pattern is illustrated in figure 4.11. 
 
 
 
 
 
 
Two participants were excluded due to medication use and two participants had 
missing data because of insufficient sample for assaying. The result of the mixed 
ANOVA revealed that neither the main effect of time (F 3, 117 = 1.28, p = 0.28) nor PA 
condition (F 1, 39 = 1.90, p = 0.18) or the PA condition by time interaction (F 3, 117 = 
0.84, p = 0.47) were statistically significant suggesting that MHPG did not increase 
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 Fig-4.11 MHPG responses to mental stress in the 2 PA conditions (n = 43).  
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significantly after stress in the two stress testing sessions. The main effect of gender 
was also not significant (F 1, 39 = 0.39, p = 0.53).  
MHPG AUC values were normalized with a square root transformation and 
compared between PA conditions using a paired t-test. PA withdrawal MHPG AUC 
was 24.182 ± [SEM] 1.40 whereas PA maintenance MHPG AUC was 22.68 ± [SEM] 
1.07 but this difference did not reach significant levels (t 42 = 1.34, p = 0.18). 
 
 
4.4.7 The Effect of PA Withdrawal on Stress-Induced Cortisol Responses. 
 
The cortisol response to stress in the two PA conditions was analysed in three 
ways. First, by using a two (exercise condition) by four (cortisol samples) mixed 
model ANOVA with gender as between-subjects factor and Greenhouse-Geisser 
degree of freedom correction where appropriate. Second, by calculating the cortisol 
area under the curve (AUC), which is an index of total cortisol release during the 
stress sessions, and comparing it using a within-subjects test. Finally, the absolute 
cortisol values immediately after stress, at 20 and 45 minutes post-stress were 
compared within the PA withdrawal and maintenance conditions using paired t-tests.  
Two participants were excluded from these analyses because they reported to 
have taken medication known to interfere with cortisol activity leaving a final sample 
of 45 participants. The stress-induced cortisol reactivity in the two stress sessions is 
depicted in figure 4.12. 
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Overall, cortisol responses to stress in the two psychophysiology stress 
sessions were of small magnitude. The main effect of time was significant (F 2.45, 
105.62 = 10.35, p = <0.001) indicating that cortisol levels changed significantly in 
response to the tasks in the two stress sessions. There was no main effect of PA 
condition (F 1, 43 = 2.21, p = 0.14) or PA condition by time interaction (F 3, 129 = 0.79, p 
= 0.49) and no gender effect (F 1, 43 = 0.008, p = 0.93).  
Total cortisol released during the stress sessions (AUC) was examined using a 
paired t-test. Results indicated a higher AUC during PA withdrawal but this difference 
only approached statistical significance (t 44 = 1.58, p = 0.12, M withdrawal 206.22 ± 
[SEM] 20.30 nmol/L/m vs. M maintenance 173.35 ± 12.86 nmol/L/m).  
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   Fig-4.12 Salivary cortisol responses to mental stress in the 2 PA 
conditions (n = 45).  
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Stress-induced cortisol activity was analysed by performing paired t-tests at the 
immediately after tasks, the 20 and 45 minutes post-stress time points. No difference 
emerged immediately post-tasks (t 44 = 1.03, p = 0.30) but cortisol level was higher at 
20 minutes post-stress (t 44 = 2.0, p = 0.05) during PA withdrawal (M withdrawal 3.14 
± [SEM] 0.33 vs. 2.42 nmol/L ± 0.22) compared to PA maintenance. This difference 
became not significant at 45 minutes into the post-stress recovery (t 44 = 1.58, p = 
0.12). These results show that a small difference in stress-induced cortisol can be 
detected 20 minutes post-tasks when cortisol released from the adrenal medulla in 
response to stress reaches a peak.  
 
 
4.4.8 The Effect of PA Withdrawal on Basal and Stress-Induced 
Inflammatory Cytokines.  
 
For the analyses of the cytokine IL-6 one participant was excluded due to anti-
inflammatory medication use prior to the lab visit, one participant refused blood 
sampling and another participant was excluded for very high levels at both visits (<10 
pg/ml), possibly indicative of an underlying illness such as an acute infection.  
Baseline IL-6 at PA withdrawal averaged 0.84 ± [SD] 0.89 pg/mL (range = 0.23 – 
5.37 pg/mL) and 0.87 ± 0.94 pg/mL post-stress (range = 0.16 – 5.60 pg/mL) but this 
increase was not significant (t 43 = 1.49, p = 0.14). In the PA maintenance stress 
session, the baseline IL-6 was 0.81 ± [SD] 0.66 pg/mL (range = 0.17 – 3.05 pg/mL) 
and 0.83 ± 0.73 pg/mL post-stress (range = 0.17 – 3.37 pg/mL) but this increase was 
again not significant (t 43 = 0.63, p = 0.53). Figure 4.13 shows the IL-6 stress 
reactivity data. 
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Baseline IL-6 levels did not change significantly between conditions (t 44 = 0.20, 
p = 0.84) suggesting that two weeks PA withdrawal did not alter basal IL-6 levels. 
Since there was great variability in plasma IL-6 in response to the stress task, a 
relative per cent change was calculated. During PA withdrawal participants had a 
5.85% increase in IL-6 relative to baseline whereas during PA maintenance the 
increase was 1.94%. However, this difference in relative IL-6 stress reactivity was 
again not statistically significant (t 43 = 0.72, p = 0.47). 
 
Basal CRP levels were also assessed at the end of each of the two weeks PA 
condition in order to determine whether PA withdrawal had an effect on this stable 
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 Fig-4.13 IL-6 responses to mental stress in the 2 PA conditions (n = 44).  
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marker of systemic inflammation. CRP data were available for 43 participants and no 
value was above the 10 mg/L threshold that might indicate an underlying infection. 
Since the data were skewed a log transformation was applied but the data in Figure 
4.14 are presented as untransformed mean ± SEM.  
 
 
 
 
 
 
Mean CRP at PA maintenance was 0.95 ± [SD] 1.57 mg/L and 1.06 ± 1.71 
mg/L at PA withdrawal. The mean baseline CRP per cent increase from PA 
maintenance to PA withdrawal was 11.5. A within-subjects t-test performed on the 
log transformed values showed that the increase in CRP following PA withdrawal 
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Fig-4.14 Basal CRP levels during the PA maintenance and withdrawal 
conditions (n = 43) 
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was not statistically significant (t 42 = 0.43, p = 0.67). Therefore, neither systemic 
levels of CRP nor IL-6 were significantly affected by the PA withdrawal intervention.  
 
4.4.9 The Effect of PA Withdrawal on Subjective Stress Measures. 
 
Data on subjective stress measures were available for all participants. In order to 
assess whether an equal level of engagement was maintained in the two stress 
testing session, participants were asked to rate the degree of involvement in each 
task using a self-report scale ranging from 1 to 7. Results showed that participants 
had the same level of engagement when performing the speech scenario during PA 
withdrawal and PA maintenance testing (4.68 ± [SD] 0.21 vs. 4.62 ± [SD] 0.22; t 46 = 
0.29, p = 0.77), and when performing the mirror tracing task (5.81 ± 0.18 vs. 5.74 ± 
0.19; t 46 = 0.38, p = 0.70). Therefore, it can be concluded that participants 
maintained the same level of engagement in performing both stress tasks in the two 
stress testing sessions.  
Subjective stress and relaxation during the testing sessions, perceived control 
over the tasks, and perceived difficulty of the tasks were assessed. These subjective 
responses to speech and mirror tracing were only moderately correlated and were 
therefore analysed separately. Figure 4.15 illustrates the stress-induced subjective 
responses in the two stress sessions. 
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There was a main effect of time (F 2.31, 103.89 = 51.5, p = <0.001) indicating that 
subjective stress increased during the tasks and returned below baseline levels by 
the end of the session. The same was true for subjective relaxation (F 2.5, 112.47 = 
94.48, p = <0.001) in that participants’ level of relaxation decreased during the tasks 
and returned above baseline levels by the end of the session. There was a main 
effect of PA condition for subjective stress (F 1, 45 = 4.43, p = 0.04) but not for 
relaxation (F 1, 45 = 0.23, p = 0.63), and neither stress by PA condition (F 4, 180 = 0.16, 
p = 0.96) nor relaxation by PA condition interaction (F 4, 180 = 0.21, p = 0.93).  
Within-subjects comparisons revealed that participants rated the speech task 
and the mirror tracing task as slightly more difficult during PA withdrawal compared 
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    Fig-4.15 Subjective stress ratings in the 2 PA conditions n = 47.  
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to PA maintenance (4.36 ± [SEM] 0.22 vs. 3.89 ± [SEM] 0.22; t 46 = 1.76, p = 0.08); 
(4.13 ± [SEM] 0.23 vs. 3.70 ± [SEM] 0.21; t 46 = 1.75, p = 0.08). However, no 
difference emerged for perceived control over the speech task (p = 0.74) or the 
mirror task (p = 0.41) in the two PA conditions suggesting no effect of PA withdrawal 
on subjective feelings of control over the stress tasks. There was no gender effect in 
subjective stress (F 1, 45 = 1.81, p = 0.19) or relaxation (F 1, 45 = 0.57, p = 0.45). 
 
 
4.4.10 Associations Between Changes in MHPG and Stress-Induced 
Parameters. 
 
Correlation analysis was used to examine whether changes in basal levels of 
MHPG after PA withdrawal correlated with changes in mood and reduction in CPM/d 
as well as stress-induced markers. A baseline MHPG change score (∆bl-MHPG) was 
computed as the mean difference between baseline values. In this way a high score 
represents greater changes in basal MHPG following PA withdrawal which is 
indicative of a heightened sympathetic drive. ∆bl-MHPG values were not normally 
distributed so Spearman rho correlation analysis was used. 
There was no association of ∆bl-MHPG with reduction in ActiGraph recorded 
CPM/d (rho = 0.08, p = 0.57) but negative mood following PA withdrawal measured 
with the GHQ-28 showed a marginally significant association with ∆bl-MHPG (rho = 
0.25, p = 0.09) suggesting that individuals with greater mood disturbance tended to 
have a slightly higher level of sympathetic activation as indexed by the noradrenaline 
metabolite MHPH.  
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In order to examine associations between stress-induced CV and inflammatory 
markers and MHPG AUC during PA withdrawal stress testing, Pearson’s zero-order 
correlations were used. MHPG AUC correlated with IL-6 reactivity (r = 0.31, p = 
0.04), DBP reactivity (r = 0.36, p = 0.02) and marginally with TPR reactivity (r = 0.26, 
p = 0.09) but not with any of the stress-induced cortisol indexes. These correlations 
suggest a link between total sympathetic activation during stress and CV and 
inflammatory reactivity. 
 
 
4.4.11 Secondary Analyses. 
 
In order to investigate whether variation in the degree of adherence to the 
experimental protocol had an effect on the primary outcomes of interest, subsidiary 
analyses were carried out in two ways. First, I excluded participants whose daily 
levels of objectively measured PA was not reduced by at least 25 per cent based on 
data from the accelerometer and expressed in average daily counts per minutes 
(CPM/d). This was achieved by calculating a proportional CPM/d change within the 
PA conditions so that lower negative values represent greater reduction in daily 
activity levels. As evidenced by the distribution of these score there was great 
variation in adherence to the experimental protocol (see Figure 4.5). The median per 
cent reduction in CPM was - 37.35% (25th and 75th percentiles - 59.68% - 9.11% 
respectively). The choice of this cut-off threshold was based on the distribution of the 
CPM data alone since there is no consensus in the literature on what constitutes a 
significant reduction.  
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Second, the mood change following PA withdrawal was used as an index of the 
effectiveness of the intervention and is based on previous findings that withdrawal 
from habitual exercise or regular PA is associated with the development of mood 
disturbance in healthy participants after one or more weeks (reviewed in the 
Introduction). This mood change score was used as a continuous predictor variable 
in several regression models. Mood change and CPM/d reduction may be 
considered two independent methods of the effectiveness of the intervention as they 
correlate only moderately well with each other. For example, as reported above the 
correlation between mood change measured with the POMS and reduction in CPM/d 
was 0.36 and with the GHQ was 0.16 (n.s.). In addition, excluding participants only 
on the basis of ActiGraph use may result in the exclusion of genuine participants 
who might have followed the instructions but forgot to wear the device. Likewise, 
participants might be unfairly excluded because certain activities such as swimming 
or cycling are not easily recorded by the ActiGraph.   
 
 
4.4.12 Secondary Analyses: CPM Reduction. 
 
In this analysis 18 participants were excluded (16 with less than a 25% reduction 
in CPM and 2 who did not have valid accelerometer data in either condition). The 
main effect of time for SBP and DBP was still significant but the PA condition by time 
interaction was not significant, as was also found in the previous main analysis. 
The main effect of time for TPR was still significant but gender became only 
marginally significant (p = 0.08) whereas the main effect of PA condition stayed non-
significant and the PA condition by time interaction did not change either (p = 0.13). 
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The main effect of PA condition became significant (F 1, 27 = 6.82, p = 0.01) for 
HR responses but the PA condition by time interaction only approached statistical 
significance (p = 0.09). Paired t-test on the reactivity and recovery scores adjusted 
for the baseline did not show any significant difference as in the main analysis.  
The main effect of time for HRV stayed significant but the main effect of PA 
condition became not significant. The Within-subjects comparison showed the same 
patterns of reduced HRV in response to the speech task but again not statistically 
significant. 
Secondary analyses for stress-induced IL-6 responses showed a near significant 
PA condition by time interaction (F 1, 27 = 3.73, p = 0.06) but again no main effect of 
time suggesting a small difference in the IL-6 response. This difference was explored 
using a within-subject test comparing the IL-6 reactivity score in the two PA 
conditions. Results showed a near significant greater IL-6 reactivity during PA 
withdrawal compared to PA maintenance (0.062 ± [SEM] 0.03 pg/mL vs. - 0.028 ± 
0.04 pg/mL, t 27 = 1.93, p = 0.064). These data suggest that when excluding 
participants with poor adherence to the study protocol, greater IL-6 responses to 
stress begin to emerge in the predicted direction. The difference in resting CRP 
levels remained statistically not significant (1.32 ± [SEM] 0.41 mg/l vs. 1.11 ± 0.37 
mg/L, t 26 = 0.55, p = 0.58 in the PA withdrawal and PA maintenance respectively) 
suggesting that even though basal CRP levels were slightly elevated following PA 
withdrawal it cannot be attributable to exercise withdrawal. 
Cortisol changes were compared within the two PA conditions. As in the 
previous analyses, only the main effect of time was significant. Within-subjects 
comparisons showed that the higher cortisol concentration following PA withdrawal 
previously observed at 20 minutes post stress became non-significant (p = 0.13) 
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although it became nearly significant at 45 minutes (t  28 = 1.76, p = 0.09). The total 
cortisol output during the stress session (AUC) stayed non-significant. There were no 
significant changes in the MHPH stress responses.  
Reduction in CPM/d used as a continuous variable did not correlate with any 
stress-induced cardiovascular or inflammatory reactivity measures. 
 
 
4.4.13 Secondary Analyses: Mood Change. 
 
In these analyses two participants were excluded for use of medications before 
the stress session. Since the main findings illustrated above seems to suggest a 
weak effect of PA withdrawal on IL-6, cortisol and HR responses, a stress reactivity 
score was again calculated for these variables in the two testing sessions. Stress 
reactivity was operationalized as the mean difference between average stress values 
and baseline values (greater scores = greater reactivity). 
Two steps linear regression models were run with the stress reactivity values 
during PA withdrawal as the dependent variable outcome and the equivalent 
reactivity value during PA maintenance as predictor at step one. The change in 
mood was therefore the predictor added at step two of the model. In this way it is 
possible to quantify the association of negative mood with stress-induced reactivity 
during withdrawal testing which is independent of the maintenance (control) testing.  
Negative mood change was operationalized as the mean difference score 
between the total GHQ psychological distress during PA withdrawal and PA 
maintenance. The mean GHQ score difference was 6.6 ± [SEM] 1.52 (95%CI 3.54 to 
9.66).  
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Results are presented (Table 4.3) as coefficients (B) and 95% confidence 
intervals (CI), and the amount of variance explained by PA withdrawal induced 
negative mood over and above the variance explained by stress reactivity during PA 
maintenance testing. 
 
 
 
 
Outcome 
 
 
B 
 
 
95% CI 
 
 
∆R2 
 
 
IL-6 reactivity 0.006 0.001 – 0.011* 0.10 
HR reactivity 0.19 0.02 – 0.36* 0.08 
Cortisol AUC -4.83 -10.25 – 0.58 ** 0.06 
     
 
 
Table 4.3 shows that controlling for PA maintenance IL-6 reactivity, PA withdrawal 
IL-6 reactivity was positively associated with greater mood changes (B = 0.006, 95% 
CI = 0.001 – 0.011, p = 0.03), accounting for about 10 per cent of the variance. This 
association is illustrated in figure 4.16 where the ∆GHQ has been computed into 
tertiles of negative mood and plotted against the stress-induced IL-6 reactivity. 
PA withdrawal HR reactivity to stress was also positively associated with negative 
mood after adjusting for PA maintenance HR reactivity, accounting for 8 per cent of 
the variance (B = 0.19, 95% CI = 0.02 – 0.36, p = 0.03). This association is illustrated 
in figure 4.17.  
Outcomes are adjusted for the corresponding reactivity at PA maintenance stress testing. 
*p = 0.03; **p=0.07 
Table 4.4 ∆GHQ following PA withdrawal as predictor of stress-induced indexes n = 45. 
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Participants with greater mood changes had a near significant attenuated cortisol 
output during the PA withdrawal stress session controlling for cortisol AUC during 
their PA maintenance session. There were no significant associations of mood 
change with systolic or diastolic blood pressure, systemic vascular resistance, HRV 
and MHPG, or with stress recovery values. 
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4.5 DISCUSSION 
 
 
This study was designed to experimentally manipulate physical activity (PA) 
levels in order to investigate whether psychophysiological and immune responses to 
mental stress are altered by forced PA abstinence in healthy participants. This 
method, which has been termed exercise withdrawal paradigm (EWP), represents an 
experimental model of physical inactivity that can be implemented in a relatively 
short time course and presents several advantages compared to an active PA 
intervention trial. The EWP has been used previously to investigate the effect of PA 
on mood symptoms and other immunological parameters. This study has extended 
to incorporate a psychophysiological stress component in order to investigate the 
causal processes and mechanisms that may account for the association of PA, 
mood and physiological and immunological activity under stimulated conditions. 
Cross-sectional work has shown associations of PA and fitness levels with 
attenuated stress-induced cardiovascular responses but not all randomized exercise 
trials have been able to show an effect of PA on CV reactivity to stress (Sloan et al., 
2011; Forcier et al., 2006). No experimental study has so far addressed whether PA 
is associated with attenuated inflammatory responses. The main hypothesis was that 
physiological and immune responses to mental stress would be heightened following 
two weeks of PA withdrawal when compared to two weeks PA maintenance (the 
control condition). The secondary hypotheses stated that PA withdrawal would result 
in the development of negative mood symptoms and fatigue in a dose-response 
manner with the amount of objectively recorded change in physical activity. 
The PA withdrawal intervention was successful in modifying the amount of daily 
PA. The relative within-subjects reduction in average daily counts per minute 
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(CPM/d) in the two PA phases was 34% and did not differ by gender. The 
participants recruited had higher than average cardiovascular fitness compared to 
the general population (HSE, 2008) and their self-reported amount of vigorous and 
very vigorous PA in the week before study entry was over two hours although there 
was large variation between-participants.  
Two weeks of PA abstinence resulted in robust mood disturbances that were 
particularly marked in the somatic, fatigue and vigour subscales. Since these latter 
dimensions are reminiscent of, and phenotypically similar to, the symptoms of 
sickness behaviour, this finding is of particular significance given the hypothesized 
link between negative mood and inflammatory activity (Wright et al., 2005; Strike, 
Wardle, & Steptoe, 2004). The mood change was positively associated with changes 
in objectively recorded physical activity (CPM/d) suggesting a direct link between 
reduction in PA and the development of depressive symptoms. Interestingly, this 
dose-response between PA reduction and mood became stronger when participants 
with poor compliance with the ActiGraph were excluded. Overall, these results 
strongly indicate that a reduction in objectively measured PA is likely to drive the 
mood change rather than other non-specific factors such as social contact or 
interaction during exercise training.  
Previous epidemiological work has shown that physically active individuals are 
less likely to develop depressive symptoms (Hamer & Chida, 2008). Data from 
exercise intervention trials were not consistent in showing positive effects of PA on 
depression (Lawlor & Hopker, 2001), which may in part be due to poor 
methodological quality (Rethorst et al., 2009). Although improvements in depression 
have been shown, and especially among depressed individual with a chronic illness 
(Herring et al., 2012), other non-specific factors related to exercise interventions 
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including increased social contact and general expectations may play an important 
role in mediating this effect (Steptoe, 2007). Therefore, I have shown that using an 
experimental approach, reduction in daily PA in regularly active and fit individuals 
induces negative mood symptoms.  
This study provides further evidence in support of the PA and mood regulation 
relationship. However, the correlation between mood change and change in 
objectively measured CPM/d was not significant when mood symptoms were 
assessed with the GHQ-28. This could suggest that other factors besides an actual 
reduction in PA might play a role. However, there are two arguments that might not 
support this notion. First, the ActiGraph (accelerometers) device used to monitor 
compliance with the study protocol has some important limitations. For example, this 
device relies on the participant’s compliance with the protocol (i.e. wearing the 
device as instructed) but ActiGraph wear time was mixed. In addition, not all physical 
activities are accurately recorded by the ActiGraph (Freedson, Bowles, Troiano, & 
Haskell, 2012) and there is little agreement in the literature on the cut-off boundaries 
that define moderate and vigorous/very vigorous PA intensity (Matthews, 
Hagstromer, Pober, & Bowles, 2012).  
Second, this study used a cross-over, randomized design so between-subjects 
variability and individual difference is minimized. Participants were carefully 
interviewed and selected to reflect a sample of regularly active and healthy 
individuals free of any mental health issue. Therefore, the findings add to the cross-
sectional and prospective literature by showing that experimental reduction in PA is 
associated with marked negative changes in mood and fatigue symptoms in a partial 
dose-response manner as hypothesized in the introduction. 
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A further objective of this study was to examine whether stress-induced 
autonomic and immune responses differed after PA withdrawal when compared to 
the usual PA maintenance regime. The main finding was that systolic, diastolic and 
total peripheral resistance responses to mental stress did not change following PA 
withdrawal and were remarkably stable over the two stress sessions. Heart rate (HR) 
recovery from stress was slightly enhanced in the PA maintenance condition but the 
difference could be explained by lower overall HR during the stress session. This 
suggests that stress-induced cardiac autonomic reactivity was not affected by PA 
withdrawal. However, higher overall HR activity in the PA withdrawal phase suggests 
that autonomic changes in cardiac modulation in response to exercise deprivation do 
not suddenly reflect in exaggerated reactivity or impaired recovery. It is possible that 
these differences may emerge after prolonged exercise abstinence.  
According to the allostatic load theory of the effect of physiological stress 
activation, delayed post-stress autonomic return to baseline levels (pre-stress), in 
addition to heightened reactivity, is an important mechanism linking stress with the 
development of cardiac risk factors. However, this study offered no support for a 
causative model wherein experimental manipulation of PA results in heightened or 
disturbed cardiovascular responses to mental stress. This finding is not in line with a 
study showing that moderate intensity exercise was associated with reductions in 
sympathetic tone and greater peripheral vasodilation in response to mental stress 
mediated through enhanced beta 1 and beta 2 receptor sensitivity (Brownley et al., 
2003). However, that study was an acute exercise model whereas we used an 
exercise withdrawal model that reduces acute exercise effects. Previous work has 
shown that although resting blood pressure is reduced after exercise training 
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(Cornelissen, Verheyden, Aubert, & Fagard, 2010) the effect on CV reactivity to and 
recovery from mental stress is mixed.  
This is an important issue given that heightened and sustained CV responses to 
laboratory stress predict the development of cardiac risk factors (Chida & Steptoe, 
2010). For example, a small, randomized eight week aerobic exercise training found 
no evidence of an effect of exercise on muscle sympathetic nervous activity and HR 
reactivity despite improvements in CV fitness (Ray & Carter, 2010). Jackson and 
Dishman (Jackson & Dishman, 2006) reported that fitness was related to greater 
heart rate reactivity but better recovery from mental challenge in 73 studies, although 
these effects were diminished when only randomized controlled exercise training 
studies were included and when fitness was measured as peak oxygen uptake. In 
contrast, Forcier and colleagues (2006) demonstrated an inverse association 
between fitness and heart rate reactivity in an analysis containing only trials with 
evidence of an exercise training effect. One of the difficulties in interpreting data from 
short term (often 8 – 12 weeks) exercise trials is that individual changes in fitness 
are usually modest, which suggests a short period of exercise training may not be 
sufficient to induce the type of chronic adaptations required to observe stress 
buffering effects. 
A common problem in this area has been limited sample size that can often 
lead to studies with insufficient statistical power. This issue was, however, addressed 
in a recent large randomised trial consisting of 149 healthy, young sedentary 
participants who were randomised to a twelve week exercise program followed by a 
further four weeks of sedentary de-conditioning (Sloan et al., 2011). Participants 
performed various stressors before and after the intervention, and after detraining, 
including a public speaking task, mental arithmetic, and the Stroop Color-Word task, 
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although there was no indication of any stress-buffering effects following exercise 
training. However, the study protocol did not include any objective measure of 
adherence to the training regime. In addition, participants were tested three times 
during the course of the study which may lead to an habituation effect that may be 
difficult to quantify in the absence of a control group. Therefore, the finding of a lack 
of an exercise training effect on CV reactivity may be due to the methodological 
limitations of the study.   
In the present study, the lack of a PA withdrawal effect on blood pressure 
reactivity may be explained by the post-exercise hypotension hypothesis (Hamer, 
2006). This suggests that an acute bout of exercise is associated with lower blood 
pressure eight to twelve hours following exercise. Blood pressure responses to 
mental stress are indeed attenuated after an acute bout of exercise (Hamer et al., 
2006) but in this study participants were instructed not to undertake any form of 
exercise for at least 16 hour prior to stress testing. This requirement was 
implemented in order to avoid a carryover hemodynamic or mood enhancing effect 
of acute exercise. Therefore, the attenuated stress-induced blood pressure 
responses could be explained by the fact that participants are likely to be in the post-
exercise window period when they encounter a stressor, and asking them to refrain 
from exercise for 16 hour prior to mental stress exposure might have cancelled out 
the blood pressure effect. This would suggest that acute exercise is more important 
than chronic training effects and may explain why there was no difference in stress 
reactivity after withdrawal.  
An alternative explanation may be that PA abstinence in habitually active 
individuals leads to vascular and autonomic changes or adaptations which are not 
immediately reflected in heightened blood pressure reactivity. Indeed, it has been 
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shown that resting blood pressure returns to pre-aerobic training levels after a couple 
of weeks of detraining (Meredith et al., 1990). However, since the beneficial effects 
of chronic PA is likely to result from accumulated bouts of acute training sessions 
(Hamer, 2006) it may be feasible to hypothesized that blood pressure reactivity to 
stress is not affected by two weeks of PA withdrawal. 
MHPG levels did not increase significantly in response to stress in the two PA 
conditions. Following PA withdrawal there was no increase post-stress but a steady 
decline to 45 minutes. In the PA maintenance phase, baseline levels were lower with 
a near significant increase 20 minutes after stress and return close to baseline levels 
at 45 minutes post-stress. The lack of a post-stress increase in the PA withdrawal 
phase may indicate a possible ceiling effect, in that already heightened baseline 
levels made it difficult to detect a further increase. This is indicative of an increased 
baseline sympathetic activity following PA withdrawal compared to the PA 
maintenance. However, an heightened sympathetic drive resulting from PA 
withdrawal can only be speculative in the absence of validated cut-off values for 
MHPG levels that indicate hyperactivity (such as blood pressure). The change in 
baseline MHPG levels between PA conditions was associated with the change in 
negative mood following PA withdrawal but only marginally. This suggests that the 
heightened resting sympathetic activity in individuals withdrawn from their regular PA 
regime may be linked to greater distress due to exercise abstinence. There were 
also correlations between MHPG AUC and inflammatory and blood pressure 
reactivity indicating that higher catecholamine output during stress testing were 
related to higher CV and immune reactivity lending more support to the validity of 
this marker of sympathetic activation. However, it is important to emphasise that 
178 
 
some of the correlations observed between MHPG and mood and other markers 
were only marginally significant and of small magnitude.      
Salivary cortisol responses to mental stress, which is an index of the HPA axis 
reactivity, were also assessed. Overall, cortisol responses to the stress tasks were 
modest. Nonetheless, it was observed that compared to PA maintenance, cortisol 
was heightened at 20 minutes post-stress during PA withdrawal testing. The total 
level of cortisol exposure during the stress sessions was indexed as the area under 
the curve (AUC). Although this measure was heightened following PA withdrawal 
compared to PA maintenance, the difference did not reach statistical significance. 
Previous work that investigated associations of fitness levels with stress-induced 
cortisol responses has generally found lower cortisol levels in fitter participants 
(Rimmele et al., 2007; Rimmele et al., 2009). However, it is difficult to draw firm 
conclusions from those studies due to the cross-sectional nature of the design and 
because some of the participants were highly trained athletes. Therefore, the finding 
of heightened cortisol responses to stress following PA withdrawal may add more 
experimental support to a biological model wherein the health protective effects of 
regular PA are in part mediated through HPA regulation and cortisol release. 
Inflammatory activity was measured in response to stress (IL-6) and as baseline 
change following PA withdrawal (CRP). Although CRP and IL-6 levels were slightly 
higher following PA withdrawal compared to the PA maintenance, the difference did 
not reach statistical significance. Recent work using a similar PA modification model 
has found that most inflammatory markers are not affected by a two week PA 
abstinence (Kop et al., 2008; Lund et al., 2010). Therefore, by using a randomized, 
cross-over method that overcomes problems of between subjects variability, this 
study further supports previous findings that short-term PA withdrawal does not alter 
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systemic levels of CRP. However, the lack of an effect could also be due to the fact 
that participants were young and fit, and CRP levels are generally low in this group, 
which makes finding an effect of PA withdrawal difficult. It may be possible that by 
employing a different sample such as active older individuals or participant with an 
inflammatory condition, an effect of PA withdrawal on inflammatory markers may 
become apparent. 
The IL-6 stress reactivity response showed null results. There was no IL-6 
increase at 45 minute post stress in both testing sessions, and no effect of PA 
withdrawal on the stress-induced response. There might be several reasons for this 
null effect. The stress-induced inflammatory response may already be attenuated in 
young and fit individuals and the stressors used in this study may not have been 
challenging enough to produce a marked IL-6 response. In addition, blood samples 
were drawn pre and post stress only. Although some reports have suggested that 
the IL-6 stress response may be detectable at 45 minutes post stress, further IL-6 
increases for up to two hours post-stress have also been reported in the literature 
(Brydon, Edwards, Mohamed-Ali, & Steptoe, 2004).  
For example, Von Kannel (von Kannel et al., 2006) has shown that with the Trier 
Social Stress Test maximum levels of IL-6 are reached at 105 minute post-stress in 
a sample of middle age men. In a cross-sectional study of young and healthy 
women, Brydon showed a 37 per cent stress-induced increase in IL-6 at 45 minutes 
using a stress protocol similar to the one used in this study, although no further blood 
samples were collected post 45 minutes (Brydon et al., 2008). Therefore, it is 
possible that the lack of a stress-induced IL-6 response observed in this study is 
attributable to a combination of the relatively mild stress protocol, the sampling time 
lag, and the participants’ high level of fitness and relatively young age. Indeed, the 
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time lag of the IL-6 response to behavioural stimulation may vary by age, SES, 
gender and other factors which may make it difficult to detect a stress-induced 
increase when only one post-baseline sample is drawn.    
Due to the fact that adherence to the PA withdrawal intervention protocol was 
mixed, secondary analyses were performed using two different methods. In the first 
method, participants with less than a 25 per cent reduction in daily CPM relative to 
their PA maintenance were excluded. The second method consisted of the use of 
mood disturbances caused by PA withdrawal to index the effectiveness of the 
intervention. Changes in mood following PA withdrawal were therefore used as a 
predictor continuous variable in several linear regression models. The most 
consistent finding from these secondary analyses was that the null effect of PA 
withdrawal on systolic and diastolic blood pressure, systemic vascular resistance 
and HRV responses to stress was confirmed. However, there was a near significant 
PA condition by time interaction for the HR response suggesting heightened HR 
responses following exercise withdrawal. Yet, within-subject comparisons of stress-
induced HR reactivity and recovery indicated that the interaction could be explained 
by lower resting HR in the maintenance phase. Analyses involving mood change 
instead showed an association between HR reactivity and mood. The HR reactivity 
to the stress tasks after PA withdrawal was heightened in more distressed 
participants after adjusting for reactivity during PA maintenance. Therefore, the 
results of this secondary analysis suggests that an effect of PA withdrawal on HR 
can only be observed when using mood disturbance to index the effectiveness of the 
PA withdrawal protocol. 
Interestingly, there was a borderline significant stress-induced IL-6 increase in 
the PA withdrawal testing session when participants with poor adherence were 
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excluded. Consistent with this finding, greater mood changes predicted heightened 
IL-6 reactivity during PA withdrawal after adjusting for IL-6 reactivity during PA 
maintenance. Negative mood independently accounted for 10 per cent of the 
variance in stress-induced IL-6. This indicates that an effect of PA withdrawal on IL-6 
reactivity in this study may only be detectable in subgroup analysis. Therefore, it 
seems that overall the effects are greater in those participants that were more 
distressed by the intervention. Adherence to the study protocol and participant 
selection is crucial in this kind of experimental studies, and may also explain why 
other studies did not find an effect of exercise training on CV reactivity for example 
(Sloan et al., 2011).    
Strengths of this study include the use of a single-blind, cross-over design which 
minimizes inter-individual variability, the standardized cardiovascular fitness 
assessment, and the recruitment of highly active and healthy participants. A further 
strength is the use of accelerometers to measure PA participation objectively and 
thus not only relying on self-report data. Strengths and weaknesses of the study 
design and protocol will be discussed in greater depth in Chapter six. However, 
some limitations of the study include the fact that it was not possible to test 
participants before randomization and then again after PA withdrawal and PA 
maintenance. In this way the comparisons might have been stronger but could have 
potentially biased the study because the administration of three repeated stress 
sessions over a month may lead to habituation or practice effects. Another limitation 
of the study is that PA participation before study entry was assessed by self-report 
as it would have been too cumbersome for participants to wear the accelerometer for 
an extra week. A non-stress control group was not employed. However, it has 
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previously been shown that with a non-stress control group, blood pressure and IL-6 
remained stable over a 2 hour period (Brydon et al., 2005; von Kannel et al., 2006).  
In summary, this randomized, cross-over study has found that two weeks of PA 
withdrawal does not alter blood pressure responses to mental stress. The heart rate 
stress reactivity response was heightened following PA withdrawal but only in 
secondary analysis using mood change to index the effectiveness of the intervention.  
The cytokine IL-6 was not affected by mental stress or PA withdrawal although a 
small post-stress increase following PA withdrawal was observed with the exclusion 
of participants with poor compliance to the study protocol. Furthermore, PA 
withdrawal induced negative mood predicted greater IL-6 reactivity independently of 
PA maintenance IL-6 reactivity. A small but consistent increase in stress-induced 
cortisol following PA withdrawal was also reported. Robust negative mood 
disturbances were observed following PA withdrawal that developed in a dose-
response manner with reduction in daily level of physical activity. Overall, the study 
offers only partial support for the hypotheses laid down in the introduction. 
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CHAPTER5: ADIPOSITY AND STRESS REACTIVITY  
 
 
5.1 INTRODUCTION 
 
Obesity is an important risk factor for cardiovascular disease (CVD) mortality, 
certain cancers, and poor quality of life (Adams et al., 2006; Finucane et al., 2011). 
Being obese or overweight greatly increases one’s chances of developing metabolic 
disturbances such as insulin resistance, dyslipidaemia, type 2 diabetes and 
atherosclerosis which are strong and independent risk factors for coronary heart 
disease morbidity and mortality (Hafner, 2007; Adams et al., 2006; Reaven, Abbasi, 
& McLaughlin, 2004). It has been proposed that the adipose tissue is an active 
endocrine organ that communicates with the central nervous system and other 
organs such as the skeletal muscle, and secretes several inflammatory and 
metabolic factors that contribute to a low grade systemic inflammatory state (Rocha 
& Libby, 2009; Li, Wang, & Miao, 2011).  
 
5.1.1 Adipokines. 
 
Adipokines is the term used to describe pro and anti-inflammatory cytokines that 
are mainly produced by the adipose tissue and include interleukin-6 (IL-6), IL-18, 
interleukin-1 receptor antagonist (IL-1ra), leptin, resistin, tumour necrosis factor 
alpha (TNF-α), C-reactive protein (CRP) and adiponectin (Eder, Baffy, Falus, & 
Fulop, 2009; Pou et al., 2007; Rexrode, Pradhan, Manson, Buring, & Ridker, 2003). 
Basal levels of some of these inflammatory markers are raised in individuals with 
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excess adipose tissue and in overweight people (Trayhurn & Wood, 2005) making 
this an important pathway mediating the effect obesity on metabolic functions and 
health outcomes (Caruso, Balistreri, & Candore, 2010; Gregor & Hotamisligil, 2011). 
Psychosocial stress is another important risk factor for CVD (Dimsdale, 2008; 
Hjemdahl, Rosengren, Steptoe, 2012) and adiposity accumulation (Wardle, Chida, 
Gibson, Whitaker, & Steptoe, 2011) in which inflammatory mechanisms play a 
possible aetiological role (Li & Fang, 2004). Indeed, acute stress administered under 
controlled condition has been shown to activate a transcription factor resulting in the 
release of pro-inflammatory cytokines (Steptoe, Hamer, & Chida, 2007; Bierhaus et 
al., 2003; von Kannel, Kudielka, Preckel, Hanebuth, & Fischer, 2006) as well as 
eliciting robust and consistent cardiovascular (CV) and neuroendocrine responses 
(Hamer, Gibson, Vuononvirta, Williams, & Steptoe, 2006; von Kannel et al., 2006). In 
addition, these CV and neuroendocrine responses to acute mental stress have been 
shown to longitudinally predict risk factors including hypertension, increased intima 
media thickness and greater coronary artery calcification (Carroll, Phillips, Der, Hunt, 
& Benzeval, 2011; Chida & Steptoe, 2010; Hamer, O'Donnell, Lahiri, & Steptoe, 
2010). Therefore, acute mental stress is a valuable experimental tool for 
investigating the mechanisms involved in the association between inflammatory 
responses and adiposity. 
 
5.1.2 Adiposity and Stress-Induced Autonomic Responses. 
 
 Some evidence suggests that adiposity (waist to hip ratio [WHR] and waist 
circumference) and obesity (body mass index [BMI]), and obesity-related conditions 
such as insulin resistance are associated with disturbed autonomic reactivity to acute 
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mental stress. An early small study comparing insulin resistant overweight women 
with non-insulin resistant normal weight women showed exaggerated blood pressure 
responses to mental stress in the obese group which correlated with insulin levels 
(Sung, Wilson, Izzo, Ramirez, & Dandona, 1997).  
Another small study of overweight women showed greater stress-induced blood 
pressure responses in individuals with central obesity compared to women 
characterized by peripheral obesity (Davis, Twamley, Hamilton, Swan, 1999). 
Greater systemic vascular resistance in overweight women was also observed in two 
cross-sectional studies (Seematter, Guenat, Schneiter, Cayeux Jaquier, Tappy, 
2000; Agapitov, Correia, Sinkey, Dopp, Haynes, 2002), although in one of the study 
blood pressure responses did not differ between the obese and lean group (Agapitov 
et al., 2002). A large study of adolescent boys and girls found that waist 
circumference was positively associated with blood pressure reactivity independent 
of BMI and the effect was stronger in boys (Goldbacher, Matthews, & Salomon, 
2005). This study is especially notable because it employed a larger sample size of 
healthy adolescents not at risk for CVD. 
Further studies have also investigated neuroendocrine responses to mental 
stress in obesity, mainly by measuring the glucocorticoid cortisol as an index of HPA 
axis activation. In one study it was found that women with greater WHR secreted 
significantly more cortisol in response to mental stress and this response was 
consistent over 3 days of testing (Epel et al., 2000). This suggests that even in non-
obese women greater central fat is related to larger stress-induced cortisol 
responses. However, another study performed with men (Ljung et al., 2000) found 
that men with greater WHR had lower cortisol responses to stress independent of 
BMI but larger hear rate (HR) responses and higher catecholamine excretion than 
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men with lower WHR. Furthermore, a more recent cross-sectional study comparing 
obese and non-obese (stratified by BMI) postmenopausal women found no 
difference in neuroendocrine (cortisol and ACTH) responses to a public speaking 
stress between the groups but HR and diastolic BP (DBP) were higher 15 minutes 
post-task in the obese group (Benson, Arck, Tan et al., 2009). Inconsistent findings 
clearly exist regarding CV and neuroendocrine reactivity to mental stress in obesity. 
Some of these inconsistencies may be accounted for by differences in the population 
under investigation as well as the different measure of adiposity used. Additionally, 
few studies controlled for physical activity participation which may confound 
associations with CV reactivity. 
 
5.1.3 Adiposity and Stress-Induced Inflammatory Responses. 
 
Recent investigations have also examined the association of pro-inflammatory 
responses and measures of obesity and adiposity. For example, In the study by 
Benson and colleagues (Benson et al., 2009), stress-induced IL-6 was higher in the 
obese group at both baseline and 45 minute post-stress but there was no evidence 
of an interaction effect between the groups. Furthermore, no group differences were 
observed in the stress-induced redistribution of circulating leukocyte immune cell 
subpopulation. A study of young women (Brydon, Wright, O’Donnell et al., 2008) 
showed that the adipokine leptin and IL-1ra stress response were positively and 
significantly correlated with waist circumference independent of BMI, age and 
smoking status. Delayed blood pressure recovery from stress was also associated 
with BMI and waist circumference so that the more obese women had slower post-
stress recovery suggesting sustained sympathetic activation.  
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A recent quasi-experimental study comparing salivary cortisol responses to the 
Trier Social Stress Test (TSST, a marked social evaluative stressor (Kirschbaum, 
Pirke, & Hellhammer, 1993) in normal weight, obese and participants who had 
recently lost weight found some inconsistent results (Therrien et al., 2010). Men who 
had recently lost weight showed the smallest cortisol change from baseline to 20 
minute post-stress (peak cortisol response), and the cortisol response was strongly 
and negatively correlated with the percentage change in weight loss. However, the 
non-obese men showed the greatest stress-induced cortisol change clearly pointing 
to a non-linear effect. There were no differences in cortisol responses reported in 
women. However, the weight loss in the reduced obese group was largely 
unsupervised and achieved through lifestyle changes including exercise.  
Hence it is difficult to tease apart whether the observed effects were attributable 
to adiposity or to an unmeasured factor such as improvements in mood and self-
esteem, or to an HPA axis adaptation to recent physical activity. Some of the 
discrepancies observed in these studies may be attributable to the different age 
group tested, the small sample size in some studies, differences in stress protocols 
and the failure to control for possible confounders such as physical activity or resting 
autonomic parameters. 
 
  5.1.4 Prospective Studies. 
 
Inflammatory and adrenocortical responses to stress may therefore be biological 
pathways driving the relationship between obesity and CV risk factors, but the 
majority of the existing work has been cross-sectional making interpretation of 
results difficult. Limited longitudinal work has investigated the association of CV and 
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inflammatory responses to stress with the development of obesity or adiposity 
measure. This work has generally shown conflicting results.  
In a large sample of healthy, middle age men and women drawn from the 
Whitehall II cohort, BMI and WHR were associated with impaired recovery in systolic 
blood pressure (SBP) and cardiac output (CO) in a linear fashion (Steptoe & Wardle, 
2005). This impairment in SBP and CO stress recovery was independently 
associated with an increase in WHR at three years follow-up in men only. This study 
offers some support to a causative model in which disturbed CV responses to stress 
predict the development of central obesity. However, other studies do not support 
this hypothesis suggesting that it is a blunted CV response to mental stress that is 
associated with obesity. In the largest CV stress response study to date using the 
West of Scotland Twenty-07 (Ford, Ecob, Hunt, MacIntyre, & West, 1994) study 
cohort, the HR response to a 5 minute mental arithmetic task was negatively 
associated with BMI and WHR independent of a range of covariates (Carroll, Phillips, 
& Der, 2008). The BP response instead was positively associated with obesity but 
this association became non-significant after adjustment for covariates including age, 
social class, medication status, and resting blood pressure. Interestingly, HR 
reactivity was associated with a reduced likelihood of becoming obese after five 
years follow up (OR = 0.97, 95% CI 0.95 – 0.99) after controlling for a range of 
confounders including obesity at previous screenings.  
No other stress-induced CV or immune parameters were measured in the West 
of Scotland Twenty-07 study, and CV stress recovery was not assessed. The 
authors argued that their finding cannot be explained by a ceiling effect of reactivity 
driven by higher resting levels since the results were adjusted for resting HR. Rather, 
they suggested (Phillips, 2011) that the lower sympathetic reactivity found in their 
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study may be explained by obesity-related elevations of the hormone leptin, which 
may be indicative of tissue resistance to the sympathetic nerve activation effect of 
this hormone (Trayhurn & Bing, 2006).  
 
  5.1.5 Leptin in Obesity. 
 
 Leptin is an important adipokine hormone involved in the production of the T-
helper 1 cytokines and the suppression of T-helper 2 anti-inflammatory cytokines 
(Quilliot, Boahme, Zannad, Zielger, 2008). Leptin levels are markedly raised in the 
obese state especially in women. Therefore, elevations in plasma leptin may suggest 
that a leptin resistant obesity phenotype is inhibiting CV and autonomic reactivity to 
stress. Indeed, levels of leptin are proportional to body fat and it has been shown in a 
cross-sectional study of young women that high levels of resting leptin were 
associated with greater stress-induced HR and IL-6 increases (Brydon, O'Donnell 
Wright, Zachary, Wardle, Steptoe, 2008). This suggests a link between leptin and CV 
and inflammatory activation even in a non-obese sample which may further 
corroborate the notion that the visceral adipose tissue is important in mediating the 
activation of pro-inflammatory cytokines during stress.  
 
 5.1.6 Obesity and Depression. 
 
In addition to disturbances in psychophysiological responses, obesity has also 
been associated with increased risk of depression and psychological distress, which 
might partly account for some of the inconsistencies in the psychophysiological area 
highlighted above. However, the data on obesity and depression are also 
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inconsistent. For example, a recent meta-analysis of prospective cohort studies 
suggest that people with greater BMI have an increased risk of depressive 
symptoms and depression (Luppino et al., 2010), but depression at baseline was 
also associated with increased odds of developing obesity. Another large scale 
prospective study has shown that obesity, and especially central obesity, during 
adolescence is associated with depression in adulthood (Herva et al., 2006).  
Although some individual studies report no association between obesity and 
depression or depressive symptoms (Istvan, Zavela, & Weidner, 1992), another 
group of studies show greater BMI to be associated with reduced risk of future 
mental health problems and suicide (Magnusson, Rasmussen, Lawlor, Tynelius, & 
Gunnell, 2006). A negative association between overweight and obesity and 
depression has also been reported in two prospective studies of elderly individuals in 
a non-Western population (Wong, Leung, Leung, & Woo, 2011; Chang & Yen, 2011).  
Recent Mendelian randomization studies, using adiposity-related genetic 
variants as un-confounded instrument variables for obesity have also produced 
inconsistent findings. For example, higher BMI attributable to genetic influences was 
associated with increased risk of depressive symptoms in men participating in the 
Whitehall II study (Kivimaki et al., 2011), but lower likelihood of psychological 
distress and antidepressant use in a study of Danish adults (Lawlor et al., 2011). 
Therefore, evidence to date seems to suggest that obesity or overweight lead to 
depression but depression may also lead to the development of obesity. This issue is 
likely to be further confounded by cultural differences since negative associations of 
obesity with depression have also been reported in non-western samples. 
It has been argued that markers of inflammation may account for the positive 
association of chronic stress and depression with obesity (Hamer & Stamatakis, 
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2008), and increasing evidence suggests that pro-inflammatory cytokines and 
adipokines are implicated in the pathophysiology of depressive disorders (Miller, 
Maletic, & Raison, 2009; Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008). It 
has been shown in one study that depressive symptoms promote expansion of 
adipose tissue with consequent release of IL-6 and leptin which may further 
contribute to a low grade inflammatory state (Miller, Freedland, Carney, Stetler, & 
Banks, 2003). However, that study argued against a model in which the inflammatory 
response arising from enlarged adipose tissue causes depression.  
More recently, it has been shown that the hormone leptin was associated with 
depression in men with type 2 diabetes, after adjustment for covariates including 
BMI, medication use and glycated haemoglobin (Labad et al., 2011). In another 
study elevated serum leptin at baseline was a predictor of major depression over a 
five year follow-up period in women (Pasco et al., 2008). Therefore, enlarged 
adipocytes in visceral fat depots contribute to macrophage accumulation with 
subsequent release of inflammatory adipokines including IL-6, TNF-α and leptin. 
Increases in systemic levels of these inflammatory mediators may result in 
depressive symptoms (Shelton & Miller, 2010) but also in disturbances in the 
homeostatic balance and in impairments in autonomic responses to stress which 
may lead to the development of CV risk factors (Straznicky, Lambert, & Lambert, 
2010).  
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5.1.7 Weight loss and Inflammation  
 
Experimental studies have generally shown improvements in circulating 
inflammatory markers and hemodynamic profile after weight loss (Capuron et al., 
2011; Selvin, Paynter, & Erlinger, 2007; Straznicky et al., 2010). Some evidence also 
suggests that even small reduction in visceral adiposity is associated with 
appreciable improvements in metabolic functions that can be achieved with minimal, 
or no weight loss (Ross & Bradshaw, 2009). At present, the mechanisms through 
which adiposity and stress responses are linked is not completely understood and it 
is unclear whether it is a heightened or a blunted stress reactivity that is associated 
with measures of adiposity and obesity.  
Some evidence shows associations of stress responses with adiposity but the 
causal link has not been established. For example, adiposity may also cause 
heightened stress responses. No studies have previously examined the effect of 
weight loss on inflammatory and cardiovascular responses to mental stress in a 
healthy sample. The aim of this study is to examine the effect of experimentally 
induced weight loss (through caloric restriction alone) on inflammatory and 
cardiovascular responses to mental stress. 
 
5.1.8 Hypotheses. 
 
1) Weight loss achieved through caloric restriction will be associated with 
improvements in resting inflammatory markers (CRP, IL-6 and leptin) and lipids.  
2) Cardiovascular and inflammatory responses to mental stress will be reduced after 
weight loss. 
193 
 
3) Reductions in leptin after weight loss will be associated with cardiovascular and 
inflammatory responses to stress after weight loss. 
4) Weight loss will be associated with improvements in depressive symptoms which 
will be mediated though changes in adiposity or inflammatory markers.    
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5.2 METHODS 
 
 
5.2.1 Study Design: Weight Loss & Stress Responses Study. 
 
The Weight Loss and Stress Responses Study (WLSR) is a non-randomized 
study based on a nine week supervised weight loss intervention. The study did not 
employ a control group for several reasons. Firstly, the time constrain of this PhD 
project prevented me from designing and implementing a randomized controlled trial 
(RCT). Secondly, this study was originally designed as a smaller pilot/feasibility 
project in order to inform the design of a larger RCT.  
Twenty-four women between the age of 18 and 45 years were recruited through 
newspaper adverts and intercollegiate emails for a study investigating the effect of a 
nine week caloric restriction diet on cardiovascular and inflammatory responses to 
mental stress. Participants attended the research laboratory at study entry for 
baseline anthropometric measures and psychophysiological testing.  They returned 
after the nine week weight loss period for a repeated assessment. During the weight 
loss period participants attended a weekly nutritional counselling session with a 
Health Psychologist and received Slim-Fast meal replacements. The study design is 
illustrated in Figure 5.1. 
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5.2.2 Study Sample Recruitment and Weight Loss Programme. 
 
The study sample consisted of overweight or obese but otherwise healthy 
women with a body mass index (BMI) of between 27.5 and 42.5 kg/m2 not currently 
taking part in any exercise programme or diet regime (i.e. Weight Watchers) and not 
on any regular medication (excluding the oral contraceptive). The recruitment 
selection process and response rate is shown in figure 5.2. Sixteen out of the 24 
participants that enrolled completed the study (33.3 per cent attrition) and have 
complete data on all the outcome measures. One participant became pregnant 
halfway through the study and was therefore excluded from the analyses leaving a 
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final sample of 15. There were no differences in age, BMI and WHR between 
participants who completed the study and those who did not complete. 
A Registered Clinical Dietician and a team of Health Psychologists at Weight 
Concern (Health Behaviour Research Centre) designed and delivered the weight 
loss programme. This individualized programme consisted of estimating participants’ 
daily energy requirement using the widely employed Schofield equation method 
(Schofield, 1985). The equation model is as follow: 
 
For women between 18 and 29 years basal metabolic rate (BMR) = 14.8 x body 
weight (W) + 487 standard error of estimate (SEE) = 120. For women between 30 
and 59 years BMR = 8.3 x W + 846 SEE = 112. 
 
The Schofield method is used to estimate BMR in adults and uses estimated 
errors factors (SEE) and activity factor values to adjust the equation for body type 
and activity levels. Six hundred calories were deducted from each participant 
estimated daily requirement for weight maintenance to create an energy deficit and 
induce weight loss. The daily calorie allowance consisted of two commercially 
available standardized meal replacement shakes (Slim-Fast) to provide about 450 
calories, plus one healthy meal and snacks to make up the remaining number of 
calories.  
As used in previous behavioural interventions to encourage weight loss 
(Heymsfield, Van Mierlo, Van der Knaap et al., 2003), information on meal planning, 
calorie counting, healthy snacking, distinguishing cravings from hunger, and 
methods of dealing with internal and external triggers were provided, discussed and 
197 
 
practiced during each session. Participants were asked to keep a food diary which 
would be reviewed during the weekly sessions.  
Towards the end of the programme participants were given a Shape Up (Weight 
Concern) manual and provided with a tailored weight maintenance plan in order to 
encourage proper weight management once the study had terminated. Two post-
study follow-up appointments were also offered to participants to provide on-going 
support. Weight Concern experts predicted that by following this weight loss plan 
participants were expected to lose between 0.5 and 1.0 Kg per week. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig-5.2: Flowchart of Study Participant Selection.  
Recruitment Adverts 
(January – March 2011) 
60 Initially Agreed  
          36 Non Suitable 
 
Medications = 10 
No Longer Interested = 15 
Not meeting BMI criteria = 11 
 
 Eligible = 24 
Attrition n = 8 
 
Lost at Follow-up = 7 
Unable to Stay on Programme = 1 
 
Completed Study  
n = 16 
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5.2.3 Materials 
 
At the first research laboratory visit participants signed the informed consent 
form and were seen individually by a research nurse who measured baseline 
anthropometric variables and collected the first saliva sample. This same procedure 
was adopted at the follow-up visit nine weeks later. 
 
5.2.3.1 Anthropometric Measures.  
 
Waist circumference was measured twice to the nearest 0.1 cm using a metal 
anthropometric tape midway between the lower rib margin and the iliac crest. Hip 
circumference was measured at the level of the great trochanters to index a waist to 
hip ratio. Height was recorded according to standard protocol to the nearest 0.1cm 
using a Stadiometer and weight was measured using a digital Tanita scale with 
participant in light clothing. Fat mass and fat percentage was estimated using a 
Tanita body composition analyser. Body mass index (BMI) was calculated as the 
ratio of weight in kilogram and the square of the height in meters (Kg/m2). 
 
5.2.3.2 Blood Sampling Protocol. 
 
At baseline (pre-weight loss) and follow-up (post-weight loss) two blood samples 
were obtained from the antecubital vein of the non-dominant forearm using standard 
aseptic techniques. Sample one was obtained after a 30 minute rest immediately 
before administering the stress protocol and sample two was collected 45 minute 
after the stress protocol.  
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Blood was drawn into EDTA coated vacuum tubes and serum separator vacuum 
tubes by a research nurse or the PhD candidate. EDTA samples were spun 
immediately at 2500g for 10 minutes at room temperature. Serum samples were left 
to clot for 30 minutes and spun at 2500g for 10 minutes. The resulting supernatant 
was harvested and kept in a -80 C freezer in 0.5ml aliquots. 
 
5.2.3.3 Cardiovascular Measures. 
 
Beat by beat blood pressure was monitored continuously during the two 
laboratory stress sessions with a Finometer Pro (Finapres Medical System, 
Amsterdam, The Netherlands). This device measures beat by beat pressure using a 
cuff attached to the middle finger of the non-dominant arm (see Chapter 4). Before 
the start of the stress protocol, the Finometer was initiated with the participant’s 
characteristics (age, gender, height and weight) and calibrated according to standard 
protocol. A height sensor appropriately nulled during calibration accounts for 
differences in height between the finger and the arm.  
The Beatscope software was used to derive the following cardiovascular 
variables from the Finometer raw data: Systolic (SBP) and diastolic (DBP) blood 
pressure; mean arterial pressure (MAP) and cardiac output (CO). Total peripheral 
resistance (TPR) was derived with the formula (TPR = MAP/CO x 80). An event 
button allows each time point to be marked and analysed. For each laboratory stress 
session the time points derived from the Finometer were: Baseline (the average 
recording of the last five of thirty minutes resting time); stress task 1 (5 minutes 
mean); stress task 2 (5 minutes mean); post stress recovery 1 (mean of 15-20 
minutes post-stress); and recovery 2 (mean of 40-45 minutes post-stress).  
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5.2.3.4 Inflammatory Markers and Adipokines 
 
Peripheral concentrations of Interlukin-6 (IL-6) and leptin were measured at rest 
and 45 minute after the stress protocol in each stress session. C-reactive protein 
(CRP) was measured at rest only. Samples were analysed in duplicate using 
Enzyme-linked immunoassorbent assay (ELISA) from R&D System (Oxford UK). 
The high sensitivity IL-6 assay has a limit of detection 0.016 pg/ml with a mean 
minimum detectable dose of 0.039 pg/ml and an intra and inter assay coefficient of 
variation (CV) of 7 and 7.2 per cent respectively. The CRP assay has a limit of 
detection of 0.005 ng/ml with a mean minimum detectable dose is 0.010 ng/ml and 
an intra and inter assay CV of 5.5 and 6.5 respectively. The minimum detectable 
dose of the leptin assay is typically less than 7.8 pg/mL with an intra and inter assay 
CV of 3.1 and 4.3 per cent respectively. Any one sample with a CV of >10% were re-
assayed in triplicate and the mean of the two readings with the lowest CV was 
retained.  
The device used to determine the optical density of the ELISA plates was the 
Molecular Devices (UK) Versa-Max Microplate Reader. The software used to 
analyse the optical density was the SoftMax® Pro 5 capable of reducing the raw 
absorbance data to a linear log/log parameter (IL-6 and leptin) and a 4 parameter 
logistic curve (CRP). The software is capable of generating a standard curve which 
is then used to compute the optical density values into a mean concentration value 
according to each ELISA kit protocol. All samples were processed and assayed by 
the PhD candidate. 
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5.2.3.5 Lipids analysis 
 
Blood samples were collected into serum tube separators for lipids analysis. The 
variables for lipids were: triglycerides, total cholesterol, the total to high density 
lipoprotein (HDL) cholesterol ratio, and low density lipoprotein (LDL). Total 
cholesterol was assayed in a centrifugal analyser by the enzymatic colorimetric 
method. HDL cholesterol was measured after dextran sulfate–magnesium chloride 
precipitation of non-HDL cholesterol. LDL cholesterol was computed by using the 
Friedewald equation method. Lipid analyses were carried out at a validated 
biochemistry laboratory (The Doctor Laboratory, UK). 
 
5.2.3.6 Mental Stress Protocol: 
 
The stress protocol consisted of two 5 minute tasks designed to elicit mild stress 
responses, as described previously in Chapter 4: A public speaking scenario (PS) 
and a mirror drawing task (MT). These stressors are widely used in 
psychophysiology research and they have been previously used in our lab. These 
stress tasks were deemed to be suitable for the experimental design employed in 
this study because the responses from these tasks have been shown to be 
reproducible over repeated testing sessions with little habituation (Hamer et al., 
2006)  
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5.2.3.7 Subjective Stress Appraisal and Mood Measures: 
 
Subjective ratings of stress and anxiety were taken at five time points: end of 
rest period, after the PS and MT task, at recovery 1 (20 minutes post-stress) and at 
recovery 2 (45 minutes post-stress). In addition, task appraisal ratings were also 
taken at the end of each task. Task appraisal included the perceived level of 
difficulty, involvement and controllability. All subjective ratings were measured on a 
seven point Likert scale anchored at 0 (not at all) and 7 (very). 
Mood was assessed using the 28 item General Health Questionnaire (GHQ-28) 
as previously described (Chapter 4). The GHQ-28 total score Cronbach’s alpha at 
the baseline assessment was 0.85 and at the follow-up assessment 0.81. The total 
score and the depression subscale of the GHQ-28 were used as a measure of 
psychological distress and depressive symptoms. The mood questionnaire was 
administered at the baseline and follow-up research laboratory visit during the rest 
period, before the stress protocol.  
 
5.2.4 Procedure. 
 
Eligible participants were scheduled to attend the research laboratory on a 
weekday morning. Prior to their first visit, all participants received an appointment 
letter instructing them not to exercise for 24 hours prior to the appointment, not to 
consume any caffeinated drink, not to smoke, and to only have a light, low fat 
breakfast on the scheduled day. All participants signed an informed consent form 
before a research nurse measured their baseline anthropometric variables. Blood 
pressure was measured manually twice after a 30 minute rest period using an 
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automated UA-779 digital monitor. The mood questionnaire was completed by the 
participant during the rest period just before administering the stress tasks.  
The psychophysiological stress protocol was then implemented. Briefly, after 
calibration of cardiovascular equipment and a 30 minutes rest period, the 
experimenter or the research nurse obtained blood and saliva samples and 
subjective ratings. The two stress tasks were administered in a random order with 
subjective ratings obtained after each task and a further saliva sample at the end of 
the tasks. A 45 minute post-stress recovery time then followed with subjective ratings 
and saliva samples obtained at 20 and 45 minute. The second blood draw was 
sampled at 45 minutes post-stress and the stress protocol ended. Participants 
received a light lunch and were then escorted to a research room to meet a member 
of the diet team from Weight Concern.  
The follow-up laboratory visit was scheduled to take place on average nine 
weeks later at the same time as the baseline visit, and essentially followed the same 
protocol as in the baseline research session. Participants were tested in the 
psychophysiology laboratory by the same person in the two stress session, and all 
the diet meetings were held in an interview room adjacent to the psychophysiology 
laboratory.  
All participants were reminded to avoid taking any medication in the week prior 
to testing. In case participants were ill or unwell on the testing day the appointment 
was rescheduled. Participants received an honorarium of £ 20.00 for taking part in 
the study. Figure 5.3 summarises the stress protocol and the measures collected. 
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5.2.5 Statistical Approach. 
 
Throughout the chapter the term “baseline” refers to the pre-weight loss stress 
testing session and “follow-up” refers to the post-weight loss stress session. “Rest” 
or “resting” refers to any measurement value taken before implementing the stress 
protocol when the participant is sitting down quietly. The assumption of normal 
distribution of the data was checked by examining the distribution and 
kurtosis/skewness values. Where appropriate the data were transformed using log or 
square root transformation.  
The main stress-induced analyses were carried out using repeated measure 
ANOVA with stress session (baseline and follow-up) and time (rest, stress and 
recovery) as within-subjects factors using the Greenhouse- Geisser correction for 
degree of freedom in cases where the assumption of sphericity of the data was 
Baseline 
Rest 
Rec 2 Rec 1 
2 x 5 min 
Stressors 
    - 30 min                               0                                 + 20 min                           + 45 m 
-Finometer CVmeasures 
(M of last 5m of BL rest) 
-Baseline Blood sample 
-Subjective Measures 
-Finometer CV measures 
(M of task 1, M of task 2) 
-Subjective measures 
after task 
-Finometer CV 
measures  
(M of last 5 of 20m rec.1) 
-Subjective measures  
-Finometer CV 
measures  
(M of last 5 of 45m rec.2) 
-Post-stress blood 
sample 
-Subjective measures 
Fig-5.3: Summary of the measures obtained in the Weight Loss and Stress Responses Study  
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violated. Main effect and interaction effects were explored using paired t-tests. 
Weight loss was calculated as absolute and relative change from baseline.  
Change scores (∆) were calculated as the difference between stress and rest 
values so that higher scores indicate higher reactivity. Pearson zero-order correlation 
and partial correlation was used to examine associations between stress-induced 
scores and change in leptin between baseline and follow up. Data are presented as 
means ± standard deviation (SD) or standard error of the mean (SEM). 
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5.3 RESULTS 
 
 
5.3.1 Baseline characteristics of study sample 
 
 
 
Variable Mean ± SD Range 
Age (years) 30.54 ± 7.53 19.08 – 43.17 
BMI (kg/m2) 33.42 ± 3.99 27.70 – 42.50 
WHR 0.79 ± 0.07 0.65 – 0.92 
Waist circumference (cm) 91.30 ± 10.89 74.00 – 110.00 
Fat Mass (kg) 38.52 ± 10.22 27.10 – 64.60 
SBP (mmHg) 109.9 ± 9.98 95.00 – 129.00 
DBP (mmHg) 78.7 ± 8.55 67.50 – 96.00 
CRP (mg/l) 2.97 ± 3.06 0.33 – 9.39 
Cholesterol (mmol/L) 4.88 ± 0.88 3.70 – 6.70 
 
 
 
 
Participants lost at follow-up (n = 8) did not differ from participant who completed 
the study (n = 16) in age, BMI and WHR (all P-values = ≥ 0.68). The mean follow-up 
time was 9.33 ± 0.96 weeks. Mean weight loss was - 2.65 ± 3.18 Kg (see figure 5.4) 
and the mean proportional weight change was - 3.25 ± 3.65 per cent. Mean BMI 
Table 5.1: Baseline characteristics of study sample (n = 15). 
SBP = Systolic blood pressure, DBP = Diastolic blood pressure, WHR = waist to hip 
ratio, CRP = C-reactive protein. 
207 
 
change between baseline assessment and follow-up was - 1.01 ± 1.22 Kg/m2 and 
the change in fat mass was - 3.59 ± 2.31 Kg. Data on the amount of weight lost by 
non-completers was available for seven participants only and the mean loss was 
2.46 ± 2.65 Kg.  
 
 
 
 
 
5.3.2 Change in Resting BP and CRP levels After Weight Loss. 
 
Resting SBP and DBP were measured manually following a 30 minute rest 
before administering the stress protocol. Following the weight loss intervention 
resting SBP did not change significantly from baseline (109.9 ± [SEM] 2.57 mmHg 
  
Fig-5.4: Distribution of weight loss body mass in Kg (n = 15).  
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vs. 107.76 ± 1.67 mmHg, p = 0.30). Resting DBP decreased significantly after weight 
loss (78.70 ± 2.21 mmHg vs. 74.66 ± 2.14 mmHg, p = 0.02). However, this reduction 
in DBP did not correlate significantly with reduction in fat mass (r = 0.36, p = 0.18), 
WHR (r = 0.29, p = 0.28), waist circumference (r = 0.13, p = 0.65) or body mass (r = 
0.07, p = 0.80).  
The mean CRP level at baseline was 2.97 ± [SD] 3.06 mg/L and 2.84 ± 2.91 
mg/L at follow-up. Since CRP values were skewed, in order to test for differences in 
resting values after weight loss a log transformation was applied. A paired t-test 
showed that there was no significant difference between baseline and follow-up 
resting CRP levels (t 14 = 0.65, p = 0.52).  
 
 
5.3.3 Stress-Induced CV Responses.  
 
In order to examine differences in reactivity (and recovery) to mental stress after 
weight loss it is important to examine whether subjective engagement or involvement 
in performing the two stress task is comparable across the two testing sessions. This 
was measured using a Likert scale that asked participants to rate the perceived 
difficulty and involvement of each task in each stress session. There was no 
difference in participant’s ratings of speech task difficulty (M rating 5.06 ± [SEM] 0.37 
vs. 4.73 ± 0.44, p = 0.57) and tasks’ engagement (M rating 5.20 ± [SEM] 0.31 vs. 
5.40 ± 0.36, p = 0.56) from the baseline compared to follow-up testing session.  
In the mirror drawing task, task involvement also did not differ between the two 
testing sessions (Mean rating 6.46 ± [SEM] 0.16 vs. 6.07 ± 0.28, p = 0.11). However, 
perceived difficulty was slightly, and nearly significantly, lower at the follow-up stress 
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session (Mean rating 4.66 ± 0.41 vs. 3.87 ± 0.40, p = 0.07). Overall, participants’ 
involvement in performing the stress tasks did not differ within the two stress testing 
sessions although in the mirror drawing task there was a trend towards lower 
perceived difficulty ratings in the post-weight loss stress session. 
 
The tasks elicited marked increases in the CV parameters examined. SBP and 
DBP responses to the mirror (MT) and public speech (PS) tasks were highly 
correlated (r = 0.83) and were therefore averaged to create a mean stress score. CV 
responses were analysed using repeated measure ANOVAs with stress session 
(baseline and follow-up) and time (rest, mean stress, recovery 1 and recovery 2) as 
within-subject factors applying the Greenhouse-Geisser correction for degree of 
freedom when the assumption of sphericity was violated. Main effects and interaction 
effects were further explored using within-subjects t-test. Stress-induced blood 
pressure activity was measured continuously in the two stress testing sessions using 
a Finometer as described in the Method section. 
 
5.3.3.1 Systolic Blood Pressure (SBP).  
 
Results for SBP showed a significant main effect of time (F 1.60, 22.49 = 36.19, p = 
<0.001) and stress session (F 1, 14 = 9.15, p = 0.009) as well as a stress session by 
time interaction (F 3, 42 = 3.48, p = 0.02) suggesting that SBP responses differed 
significantly across the two stress testing sessions. Resting SBP was significantly 
higher at baseline (M difference 4.79 ± [SEM] 1.77 mmHg, p = 0.01) compared to 
follow-up, as was the mean task stress value (M difference 8.58 ± [SEM] 2.12 
mmHg, p = 0.001).  
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Figure 5.5 illustrates systolic blood pressure responses to mental stress during 
baseline and follow-up testing. A task reactivity score was computed as the mean 
difference between resting and stress values so that higher scores represent greater 
stress reactivity. At the baseline stress session reactivity was 23.34 ± 2.78 mmHg 
and at follow-up it was 19.55 ± 2.68. A paired t-test showed that the difference in 
reactivity following weight loss was significant (t 14 = - 2.18, p = 0.04). 
The two stress recovery values (at 20 and 45 minute post-stress) were higher at 
baseline compared to the follow-up testing session (indicating poorer recovery from 
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Fig-5.5: Systolic Blood Pressure Reactivity During Baseline (pre-weight loss) and 
Follow-up (post-weight loss) Psychophysiology Stress Testing. Values are 
means ±SEM, n=15 
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stress) but this difference was not statistically significant (M difference recovery 1 
[15-20m post-stress] = 3.77 ± [SEM] 2.16 mmHg, p = 0.10; M difference recovery 2 
[40-45m post-stress] = 3.34 ± [SEM] 2.00 mmHg, p = 0.11).  
Pearson zero-order correlation analysis was used to examine whether the 
change in SBP reactivity (ΔSBPbaseline – ΔSBPfollow-up) following weight loss (higher 
values indicates greater attenuation) correlated with reduction in obesity and/or 
adiposity measures. ΔSBP-reactivity was related to reduction in:  WHR (r = 0.60, p = 
0.02) and waist circumference (r = 0.52, p = 0.04) but not reduction in fat mass (r = - 
0.01, p = 0.96) or BMI (r = 0.23, p = 0.41). These results suggest that the attenuated 
systolic reactivity to mental stress following weight loss is likely due to changes in 
measure of central obesity (see figure 5.6). 
 
 
 
Fig-5.6: Association of ∆SBP reactivity between baseline and follow -up with ΔWHR  post 
weight loss n = 15.  Greater ΔWHR positively associated with greater reduction in 
SBP. 
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In order to investigate whether the lower reactivity observed at the follow-up 
stress session may be accounted for by differences in resting values, a proportional 
reactivity score was calculated. In the baseline session the reactivity per cent value 
was 20.25 ± [SEM] 2.67 whereas in the follow-up stress session the value was 17.37 
± [SEM] 2.42.  
This difference was analysed with a related t-test that showed a near significant 
higher reactivity of 2.88 per cent (SEM 1.53, p = 0.08) at baseline compared to the 
follow-up testing session. This shows that the lower resting SBP after weight loss 
accounts only in part for the attenuated reactivity to mental stress observed after 
weight loss.  
 
5.3.3.2 Diastolic Blood Pressure (DBP).  
 
Analyses of stress-induced DBP responses revealed a main effect of time (F 
1.724, 24.14 = 46.52, p = <0.001), and stress session (F 1, 14 = 6.22, p = 0.02) and a near 
significant stress session by time interaction (F 3, 42 = 2.37, p = 0.08). The DBP 
reactivity to and recovery from mental stress is illustrated in figure 5.7. 
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Within-subjects analyses of DBP showed significantly higher resting DBP at 
baseline compared to follow-up (M difference 3.69 ± [SEM] 1.58 mmHg, p = 0.03) 
and during stress (M difference 5.23 ± [SEM] 1.28 mmHg, p = 0.001), but not at 
recovery 1 (M difference 2.37 ± [SEM] 1.69 mmHg, p = 0.18) or recovery 2 (M 
difference 2.64 ± [SEM] 1.71 mmHg, p = 0.14).  
The stress reactivity scores were again compared within the two stress testing 
sessions. At baseline the reactivity score was 13.67 ± 1.49 mmHg, and 12.13 ± 1.60 
at follow-up but the difference was not statistically significant (t 14 = -1.31, p = 0.21). 
Pearson correlation analysis was again used to determine whether the attenuated 
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Fig-5.7: Diastolic Blood Pressure Reactivity During Baseline (pre-weight loss) and 
Follow-up (post-weight loss) Psychophysiology Stress Testing n  = 15. 
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post-weight loss diastolic reactivity (ΔDBP-react) could be explained by changes in 
obesity and/or adiposity parameters. Similarly to SBP, ΔDBP-react was related to 
reduction in waist to hip ratio (r = 0.52, p = 0.04) and waist circumference (0.50, p = 
0.05), but not to fat mass change (r = - 0.06, p = 0.82) or BMI (r = 0.14, p = 0.63). 
Since there was a significant change in resting DBP, a proportional stress 
reactivity change score was calculated and compared within the groups. Per cent 
stress reactivity was 19.6 ± [SEM] 2.51 and 18 ± 2.59 in the baseline and follow-up 
testing session respectively but the difference was not statistically significant (p = 
0.41). This indicates that the attenuated reactivity observed post weight loss is 
largely accounted for by lower resting DBP baseline values.  
 
5.3.3.3 Total Peripheral Resistance (TPR).  
 
TPR was analysed in the same way since there was a strong correlation 
between TPR reactivity to the MT and PS stress tasks (r = 0.87). There was a main 
effect of time (F 1.48, 20.77 = 11.98, p = 0.001) but not a main effect of stress session (F 
1, 14 = 0.04, p = 0.82) nor a stress session by time interaction (F 3, 42 = 0.62, p = 0.60) 
indicating a significant change in TPR over time that did not differ between the 
weight loss groups at the baseline and follow up stress sessions. The TPR activity 
during the stress sessions is depicted in figure 5.8. 
 
 
 
215 
 
 
 
 
 
5.3.3.4 Heart Rate (HR).  
 
For HR responses to mental stress, the correlation between responses to the MT 
and the ST stress tasks were high (r = 0.94) and were therefore averaged to produce 
a mean stress task value. The HR means ± SEM values during the baseline and 
follow-up stress testing session are illustrated in figure 5.9  
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Fig-5.8: Total Peripheral Resistance at the Baseline and Follow -up Stress 
Session n =15. 
216 
 
 
 
 
 
 
The main effect of time was significant (F 1.28, 18.01 = 36.39, p = <0.001), but there 
was no main effect of stress session (F 1, 14 = 0.82, p = 0.38) or stress session by 
time interaction (F 1.8, 25.22 = 0.83, p = 0.43) suggesting that the dynamic of the HR 
responses did not differ across the two testing sessions.  
The stress reactivity score at baseline was 11.20 ± [SEM] 2.04 bpm and 8.86 ± 
2.28 bpm at follow-up. However, when this task reactivity scores were compared 
using a within-subjects t-test the results indicated that the attenuated reactivity at 
follow-up was not statistically significant (t 14 = -1.16, p = 0.26).  
Likewise, the stress recovery score (computed as the mean difference between 
resting and 45 minute post-stress values) was calculated and compared in order to 
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Fig-5.9: Heart Rate at the baseline and follow -up stress session. Weight loss and 
stress responses study n =15 
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investigate the effect of weight loss on recovery from stress. The mean difference in 
HR stress recovery from baseline to follow-up (-1.55 ± [SEM] 1.38 bpm) was not 
statistically significant (t 14 = -1.12, p = 0.28). 
 
 
5.3.4 Stress-Induced Inflammatory Responses.  
 
Pro-inflammatory IL-6 responses to mental stress were evaluated for all 
participants. At baseline, resting IL-6 averaged 1.43 ± [SD] 1.18 pg/ml (range 0.44 to 
5.42) increasing to 1.49 ± 1.33 pg/ml 45 minute post-stressor (a 4.19 per cent 
increase). At follow-up, resting IL-6 averaged 1.33 ± 0.75 pg/ml (range 0.53 to 3.28) 
increasing to 1.46 ± 0.80 pg/ml 45 minutes post-stress (a 10.5 per cent relative 
increase). Figure 5.10 depicts the IL-6 response to mental stress at the baseline and 
follow-up stress sessions. 
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The result of the within-subjects ANOVA test revealed no main effect of time (F 1, 
14 = 2.79, p = 0.11) or stress session (F 1, 14 = 0.12, p = 0.73), and a non-significant 
stress session by time interaction (F 1, 14 = 0.25, p = 0.62) suggesting no differences 
in stress-induced IL-6 responses from baseline to follow-up.  
A mean IL-6 stress reactivity score was computed as the mean difference 
between resting and 45 minute post-stress values so that higher scores represent 
greater reactivity to stress. The scores were compared between baseline and follow-
up in order to examine differences in reactivity before and after weight loss. Baseline 
reactivity was 0.06 pg/mL (SD 0.23) while follow-up reactivity was 0.13 pg/mL (0.45), 
and a paired t-test showed no statistically significant difference between baseline 
and follow-up reactivity (t 14 = 0.5, p = 0.62). Because the distribution of IL-6 data 
tended to be skewed, these analyses were repeated using square root transformed 
IL-6 values but results did not change.   
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Fig-5.10 Stress-induced IL-6 responses in the 2 stress sessions n = 15.  
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Correlational analysis showed that follow-up IL-6 reactivity did not correlate with 
changes in the adiposity related measures WHR (r = 0.09, p = 0.74), fat mass (r = - 
0.21, p = 0.44) or BMI (r = - 0.17, p = 0.53). 
 
 
5.3.5 Associations of Leptin with Inflammatory and Cardio Metabolic Risk 
Factors.  
 
Resting leptin values were normally distributed and ranged from 12.06 to 72.30 
ng/mL (Mean 41.40 ± [SD] 19.84 ng/mL) at baseline, and 5.18 to 77.54 ng/mL (Mean 
29.65 ± 19.21 ng/mL) at follow-up. Stress-induced leptin response values are shown 
in figure 5.11. 
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Fig-5.11: Stress-induced leptin responses in the two stress sessions n = 15  
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Resting leptin levels at baseline were highly correlated with baseline BMI (r = 
0.87, p = <0.001), waist circumference (r = 0.68, p = 0.005), per cent fat mass (r = 
0.66, p = 0.008), CRP (r = 0.66, p = 0.01) and basal IL-6 (r = 0.56, p = 0.03) but not 
with age (r = 0.2, p = 0.48) and resting SBP (r = 0.13, p = 0.64). Resting levels of 
CRP and IL-6 at baseline were also positively correlated (r = 0.64, p = 0.01).  
 
A within-subject ANOVA showed that the main effect of time was not significant 
(F 1, 14 = 2.60, p = 0.13) indicating no increase in response to stress but a significant 
main effect of stress session (F 1, 14 = 13.46, p = 0.003) suggesting differences in 
leptin levels between the baseline and the follow-up stress sessions. The stress 
session by time interaction was not significant (F 1, 14 = 0.05, p = 0.83). 
 
Following the weight loss intervention resting serum leptin markedly decreased 
(M difference = – 11.75 ± [SEM] 3.25 ng/mL, p = 0.003). The change in leptin 
(∆leptin) was positively and significantly correlated with reductions in BMI (r = 0.64, p 
= 0.01) and body mass (r = 0.65, p = 0.008), but only marginally with reduction in 
waist circumference (r = 0.43, p = 0.10) and not with change in WHR (r = 0.08, p = 
0.76) and fat mass (r = 0.2, p = 0.50) measured at the follow-up visit. 
In order to examine whether this reduction in leptin following weight loss 
correlated with stress-induced autonomic responses, correlation analyses were run 
with the stress reactivity values (difference between stress and rest values [∆]) of the 
follow-up stress session. There were no significant correlations between weight loss 
induced reductions in leptin and ∆SBP (r = 0.03, p = 0.92), ∆DBP (r = 0.04, p = 0.89), 
∆HR (r = 0.14, p = 0.63) and ∆TPR (r = - 0.06, p = 0.81).  
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5.3.5.1 Leptin and Inflammatory responses  
 
The same method was used to examine the correlation of reduction in leptin with 
stress-induced IL-6 responses (difference between 45m post-stress and rest values) 
at the follow-up stress session. Leptin reduction was negatively correlated with ∆IL-6 
(r = - 0.62, p = 0.01; shown in figure 5.12) suggesting that a greater reduction in 
leptin was associated with an attenuated IL-6 response to stress after weight loss.  
When controlling for ∆IL-6 during the baseline stress session the correlation 
between reduction in leptin and ∆IL-6 at the follow-up stress session was slightly 
reduced (r = - 0.53, p = 0.06). This suggests that independently of the baseline (pre-
weight loss) ∆IL-6 stress reactivity, a greater reduction in leptin is associated with an 
attenuated IL-6 response to stress at follow-up. 
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Fig-5.12 Association of leptin reduction following weight loss with  stress-induced 
IL-6 at the follow-up stress testing. 
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Since reactivity values may be influenced by resting levels, this analysis was 
repeated with further adjustment for resting IL-6 levels at follow-up. Results indicated 
that controlling for stress-induced ∆IL-6 at baseline testing and resting IL-6 at follow-
up testing, weight loss induced reductions in leptin were still associated with ∆IL-6 (r 
= - 0.58, p = 0.05).  
This finding was further explored by modelling the change in waist circumference 
and/or fat mass into the model. Since leptin is mainly produced by adipocytes, the 
association between leptin and attenuated IL-6 responses observed above may be 
due to a loss in adiposity. The reduction in leptin may therefore be secondary to 
changes in adiposity which then drives the attenuated IL-6 responses to stress.  
When changes in waist following weight loss was controlled for the association 
remained virtually unchanged (r = - 0.56, p = 0.05). The same results were obtained 
when changes in BMI was entered instead of waist circumference (r = - 0.66, p = 
0.02). However, when changes in fat mass was controlled for, the association 
became not significant (r = - 0.54, p = 0.07). These data suggest that a reduction in 
leptin after weight loss was associated with attenuated IL-6 responses but the 
association is in part explained by reductions in adiposity. 
 
 5.3.6 Stress-induced Lipid Responses 
 
As illustrated in table 5.2, resting cholesterol did not significantly change after 
weight loss (p = 0.27). Likewise, baseline triglyceride levels (p = 0.39) and the total 
to high-density lipoprotein cholesterol ratio (3.28 ± [SEM] 0.18 mmol/L vs. 3.37 ± 
0.22, p = 0.35) did not change after weight loss. 
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Lipids 
 
Baseline (M ± SD) 
 
Follow-up (M ± SD) 
 
Triglycerides 
 
1.06 (0.38) 
 
1.15 (0.54) 
Tot cholesterol 4.88 (0.88) 4.72 (0.88) 
LDL-cholesterol 2.86 (0.79) 2.75 (0.78) 
HDL-cholesterol 1.53 (0.35) 1.44 (0.26) 
 
LDL = low-density lipoprotein HDL = high-density lipoprotein 
 
 
Lipids data were normally distributed. There was a significant main effect of time 
for cholesterol (F 1, 14 = 6.91, p = 0.02) but not of stress session (F 1, 14 = 1.16, p = 
0.30) nor a stress session by time interaction (F 1, 14 = 0.035, p = 0.85) suggesting 
that cholesterol levels increased after stress by the same magnitude in both stress 
testing visits. For LDL cholesterol the main effect of time was significant (F 1, 14 = 
4.69, p = 0.048) but again there was no main effect of stress session (F 1, 14 = 0.74, p 
= 0.40) nor a stress session by time interaction (F 1, 14 = 0.10, p = 0.75). 
 
 
5.3.7 Weight Loss and Changes in Mood Symptoms. 
 
Changes in mood symptoms following weight loss were measured using the 
GHQ-28 which consists of four subscales as well as a total score. Table 5.3 shows 
the mean scores on the GHQ subscales before and after the weight loss 
Table-5.2 Summary of resting lipid values before and after weight loss n=15 
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intervention. Overall, there was an improvement in mood after weight loss as 
evidenced by a 6.63 point difference in the GHQ total score.  
This difference was more pronounced in the depression subscale with a change 
of 3.38 points. The social dysfunction scale changed by 1.9 point but only 
approached significance while the somatic symptoms and the anxiety /insomnia 
scale did not change significantly. 
 
 
Scale 
Baseline 
Pre-weight loss 
Follow-up 
Post-weight loss 
P 
Social dysfunction 8.36 ± 2.74 6.40 ± 2.89 0.08 
Anxiety/insomnia 6.93 ± 4.04 5.86 ± 3.92 0.38 
Somatic symptoms 4.81 ± 3.20 4.59 ± 4.08 0.85 
Depression 8.31 ± 4.68 4.93 ± 4.01 0.001 
GHQ-Total score 28.42 ± 9.66 21.78 ± 10.31 0.01 
 
 
In order to examine whether improvements in the GHQ depression scale and the 
total score was related to adiposity measures, zero-order Pearson’s analysis was 
used. Improvements in GHQ total score were not related to reduction in WHR (r = - 
0.17, p = 0.53), BMI (r = - 0.07, p = 0.81), body mass (r = - 0.074, p = 0.79) and fat 
mass (r = - 0.06, p = 0.82). In the depression subscale there were no significant 
correlations in any of the obesity measures. 
Table-5.3: Weight loss and stress responses study, GHQ-28 mean scores n =15. 
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Spearman Rho correlation was employed to examine whether changes in GHQ 
depression and GHQ total score following weight loss were related to changes in 
resting levels of leptin, CRP and IL-6 between baseline and follow-up. The GHQ total 
score change was not related to reduction in leptin (rho = 0.16, p = 0.57), CRP (rho = 
0.1, p = 0.74) and IL-6 (rho = - 0.45, p = 0.10). Similar results were obtained when 
changes in the depression subscale was used. These findings suggest that 
improvements in mood symptoms after weight loss are not related to changes in 
obesity and adiposity measure or reductions in inflammatory markers and leptin. 
Further correlations were used to examine whether these improvements in mood 
might be related to stress-induced CV and inflammatory responses at the follow-up 
stress testing session. However, neither the GHQ total score change nor depression 
change correlated with any of the stress-induced variables (blood pressure, heart 
rate, systemic vascular resistance and IL-6) suggesting that improvements in 
depressive symptoms following weight loss are not related to CV or inflammatory 
responses to mental stress. 
 
 
5.3.8 Secondary Exploratory Analysis. 
 
In order to carry out an exploratory subgroup analysis, participants whose fat 
mass did not change by at least two kilos were excluded (n = 3). Therefore, the 
remaining sample included 12 participants. However, results did not change from the 
main analyses and there were no further differences in any of the stress-induced 
parameters examined. 
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5.4 DISCUSSION 
 
 
The aim of this study was to examine the effects of experimentally induced 
weight loss on cardiovascular, neuroendocrine and inflammatory responses to 
standardized mental stress. At present, there is conflicting evidence on the 
association of obesity with cardiovascular stress responses. Some studies have 
reported that obesity is associated with blunted and others heightened reactivity to 
mental stress (Benson et al., 2009; Carroll et al., 2008; Epel et al., 2000; Steptoe & 
Wardle, 2005). Some of these inconsistencies may be attributable to variations in the 
stress protocols employed, study design, the markers under investigation, and in the 
population studied. For example, stress tasks used to elicit autonomic responses 
vary in the type of responses they elicit with public speaking protocol being more 
effective in eliciting a myocardial response while protocols like the TSST stimulate a 
marked HPA axis response. In addition, stress-induced inflammatory responses in 
obesity have received little attention and in general there is a lack of experimental 
work in this area.  
The nine week weight loss intervention resulted in modest reductions of body 
mass and fat mass. The reduction in waist circumference and in the waist to hip ratio 
was also small. It has been suggested that substituting a main meal with 
commercially available meal replacements results in a reduction of food intake and 
significant weight loss over a two week period (Levitsky & Pacanowski, 2011). A 
previous small weight loss intervention study that used a protocol similar to this study 
found that participants randomized to a structured meal replacement plus weekly 
support and physical activity advice group lost 8.5 per cent of body weight after eight 
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weeks (Anderson, Raymond Reynolds, Bush, Rinsky, & Washnock, 2011). However, 
that study included a physical activity component, in addition to intensive nutritional 
counselling, which we did not want to use in our study. Thus, this may be the reason 
why this study achieved a more modest change in weight (3.07 per cent). It has been 
shown that when exercise training is combined with diet it may only add a modest 
but significant additional weight loss (Shaw, Gennat, O'Rourke, Del Mar, 2006). 
Furthermore, exercise alone even without weight loss is associated with 
improvements in CV risk markers (Ross & Bradshow, 2009). Therefore, adding a 
physical activity component may result in additional reduction in weight that is likely 
to obscure the associations between adiposity and stress responses.  
Resting diastolic, but not systolic, blood pressure was significantly reduced 
following weight loss but this reduction did not correlate significantly with loss of fat 
mass or weight loss. Although the size of the correlation was 0.36 it did not reach 
significance level probably because of the low statistical power. Likewise, resting 
levels of CRP, IL-6 and lipids were not significantly reduced following the weight loss 
intervention. As expected and in line with previous studies, resting leptin levels at 
study entry were highly correlated with adiposity measures and inflammatory 
markers, and absolute levels were comparable with other studies. For example, 
resting leptin level averaged 37.9 ng/ml in a large sample of women with a mean 
BMI of 32.5 kg/m2 (Rock et al., 2010), and 36.7 ng/ml in a study of overweight older 
women with type 2 diabetes (Labad et al., 2011).  
Following the intervention leptin levels dropped by an average of 28.4 per cent, 
and this reduction was highly correlated with changes in weight, BMI and fat mass, a 
finding that is consistent with data from a recent weight loss study (Sumithran et al., 
2011). This suggests that it was the loss in adiposity that induced the reduction in 
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leptin levels rather than other non-specific factors. A previous small scale 
prospective study of overweight or obese middle age healthy men and women using 
a very low calorie dietary formulation that achieved a 14 per cent weight loss showed 
that fasting leptin levels decreased by 64 per cent at the 10 week follow-up 
(Sumithran et al., 2011). However, in another study of obese women randomized to 
a free prepared meal replacement and support group the six month change in resting 
leptin was 38 per cent (Rock et al., 2010). These latter two weight loss interventions 
were of longer duration and used either a very low calorie diet and weekly support 
sessions or free prepared meals and weekly support sessions. Therefore, those 
studies used an intensive and costly protocol including medical supervision with the 
provision of food. In this study we used a partial meal replacement strategy coupled 
with weekly supervision aimed at addressing and managing barriers to weight loss 
and adherence to the programme plus cognitive behavioural skills such as self-
monitoring, stimulus control and response substitution in order to facilitate weight 
maintenance after the intervention.  
Overall, the results indicate that despite an overall modest reduction in obesity 
and adiposity measures, the intervention was successful in modifying some cardio-
metabolic risk factors. This result may be in line with recent evidence showing that 
improvements in obesity-related metabolic dysfunctions can be achieved despite 
minimal or no weight loss (body mass) but through lifestyle modification (i.e. healthy 
diet) (Ross & Bradshaw, 2009). Indeed, these changes may be achieved through 
reduction in visceral fat depots that can be better measured using imaging 
techniques such as DEXA.  
  The psychophysiology stress protocol was implemented at baseline before the 
weight loss intervention, and again after an average of nine weeks in order to 
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evaluate whether adiposity would be associated with autonomic stress responses. A 
significant difference was observed in the systolic and diastolic blood pressure 
reactivity to mental stress between sessions. Participants showed attenuated blood 
pressure reactivity after weight loss compared to baseline values and this difference 
was only in part accounted for by an attenuation in post-weight loss resting systolic 
pressure. Systolic blood pressure recovery from mental stress although lower after 
weight loss did not reach statistical significance. The attenuated diastolic blood 
pressure reactivity instead could be wholly accounted for by lower resting values 
after weight loss. No further differences in stress reactivity and recovery were 
observed in the other cardiovascular parameters examined.  
We did not employ a non-weight loss control group and thus it is impossible to 
be certain that it was adiposity driving the attenuated reactivity and not other factors 
such as habituation to the tasks or familiarity with the experimenter or natural 
variability. However, the reduction in reactivity between the two stress sessions was 
positively and strongly related to reduction in adiposity in the predicted direction. In 
addition, we have previously demonstrated strong reproducibility of these responses 
over two repeated stress sessions, with no changes in blood pressure reactivity 
(Hamer et al., 2006). This further supports the notion that obesity is likely to result in 
heightened cardiovascular stress responses, but weight loss, especially loss of 
central fat mass, may result in attenuated responses.  
Few studies have examined the effects of experimentally induced weight loss on 
cardiovascular reactivity. Weight loss through four months exercise training and diet, 
but not diet alone, improved an impaired vasodilatation response to mental challenge 
in obese children (Ribeiro et al., 2005). In another intervention that examined the 
effects of a six month weight loss programme on stress reactivity in obese, 
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hypertensive participants, absolute BP levels were reduced during mental stress 
after weight loss although BP reactivity was unchanged compared with controls 
(Georgiades et al., 2000). Another study that has addressed this issue was a non- 
randomized 12-week low calories weight loss programme carried out with overweight 
men (Torres & Nowson, 2007). It was found that weight loss had an effect on resting 
blood pressure but not on reactivity to stress compared to a non-weight loss control 
group. In addition, post-stress recovery was enhanced in the weight loss group but 
this was in part accounted for by lower resting levels. However, Torres and 
colleagues’ study included participants on anti-hypertensive drugs and the results 
were not adjusted for medication use and resting blood pressure differences making 
the results difficult to interpret. Therefore, we have shown that reduction in adiposity 
following weight loss achieved through caloric restriction is associated with reduced 
blood pressure responses to mental stress.   
There were no significant differences in resting levels of IL-6 and CRP following 
weight loss indicating that the intervention did not have an effect on basal levels of 
pro-inflammatory markers. A meta-analysis of the effect of weight loss achieved 
through lifestyle interventions on CRP reported a weighted effect size of r = 0.3 
between weight change and decline in resting CRP levels (Selvin et al., 2007). 
However, the weight loss induced reduction in IL-6 is generally much smaller and not 
consistently observed (Byers & Sedjo, 2011; Heinonen et al., 2009). The lack of an 
effect observed in this study might be attributable to the small weight change 
achieved and the fact that our participants were overweight or obese but otherwise 
healthy. Moreover, physical activity participation was not encouraged throughout the 
duration of the study but only after the follow-up stress session in order to rule out 
possible confounding effects. It may be the case that the inclusion of participants 
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with greater obesity and a larger sample size may facilitate the detection of 
differences in inflammatory markers.  
IL-6 did not significantly increase at 45 minute post-stress in either the baseline 
or the follow-up stress session. The lack of stress reactivity is likely due a 
combination of insufficient power to detect a significant increase, the relatively mild 
mental stress tasks, and the timing of the second blood sample; peak post-stress IL-
6 responses may be detected a hour or more after behavioural stimulation (von 
Kannel, et al., 2006). Similarly, leptin did not increase post-stress but resting levels 
markedly decreased in proportion to fat mass loss between the baseline and the 
follow-up session. It is difficult to understand whether the lack of a leptin response 
indicates a state of leptin desensitization that after weight loss has improved or a 
ceiling effect on reactivity driven by higher resting level pre-weight loss. It may also 
be that, as argued above, the stress protocol was not robust enough to elicit a 
detectable inflammatory response at 45 minute, which might have been present at 
60 minute or later in this population.  
However, post-hoc analyses on weight loss induced reduction in basal leptin and 
stress-induced inflammatory changes at follow-up showed some interesting findings. 
In partial correlation analysis, a reduction in resting leptin was associated with an 
attenuated IL-6 stress response at follow up independent of resting levels. This 
relationship also remained significant when adjusted for the IL-6 stress response at 
the pre-weight loss session suggesting that the association cannot be accounted for 
by baseline IL-6 reactivity. Yet, when the change in fat mass post-intervention was 
added to the model, the association became non-significant suggesting that 
adiposity might at least in part be driving the association between leptin and post-
stress IL-6 change.  
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There are two possible interpretations for this finding. Since the observed 
reduction in leptin was mainly driven by loss of adiposity, this implies that the 
reduction in leptin may be a more precise measure of reduction in adiposity in this 
study than waist circumference or WHR. In this way the negative correlation between 
IL-6 and leptin (shown in Figure 5.12) may be accounted for by loss of adiposity 
which was better captured by a reduction in leptin. This notion may be supported by 
the observation that the leptin association with IL-6 was reduced to non-significance 
when fat mass change was entered into the model. Alternatively, the reduction in 
leptin might have partially restored the normal autonomic sympathetic – leptin 
balance which is thought to be disturbed in the obese state (Quilliot, et al., 2008). 
Consequently, this restoration of normal sympathetic function may have activated 
the cholinergic anti-inflammatory pathway resulting in an attenuated IL-6 response to 
stress.  
Previous work has shown that high resting leptin is cross-sectionally associated 
with greater stress-induced IL-6 responses, reduced heart rate variability and greater 
HR response to stress (Brydon, O'Donnell Wright, Zachary, Wardle, Steptoe, 2008). 
Since leptin levels are proportional to adipose tissue, and appear to be elevated in 
overweight and obese women, an association between weight loss induced change 
in leptin and IL-6 stress change may support the hypothesis that adiposity promotes 
greater stress-induced inflammatory responses that may resolve with weight loss. 
Indeed it has been shown that obesity related autonomic dysfunction is reversible 
even with a modest amount of weight loss leading to an improvement in cardiac 
autonomic modulation and enhanced neural sympathetic responsiveness (Straznicky 
et al., 2010). However, this hypothesis is speculative since the observed relationship 
was only present in correlational analysis and not in the main analysis. In addition, 
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we did not observe any association between changes in leptin and stress-induced 
blood pressure and HR, and we did not employ a measure of autonomic balance 
such as heart rate variability. Nonetheless, this finding suggests an intriguing 
relationship between adiposity, leptin and the inflammatory pathway.  
Mood symptoms measured with the GHQ showed an improvement after weight 
loss which was driven mainly by changes in the depression subscale. However, this 
improvement in mood did not correlate with changes in weight or adiposity 
measures, or with post-weight loss reduction in resting pro-inflammatory markers. In 
fact, there was a trend pointing towards a correlation between greater changes in 
depression and lower change in IL-6 which suggests that the mechanisms 
underlying the improvements in mood is not a loss of adiposity or an attenuation in 
inflammatory factors. This mechanism is likely to be attributable to a non-specific 
effect of the weight loss intervention. The intervention protocol included weekly 
nutritional counselling sessions with Health Psychologists that served to motivate 
and monitor participants, reviewing goals, and generally used psychological 
techniques to facilitate weight loss.  
It is therefore conceivable that since the improvements in mood did not correlate 
with the outcomes under investigation, the observed mood effect is largely explained 
by the social support and counselling element included in the weight loss protocol. 
Indeed a recent meta-analysis of the effect of weight loss on symptoms of 
depression (Fabricatore et al., 2011) reported that although weight loss interventions 
were generally associated with improvements in depressive symptoms this could not 
be fully explained by weight loss. The authors argued that factors such as learnt 
cognitive behavioural strategies led participants to master skills such as self-mastery 
and self-efficacy that were then responsible for the improvement in symptoms of 
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depression. Thus, in order to disentangle the effects of weight loss from social 
support it would have been desirable to collect further follow up data several months 
after the intervention or having employed a non-weekly support control group.  
In the Introduction it was argued that inflammatory factors might mediate the bi-
directional association between obesity and depressed mood, and it is generally 
accepted that major depression is associated with raised level of certain pro-
inflammatory cytokines (Dowlati et al., 2010). The present study did not find any 
evidence of associations between depressive symptoms and changes in CRP and 
IL-6. However, on average, there were no significant changes in resting levels of 
CRP and IL-6 post-weight loss and therefore it was not possible to examine this 
issue. In addition, this study was performed in a small, healthy sample without 
history of mental illness, thus it was not possible to examine clinically relevant 
changes in mental health. 
Leptin has also been proposed to have a role in mood regulation in obese 
individuals which may be mediated through tissue resistance to leptin in some obese 
individuals. However, the brain regions and the intracellular transduction pathways 
involved have not been identified (Lu, 2007; Lu, Kim, Fraser, & Zhang, 2006). 
Therefore, although some cross-sectional studies have found associations between 
leptin levels and depression (Labad et al., 2011) the causative role of leptin in 
depression is still under investigation. In particular, the role of leptin in mediating or 
moderating the effect of weight loss on depression in humans has not been 
experimentally investigated (Lutter et al., 2008). 
This study has several limitations that need to be highlighted. Firstly, there was a 
notable drop-out rate, although participants that failed to complete the study did not 
differ on key characteristics compared with the final analytic sample. In fact, data for 
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body mass loss of the participants that were lost at follow-up indicate that the mean 
loss registered at the last attended nutrition session was comparable to that of the 
completers. It follows that a further weakness of this study was sample size. The 
small sample might have reduced the statistical power to find an effect of weight loss 
on IL-6 reactivity for instance or heart rate. Indeed, a post-hoc power calculation 
suggested that this study achieved a 46 per cent power to detect a difference in 
stress reactivity. Nonetheless, some of the associations found were remarkably 
robust. A further limitation is that this was not a randomized study with a parallel 
group. Due to time constrains setting up this study using a non-weight loss control 
group and random allocation to conditions would not have been possible and 
consequently causal associations and firm conclusions cannot be drawn.    
In summary, this study used a supervised calorie restriction intervention to test 
the effects of weight loss on psychophysiological stress reactivity in overweight and 
obese women. The weight loss programme resulted in modest reduction in body 
mass and fat mass. Systolic and diastolic blood pressure responses to mental stress 
were attenuated after weight loss and this difference in reactivity correlated with 
reduction in waist and waist to hip ratio. However, lower basal blood pressure after 
weight loss accounted in part for the attenuated reactivity especially for diastolic 
blood pressure. Weight loss induced reductions in leptin were related to an 
attenuated pro-inflammatory IL-6 reactivity independent of basal IL-6. This study has 
provided partial support for the hypotheses outlined in the Introduction. 
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CHAPTER 6: DISCUSSION 
 
Two studies have been carried out that investigated the effect of physical activity 
on mood and daily stress, the cortisol diurnal rhythm, and autonomic and 
inflammatory stress-induced reactivity. One study has also been completed that 
examine the effect of weight loss on stress-induced autonomic and inflammatory 
reactivity and mood. The key aims of this work were to investigate underlying 
biological mechanisms explaining links between physical activity, adiposity, and 
stress with relevance to CVD risk. 
Several methodologies have been employed in this thesis. A naturalistic 
approach was used in study one whereas study two and three employed an 
experimental method. There are advantages and disadvantages in both approaches. 
Specifically, the naturalistic approach allows to examine relevant associations in 
everyday life under natural conditions without the constrain of the laboratory. 
Ambulatory measures provide valuable information on in the participant’s typical 
environment but the range of markers that can be assessed is limited compared to 
more extensive possibilities that are available in the clinic or laboratory. The 
experimental method allows to investigate the links between psychosocial factors 
and biological responses under controlled conditions with a more extensive range of 
measure available to the researcher.  
The major problem with this method is that the stimuli used are somewhat 
artificial and may not correspond to real life stressors. However, combining the 
different approaches and methodologies is likely to strengthen the evidence. For 
example, the magnitude or duration of a given response to stress in the laboratory 
may be related to future ambulatory blood pressure. Likewise, the amount of 
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objective ambulatory physical activity recorded during a week may be related to 
physiological responses to mental stress in the laboratory. In this way one may be 
more confident about the associations between certain psychosocial or behavioural 
characteristics and a given risk factors of health outcomes.    
 
 
6.1 Study I 
 
This study was a cross-sectional analysis of self-reported frequency of habitual 
physical activity, mood, and diurnal cortisol carried out in a relatively large sample of 
full-time employed, office-based women from London and Budapest. The primary 
hypothesis stating that women engaging in greater levels of moderate to vigorous 
physical activity (MVPA) would score lower on a questionnaire measure of 
depressive symptoms (Centre for Epidemiological Study Depression CES-D) was 
accepted. Specifically, after adjusting for age, BMI and between country differences, 
participants in the two higher tertiles of self-report MVPA had lower depressive 
symptoms compared to the lowest tertile. I also hypothesised that greater 
participation in MVPA would be associated with lower daily ratings of total stress 
(stress and feeling in control) derived from an aggregated Ecological Momentary 
Assessment (EMA) daily rating during a work day and a weekend day. This 
hypothesis was partially accepted because daily stress was associated with physical 
activity only during the weekday and not the weekend.  
The second hypothesis stated that higher self-reported MVPA would be 
negatively associated with several measures of the diurnal cortisol cycle assessed 
during a work day and a weekend day. This hypothesis was only partially confirmed. 
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Specifically, there was a modest difference in evening cortisol concentration between 
the highest and lowest tertile of habitual MVPA on the work day only. There was also 
a significant difference in the work day total cortisol output indexed as the area under 
the curve. The two most active groups demonstrated significantly lower cortisol 
output compared to the least active group independent of age, BMI, smoking and 
sampling country. This difference was not found for the leisure day. The magnitude 
of the cortisol awakening response did not significantly differ between the MVPA 
groups in either cortisol sampling day. Likewise, there were no significant between 
group differences in the diurnal slope of cortisol decline in either the working day or 
the leisure day.  
These findings suggests that cortisol level during the day and evening appear to 
be lower in more active women after adjusting for age, BMI, smoking status and 
sampling country. Lower cortisol levels during the day may therefore be an important 
biological pathway driving the association between regular physical activity and 
health outcomes. 
 
 
6.2 Study II 
 
Study two was a randomized, cross-over experimental study design to 
investigate the effect of physical activity on autonomic and inflammatory responses 
using a physical activity withdrawal model in healthy, regularly active individuals. The 
first hypothesis stated that two weeks withdrawal from regular exercise would cause 
changes in negative mood and depressive symptoms which would also be 
associated with the reduction in daily physical activity. This hypothesis was 
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accepted. Compared to a two week of physical activity maintenance (the control 
condition), withdrawal from regular physical activity resulted in marked negative 
changes in depressive symptoms and psychological distress. Importantly, the 
objectively measured changes in daily level of physical activity over the two weeks 
were associated with the changes in negative mood in a linear fashion.  
The results indicate that the physical activity withdrawal intervention was 
successful in inducing psychological distress and changes in negative mood, and 
that this mood disturbance was in large part attributable to a reduction in daily level 
of physical activity. The hypothesis further predicted that alterations in resting levels 
of inflammatory cytokine IL-6 and CRP following withdrawal would also be 
associated with changes in negative mood. There were no significant associations 
between changes in resting inflammatory markers and changes in mood following 
exercise withdrawal and therefore the hypothesis was not accepted.  
The second hypothesis which stated that autonomic, neuroendocrine and 
inflammatory responses to mental stress would be enhanced following two week 
physical activity withdrawal compared to two week physical activity maintenance was 
generally not supported. Specifically, a near-significant higher inflammatory reactivity 
following withdrawal was observed only when participants with poor compliance to 
the physical activity withdrawal protocol were excluded. In addition, this greater IL-6 
reactivity was associated with changes in mood following withdrawal which was 
independent of the IL-6 reactivity during PA maintenance stress testing.  
The heart rate reactivity during physical activity withdrawal testing was also 
significantly associated with mood disturbance independent of heart rate reactivity at 
maintenance stress testing. A modest difference in stress-induced cortisol was also 
observed at 20 minutes post-stress, indicating that participants had higher cortisol in 
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the withdrawal phase compared to exercise maintenance. Furthermore, this 
hypothesis also predicted that subjective stress would be greater and task appraisal 
less favourable following physical activity withdrawal compared to the maintenance 
phase.  This hypothesis was however not accepted. 
These results seem to suggest that by using an experimental model to 
manipulate physical activity, heart rate and inflammatory IL-6 responses to mental 
stress were greater in individuals who were more distressed as a result of exercise 
withdrawal. However, these associations were only apparent in secondary analysis 
prompting the need to replicate these findings in future well-controlled studies. 
 
6.3 Study III 
 
This study was designed to experimentally manipulate adiposity levels and 
compare stress-induced autonomic and inflammatory responses before and after 
weight loss. The first hypothesis stating that weight loss would be associated with 
lower levels of resting inflammatory markers was only partially accepted because 
CRP and IL-6 did not significantly change. However, there was a decrease in the 
hormone leptin and this decrease correlated with changes in BMI and waist to hip 
ratio.  
The second hypothesis predicted that autonomic responses to mental stress 
would be attenuated after weight loss. This hypothesis was only partially supported. 
Specifically, systolic blood pressure stress reactivity was attenuated independently of 
the resting value and the magnitude of this attenuation correlated with the change in 
the waist to hip ratio following weight loss. There were no other differences in 
reactivity or recovery in cardiovascular or inflammatory responses.  
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The third hypothesis stated that reductions in leptin would be associated with 
cardiovascular and inflammatory responses to mental stress at follow-up stress 
testing. This hypothesis was partially accepted. The change in leptin was not 
associated with stress-induced cardiovascular reactivity but it was positively and 
significantly associated with IL-6 reactivity independently of pre-weight loss reactivity 
and resting IL-6. 
Finally, the fourth hypothesis stating that the weight loss would result in 
improvements in depressive symptoms mediated by loss of adiposity or resting 
inflammatory markers was not accepted. Although mood significantly improved 
following weight loss, it did not correlate with any measure of adiposity or 
inflammatory markers. 
These results indicate that following a modest reduction in adiposity, blood 
pressure reactivity to stress is reduced. In addition, the weight loss-induced change 
in resting leptin appears to be partly driving an attenuation in pro-inflammatory 
responses to stress. However, the lack of a non-weight loss control group precludes 
any firm conclusion and certainty about the significance of the observed post-weight 
loss blunted reactivity. For example, although the changes in autonomic stress 
reactivity were correlated with reductions in adiposity, there may be a possibility that 
the attenuated reactivity is driven by an habituation effect to stress or some other 
non-specific confounding factors. 
6.4 Implications and Importance of Findings 
 
This thesis has shown that regular physical activity is associated with a small 
reduction in daily cortisol output and lower bedtime cortisol levels. This association 
was only reported during the working day sampling. Attenuated cortisol secretion 
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during the working day, when stress is typically higher than the leisure day, may be 
an important mechanism partly mediating the effect of physical activity on 
cardiovascular risk factors. For example, elevations in diurnal cortisol have been 
shown to contribute to endothelial dysfunction, hypertension and to a switch towards 
cardiac sympathetic predominance (Brunner et al., 2002; Broadley et al., 2005), and 
raised evening cortisol was a predictor of cardiovascular mortality in a recent study 
(Kumari, Shipley, Stafford, & Kivimaki, 2011). Indeed, the latter study was the first to 
demonstrate that a flatter decline in cortisol driven by high evening levels was 
predicted mortality for cardiovascular causes independent of several covariates.  
Depressive symptoms and aggregated rating of daily stress were also lower in 
the most active participants although some of these associations were observed in 
the work day only. I demonstrated a direct association between physical activity and 
mood symptoms by using an experimental exercise withdrawal design. The positive 
effect of regular physical activity on mood and psychological wellbeing is generally 
accepted (Rethorst, Wipfli, & Landers, 2009). However, the evidence for a causal 
association comes mainly from exercise trials. These interventions often require 
participants to exercise in groups and have therefore a certain degree of social 
contact. It may be argued that the positive effect of exercise may in part be mediated 
by improvements in non-specific factors such as self-efficacy, self-esteem or social 
support. The use of an exercise withdrawal design overcomes these limitations. A 
worsening in mood symptoms and psychological distress in these healthy 
participants which was associated with objective reduction in daily level of physical 
activity developed after two weeks of exercise abstinence.  
The participants who developed negative mood showed enhanced heart rate 
and pro-inflammatory IL-6 responses to mental stress but this enhanced reactivity 
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was not observed in the main analysis but only in secondary analysis. In contrast, 
the systolic blood pressure reactivity of participants who lost weight was reduced 
compared to the reactivity observed pre-weight loss. However, an attenuated 
inflammatory reactivity could only be observed in correlational analysis. Therefore, 
this thesis has provided only limited experimental evidence for an association of 
physical inactivity and adiposity with exaggerated stress-induced autonomic and 
inflammatory responses.  
 
6.5 Methodological Issues and Limitations. 
 
The strengths and weaknesses of the studies carried out in this thesis have 
already been highlighted in previous chapters. However, it is important to discuss 
some of the methodological issue arising from the use of the experimental design 
further.   
 
 
6.5.1 Physical Activity Withdrawal Design. 
 
This experimental paradigm has been used as a model of physical inactivity and 
to induce mood disturbance in healthy, fit and regularly active individuals. This model 
can be used to experimentally investigate effects of exercise on mood and 
underlying psychobiological mechanisms under stimulated conditions such as mental 
stress. However, the sampling technique is central to the success of this 
experimental design. Participants were only eligible if they engaged in at least three- 
weekly moderate to vigorous or higher intensity exercise sessions for one hour or 
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more in total. Since this level of physical activity may only be achieved by a minority 
of the population, the extent to which the results obtained by using this model can be 
generalized is uncertain.  
Yet, this issue needs to be balanced against the alternative model used to 
investigate the effect of physical activity on various psychological and biological 
outcomes. Active exercise intervention trials are the alternative model that has been 
used in this kind of research. This design also suffers from methodological 
shortcoming. For example, exercise trials need larger number of participants in order 
to account for attrition rates, greater manpower and monetary costs. In addition, the 
duration of the exercise intervention may need to be considerably longer  as chronic 
physiological exercise adaptations are unlikely to be observed over short trials 
lasting 3 – 6 months, when modest gains in cardiorespiratory fitness (<5%) are often 
observed. 
The mood disturbance and depressive symptoms which are reliably induced by 
the physical activity withdrawal paradigm are interpreted to represent the effect of 
physical activity on mood and general wellbeing. I measured adherence to exercise 
withdrawal using objective activity measures, which is a major strength of the study 
design. It may, however, be argued that withdrawing from a supposedly pleasurable 
activity such as exercise or sport participation may result in mood alterations which 
might not be related to the effect of physical activity itself but to other factors 
including social contact. Indeed, although a previous investigation reported a 
correlation between changes in inflammatory markers after exercise withdrawal and 
mood (Poole, Hamer, Wawrzyniak, & Steptoe, 2011) an effect of inflammatory 
activity on exercise withdrawal induced negative mood has not been demonstrated.  
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This could indicate that the mechanism driving the effect of physical activity on 
mood and wellbeing in a physical activity withdrawal paradigm may not be 
physiological but attributable to other non-specific factors such as social contact or 
the withdrawal of an enjoyable activity. This issue is however also relevant in 
exercise intervention trials since these studies require a great deal of contact time, 
social interactions, and other factors such as subjective expectations. There is some 
evidence that may argue against the proposition that the mood changes experienced 
during physical activity withdrawal are a result of merely negative feelings arising 
from withdrawal of social contact during exercise. For example, anti-depressive 
effects of exercise are comparable in home based compared to group based 
exercise settings (Blumenthal et al., 2007). Therefore, although I cannot discount the 
possibility that the mood change in this study may have partly been caused by the 
withdrawal of a pleasurable activity, it seems very unlikely that the negative mood 
experienced as a result of physical activity withdrawal in this regularly active sample 
is attributable to non-specific effects such as social contact.  
Some of the effects observed in this study, for example negative mood and 
inflammatory reactivity or heart rate reactivity, were only demonstrated in secondary 
analysis using change scores and regressions techniques. Being a post-hoc 
analysis, this method represents a weaker source of evidence compared to the 
planned, pre-hoc experimental analysis. The need to carry out secondary analysis 
arose because there was evidence that the manipulation of physical activity that is 
central to the experimental design might have not worked for all participants. For 
example, objective reduction in daily physical activity data showed great variation in 
adherence to the protocol. Therefore, there was a need to carry on secondary 
analysis that offers less reliable evidence due to its main correlational nature. 
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6.5.2 Weight Loss Intervention 
 
The nine weeks weight loss regime resulted in a small overall weight reduction 
and a higher than expected drop-out rate (estimated at 29 per cent in a meta-
analysis) (Franz et al., 2007). The most likely reason for the small weight change is 
that the intervention did not stimulate the anticipated reduction in caloric intake 
because of over-compensation. For example, the participants may have 
overcompensated during their evening meal or with their snacking.  
However, the data available on the amount of weight loss lost by non-completers 
seem to be comparable to that of study completers, thus it is unlikely that attrition 
biased the results. Participants on the weight loss study generally demonstrated 
improved mood following the intervention although this was not related to weight 
loss. Thus, these effects might have been accounted for by having weekly contact 
with the investigators, which may have also impacted on other aspects of the study 
outcomes.  
I chose to recruit women in order to limit the between gender variability of 
inflammatory responses. Moreover, since this study was designed as a feasibility 
study that could inform a larger randomised controlled trial, it was originally decided 
to recruiting women only. Indeed, the sample size for this study was small and it is 
possible that in future studies including men as well as women the attrition rate may 
be lower.  
The lack of a non-weight loss control group means that the reduction in blood 
pressure reactivity to stress observed from baseline to follow-up although correlated 
with reduction in adiposity is not strictly derived from an experimental manipulation. 
Furthermore, some secondary cardiovascular parameters such as cardiac output 
were estimated using the Finometer device algorithm (see 4.3.3.9) rather than 
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measured directly. This method, although widely used in stress reactivity research, 
may be less accurate than other more objective methods but are deemed to be less 
cumbersome for the participant. This means that caution is needed in interpreting the 
results and that replication of the findings using a control group is warranted. 
 
 
6.6 Suggestions for Further Research. 
 
Future studies examining the association between physical activity and diurnal 
cortisol may benefit from the use of accelerometer devices. At present, the majority 
of ambulatory physical activity research is based on self-report measures. In 
addition, studies of ambulatory physical activity and cortisol may be confounded by 
the acute effect of exercise on the HPA axis and therefore the accelerometer could 
be used as a further check of adherence to sampling protocol. Likewise, 
incorporating repeated momentary measures of stress and general mood into 
research protocols would prevent some of the problems associated with 
questionnaire measures of mood such as recall bias. It would also be desirable to 
conduct larger studies that include men as well. 
Receptor or tissue sensitivity to the effect of glucocorticoids such as cortisol may 
be an important mediator of the effect of physical activity on immunological 
processes but this is currently an under researched area. The exercise withdrawal 
paradigm could therefore be employed to investigate the effect of physical inactivity 
on tissue sensitivity to cortisol. In addition, further studies that employ the exercise 
withdrawal design will benefit from the application of more advanced 
psychoneuroimmunological techniques. For example, since the stressors used did 
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not elicit marked pro-inflammatory responses, it would be advantageous to use an 
ex-vivo challenge model in which blood samples drawn before and after the 
stressors are challenged with an inflammatory stimulus such as lipopolysaccharide 
(Rohleder, Wolf, & Wolf, 2010). In this way the ensuing pro-inflammatory response 
can be measured and compared between the physical activity withdrawn and the 
control group. 
Further work should aim to investigate the effect of physical activity and adiposity 
on stress reactivity in a single randomized study. In this way it would be possible to 
examine whether these two factors are associated with stress independently. For 
example, overweight or obese men or women could be recruited and tested in the 
psychophysiology laboratory at baseline before being randomly assigned to either a 
reduced calories weight loss, an exercise intervention or an advice only control 
group. When stress testing is repeated at follow-up one will be able to test which 
factor is more important in reducing CV reactivity. In addition, by adopting such 
design it may be possible to test the effect of weight loss on mood. In study three I 
showed that weight loss was associated with improvements in depressive symptoms 
which were unrelated to adiposity. Hence it is unclear whether improvements in 
depressive symptoms after weight loss are due to non-specific effects such as social 
contact or to loss of adiposity with subsequent improvements in the inflammatory 
profile. 
6.7 Conclusions 
 
Between forty to sixty per cent of all cardiovascular events can be explained by 
traditional risk factors including smoking, lipids, hypertension, physical inactivity and 
family history. Other factors such as cardiovascular and inflammatory activation 
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during psychosocial stress have been proposed to account for the development of 
cardiac risk factors. Psychophysiological stress testing in a controlled laboratory 
setting represents a way to investigate the contribution of physiological reactivity to 
risk factors and the mediating or moderating role played by physical activity and 
adiposity. Evidence has shown that these autonomic responses are prospectively 
associated with risk factors including hypertension (Chida & Steptoe, 2010) as well 
as the progression of subclinical atherosclerosis plaques (Hamer, Endrighi, 
Venuraju, Lahiri, & Steptoe, 2012).  
Previous work suggested that higher physical activity levels and low adiposity 
may act as a buffer against sustained or exaggerated autonomic responses to 
stress. However, much of this work has been observational highlighting the need for 
more experimental evidence. The present series of studies has provided only weak 
experimental evidence for an association between modifiable risk factors such as 
physical activity and adiposity and responses to mental stress. Regular physical 
activity may also contribute to better health outcomes through regulation of 
inflammatory and cardiovascular responses to acute or chronic stressors but more 
experimental evidence is needed to confirm this hypothesis. Furthermore, adiposity 
levels may negatively affect cardiovascular and inflammatory responses to stressful 
or challenging situations which may also be mediated through leptin regulation. Even 
though heightened autonomic responses in obesity may be an important pathway in 
the association between obesity and the development of cardiovascular risk more 
research is warranted before a direct association between adiposity levels and up-
regulation of autonomic responses is firmly established. 
In summary, physical activity and adiposity seems to be associated with several 
psychobiological mechanisms that could be potentially important for various health 
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outcomes. The studies presented in this thesis have contributed to the 
psychophysiology literature by evaluating autonomic and inflammatory responses to 
acute stress before and after experimental manipulation of physical activity and 
adiposity. In addition, this thesis has contributed to current knowledge on the 
association between diurnal cortisol profile and physical activity. 
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Appendix 1: Physical Activity Withdrawal Study Information Sheet  
 
 
 
 
 
 
 
Volunteer Information Sheet V.1 15/01/09 (Confidential) 
(The Exercise Withdrawal and Stress Study ) 
 
This study has been approved by the NHS Research Ethics Committee. We are interested in studying 
how the cardiovascular and immune systems respond to physical activity. The study is part of a larger 
programme of research into biological aspects of stress in relation to cardiovascular disease risk 
funded by the British Heart Foundation. 
 
Who can take part? 
This study will be carried out with healthy, non-smoking men and women aged 18-35 years who 
exercise regularly. We will not be able to include anyone who is diabetic, or has a liver, kidney, heart, 
lung, blood or skin disease. We also cannot include you if you have been taking any medicine or pills 
prescribed by a general practitioner over the past month (oral contraceptives are allowed). You need 
to be exercising at least three times a week for 30 minutes per session of vigorous, intense activity, 
and to have maintained this level of activity for at least the past six months. 
 
What will I have to do?  
You will come to the laboratory on three occasions over a total of 4 weeks. The appointments will be 
at UCL (1-19 Torrington Place), and will take place on a weekday morning or afternoon. At least three 
hours before the session we want you to avoid eating a large meal, drinking coffee or alcohol, 
because these may affect the validity of the study. In addition, please do not exercise for 12 hours 
before your appointment because, again, this could affect the results. If you become unwell 
beforehand or are suffering with an infection, please contact us to reschedule your appointment. 
 
The first visit is for an assessment and will last approximately 1 hour and 10 minutes. During this visit 
we will measure your height, weight, give you a questionnaire and ask you to cycle on an exercise 
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bike for 16 minutes to assess your fitness level. At the end of this session you will also be told whether 
you will be expected to maintain your regular exercise regime or withdraw from it for the 14 day 
interval between appointments. If you are asked to maintain your regime, you will carry on doing at 
least three 30-minute intervals of vigorous, intense exercise per week. If you are asked to withdraw 
from your exercise regime, you will need to stop any physical activity that is of low, moderate or 
vigorous intensity or greater during the two weeks. You should continue your daily routines as normal 
(excluding any exercise sessions), and not compensate for your lack of regular exercise. You will also 
be asked to wear a tiny device fitted to your belt called an Actigraph, which will measure your activity 
levels to check that you are adhering to the exercise instructions. This is a randomised study, so we 
do not know which condition you will be in first.  
 
The second appointment will be 14 days later and will last approximately 2 hours and 15 minutes. 
During this session you will be asked to complete a set of short questionnaires which assess your 
exercise habits, general stress levels, mood and physical health, and we will take a small blood 
sample from your arm. You will then be asked to perform two 5 minute tasks; a speech task and a 
hand-eye-co-ordination task. These tasks do not require any special skills and most people find them 
interesting and even fun to do. After the tasks you will rest comfortably for 45 minutes and we will take 
another small blood and saliva sample. At the end of the visit we will ask you to switch to the condition 
to which you were not originally randomised (i.e. if you maintained regular exercise you will now stop 
exercising for two-weeks and vice versa). You will again be fitted with an Actigraph which will monitor 
your activity levels for the following 2 weeks. 
 
Finally, we will ask you to come back for a third appointment at the end of the second 2 week interval. 
In this final visit we will again give you the questionnaires, tasks and take two small blood and saliva 
samples as we did previously. This last visit will last approximately 2 hours and 15 minutes 
 
You will be provided with an honorarium sum of £80 for taking part in the study.  
 
What will happen to the blood sample and other information?   
All the information we obtain from this study about you, including your name, will be confidential and 
will only be used for research purposes. The data will be stored in accordance with the data protection 
act. Since data will be combined, it will not be possible to identify any individual within published 
results. Only those people directly involved in this study will have access to the blood samples. When 
the study is complete, your sample will be destroyed in accordance with UCL biohazard disposal 
policy.  
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What will happen to the results from this study? 
This study is being undertaken in part fulfilment of a Ph.D. project that investigates behavioural and 
lifestyle factors that are relevant to cardiovascular health and has been funded by the British Heart 
Foundation. We wish to report our findings in academic/health related journals and present them at 
scientific meetings and conferences. You will not be identified in any report or publication arising from 
the study. 
 
Are there any advantages/benefits from taking part?  
We cannot promise the study will help you directly but the information collected from you and other 
participants will help to improve our understanding of the effects of lifestyle and exercise on health. At 
the end of the study we can give you feedbacks on your blood pressure, weight, BMI and fitness test 
score. 
 
Are there any disadvantages from taking part? 
We consider there to be minimal disadvantages e.g. the inconvenience of attending /completing the 
questionnaires. We realise that not everyone likes having a blood test but this is a crucial part of the 
study. The procedure for obtaining the blood sample may cause a little discomfort. Blood will be taken 
by a trained phlebotomist who will follow procedures and take appropriate precautions to minimise any 
discomfort. 
 
What if there is a problem? 
Complaints: If you have any concerns or wish to complain about any aspect of the way you have been 
approached or treated as part of this study, you should initially contact Dr. Hamer who will do his best 
to answer your questions. His contact details are provided at the end of this information sheet. If you 
remain unhappy and wish to complain formally, you can do this through the Research Governance 
Sponsor of this study, University College London (UCL). Please write to Joint UCL/UCLH Biomedical 
Research Unit, R&D Directorate (Maple House), Rosenheim Wing, Ground Floor, 25 Grafton Way, 
London WC1E 5DB quoting reference 08/0284. All communication will be dealt in strict confidence. 
 
Harm: Every care will be taken to ensure your safety during the course of the study. However, UCL 
has insurance arrangements in place for no-fault compensation in the unlikely event that something 
unforeseen goes wrong and on the balance of probabilities, harm is attributed as a result of taking part 
in the research study. 
 
What if I change my mind during the study?  
If at any point for any reason you do not want to carry on, then you may stop. There are no 
consequences of withdrawal from the study. 
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Thank you for taking the time to read this information sheet! We hope you are able and 
willing to take part in this study. 
 
If you have any questions, please contact Romano Endrighi on 020 76798328 (voice mail 020 
76791804 r.endrighi@ucl.ac.uk). Postal address: Psychobiology Group, Research Dept of 
Epidemiology and Public Health, 1-19 Torrington Place London, WC1E 6BT 
Further information about the work carried out in the Psychobiology Group can be found at 
www.ucl.ac.uk/psychobiology 
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Appendix 2: Condition Allocation Letters (Exercise Withdrawal Study) 
 
 
 
PSYCHOBIOLOGY GROUP                                                                                                            
RESEARCH DEPT OF EPIDEMIOLOGY AND 
PUBLIC HEALTH 
 
 
Dear Participant: 
You have been allocated to the EXERCISE WITHDRAWAL group. 
 
Please read these instructions carefully and keep them safe. It will tell you exactly what 
you will have to do in the next 14 days, starting from now, in order to successfully 
complete the study. 
 
 Please refrain from doing your usual exercise regime, including all aerobic 
exercise, resistance training and weight lifting at the gym or outdoors. 
 Please do not take up any physical activity to replace the exercise you would 
normally be doing. It is very important that you adhere to this rule. For your 
convenience we have compiled a list of activities that you may do during a typical 
day: 
1. Do take the bus (or tube) instead of walking to go to university or work 
2. Do not cycle  
3. Do use the lift rather than walking up and down the stairs 
 Try to be sedentary as much as possible! 
 
Your activity levels will be monitored for the duration of the study to check how well you 
are complying with these rules. You will be given a small device called an Actigraph. 
Please make sure you keep this device strapped snugly round your waist, with the 
pouch positioned against the side of your hip. You can wear it above or below your 
clothes, it does not necessarily have to touch your skin. Keep the Actigraph positioned 
the correct way up (see sticker on Actigraph). 
It is important that you wear this device during waking hours, but DO NOT get the 
Actigraph wet as it is not waterproof! 
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In the meantime if you have any questions, call or email Mark Hamer 020 7679 5969/ 
m.hamer@ucl.ac.uk or Romano Endrighi 020 7679 8328 r.endrighi@ucl.ac.uk  
 
Thank you for taking part in this research. 
 
 
 
 
 
 
 
PSYCHOBIOLOGY GROUP                                                                                                            
RESEARCH DEPT OF EPIDEMIOLOGY AND 
PUBLIC HEALTH 
 
 
Dear Participant: 
 
You have been allocated to the EXERCISE MAINTENANCE group. 
 
Please read these instructions carefully and keep them safe. It will tell you exactly what 
you will have to do in the next 14 days, starting from now, in order to successfully 
complete the study. 
 
 Please carry on doing your daily activities as usual.  
 Carry on doing your usual exercise regime, including all aerobic exercise, 
resistance training, sport or weight lifting as you normally do, and certainly more if 
you so wish.  
 
Your activity levels will be monitored for the duration of the study to check how well you 
are complying with these rules. You will be given a small device called an Actigraph. 
Please make sure you keep this device strapped snugly round your waist, with the 
pouch positioned against the side of your hip. You can wear it above or below your 
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clothes, it does not necessarily have to touch your skin. Keep the Actigraph positioned 
the correct way up (see sticker on Actigraph). 
 
It is important that you wear this device during waking hours, but DO NOT get the 
Actigraph wet as it is not waterproof! 
In the meantime if you have any questions, call or email Romano Endrighi 020 
76798328/ r.endrighi@ucl.ac.uk or Mark Hamer 020 7679 5969 m.hamer@ucl.ac.uk    
 
Thank you for taking part in this research.  
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Appendix 3: Weight Loss Study Information Sheet 
 
 
 
 
 
 
 
Volunteer Information Sheet V. 3 04/02/11 (Confidential) 
Adiposity, Stress and Immunity Study (Weight loss Study) 
 
You are being invited to take part in a research study. Before you decide to take part it is 
important for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and discuss it with others if you wish. Ask us 
if there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part.  
What is the purpose of the study? 
We believe that a person’s weight (body fatness) may be linked to the way he or she respond to 
psychological stress, and this might predispose towards the development of chronic conditions 
such as cardiovascular disease. In this study we are trying to find out whether people who lose 
weight react differently to stress. This study is part of a larger programme of research that 
investigate how psychological and lifestyle factors may be related to cardiovascular disease and 
is funded by the British Heart Foundation. 
Who can take part? 
The research study will be carried out with healthy, non-smoking women aged 18-45 years who 
are overweight (this will be ascertained by a short interview), but who would like help and support 
in managing their weight safely and effectively. We will not be able to include anyone who is 
diabetic, or has a liver, kidney, heart, lung, blood or skin disease. We also cannot include you if 
you have been taking any medicine or pills prescribed by a general practitioner over the past 
month (oral contraceptives are allowed).  
What will I have to do if I decided to join the study?  
UNIVERSITY COLLEGE LONDON 
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The study consists of two parts, (lasting 8 weeks in total) and we can only enrol you if you agree 
to participate in both parts:  
1. An 8 week supported weight loss programme based on daily meal replacements with regular 
contact time and advice. 
2. Two laboratory testing sessions in which you will complete two mild mental stress tasks during 
each session and a questionnaire. Throughout these laboratory sessions we will be taking a 
number of measures, which include: blood pressure, saliva and blood samples. A chemical that is 
produced during stress called cortisol can be measured in the saliva and various chemicals in the 
blood will be measured as a marker of immune function. 
The weight loss programme 
Research has shown that a meal replacement diet combined with advice and support is a safe 
and effective method for weight loss. You will be given two commercially available meal 
replacement shakes per day for eight weeks and will be allocated a Health Psychologist 
researcher who will work out a detailed strategy that will help you plan and manage your third 
meal and snacks as well as providing ideas for helping you to stick to the dietary plan. An 
important component of the weight loss programme is practical support which we will offer on a 
weekly basis in the form of face to face contact with Health Psychologist researchers who are 
supervised by a Registered Dietician experienced in weight management. At the beginning of the 
study you will agree the dates for your sessions with your allocated expert, which may also be 
reviewed throughout the duration of the study. We expect each session to last between 30 
minutes to a hour and the timing of these will be flexible to accommodate your other 
commitments. At the end of the eight week weight-loss programme, we will also offer you two 
follow-up appointments and provide you with strategies to help in maintaining weight loss after 
you have stopped taking the meal replacements. 
 
The laboratory testing session 
This part of the study will be carried out twice: once at the very beginning of the weight loss 
programme on the same day that you come in to see us and again at the end of the 
programme, which will be about eight weeks later. The session takes approximately 3 and a 
half hours, starting on a weekday morning or afternoon. During the session you will be asked 
to perform two 5-minute tasks; a speech scenario and a hand-eye coordination task whilst 
your blood pressure is recorded by a small cuff attached to your middle finger. These tasks do 
not require any special skills and most people find them interesting or even fun to do. We will 
also measure your height, weight and fat percentage before these sessions and take two 
small blood samples (about 3 tablespoons) and five saliva samples. During these laboratory 
sessions we will also ask you to complete a questionnaire about general stress, mental and 
physical wellbeing, and physical activity levels. We will provide some refreshments at the end 
of each session. 
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The questionnaires are to provide research data, not to diagnose medical or mental health 
issues. If any of the questions raise concerns for you then we recommend that you speak to your 
GP 
 
Where will the study take place? 
If you agree to take part in the study, we will arrange an appointment for you to attend at the 
Department of Epidemiology and Public Health, University College London (1-19 Torrington 
Place).The study (both the laboratory tests and the weight loss support) will take place in our 
research rooms at UCL. 
We will reimburse your travel expenses where applicable. In addition, if you request it, we 
can give you a written record of your blood pressure, weight, body mass index and (non-
fasting) lipid profile (cholesterol and triglycerides) and give you an extra copy to take to 
your GP if you so wish. We will, however, not get in contact with your GP under any 
circumstances. 
What will happen to the blood sample and other information?   
We want to emphasise that all results obtained will be strictly confidential and will only be used for 
medical research purposes.  All information about you will have your name and address removed 
so that you cannot be recognised from it. You are free to withdraw from the study at anytime 
without the need to give any reasons and there will be no consequences if you decide to withdraw 
or not to take part. In that case we will destroy your blood and saliva samples and the data we 
have obtained from you.   
Blood samples will be analyzed in our laboratory for biological markers that we believe are 
affected by both stress and weight loss and therefore potentially relevant in chronic conditions 
such as cardiovascular disease. 
When the study is complete, your samples will be destroyed in accordance with UCL biohazard 
disposal policy.  
What will happen to the results from this study? 
This study is being undertaken in part fulfilment of a Ph.D. project that investigates psychosocial, 
behavioural and lifestyle factors that are relevant to cardiovascular health and has been funded 
by the British Heart Foundation. We wish to report our findings in academic/health related 
journals and present them at scientific meetings and conferences. You will not be identified in any 
report or publication arising from the study. 
Are there any advantages/benefits from taking part?  
By taking part in this weight loss programme you will be supported and receive advice to 
overcome possible barriers to weight loss. Our team will decide with you how many sessions of 
contact time you will need. We recognize that some people may find it difficult to maintain the 
weight loss achieved during the study once the meal replacements are stopped. We will provide 
you with strategies to help maintain any weight you have lost and offer two follow-up contact 
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appointments to help you deal effectively with this. The information collected from you and other 
participants will help to further our understanding of how weight may affect the way people 
respond to stress and ultimately improve the management of chronic condition such as heart 
disease. 
Are there any disadvantages from taking part? 
We consider there to be minimal disadvantages e.g. the inconvenience of attending /completing 
the questionnaires. We realise that not everyone likes having blood samples taken, but this is a 
crucial part of the study. The procedure for obtaining the blood sample may cause a little 
discomfort or small bruising. Blood will be taken by a qualified nurse who will follow procedures 
and take appropriate precautions to minimise any discomfort. 
What if there is a problem? 
We do not expect you to suffer any adverse effects from this study.  
Complaints: If you have any concerns or wish to complain about any aspect of the way you have 
been approached or treated as part of this study, you should initially contact Dr. Hamer who will 
do his best to answer your questions. His contact details are provided at the end of this 
information sheet. If you remain unhappy and wish to complain formally, you can do this through 
the Research Governance Sponsor of this study, University College London (UCL). Please write 
to Joint UCL/UCLH Biomedical Research Unit, R&D Directorate (Maple House), Rosenheim 
Wing, Ground Floor, 25 Grafton Way, London WC1E 5DB quoting reference 09/0417. All 
communication will be dealt in strict confidence. 
Harm: Every care will be taken to ensure your safety during the course of the study. UCL does 
not have insurance arrangements in place for no-fault compensation and, in the unlikely event 
that something unforeseen goes wrong and on the balance of probabilities harm is attributed as a 
result of taking part in the research study, negligence will have to be proved. 
 
Contact for further Information 
If you have any questions, please contact: Psychobiology group, Department of Epidemiology 
and Public Health, University College London, 1-19 Torrington Place, London, WC1E 6BT. 
Telephone 020 7679 8328.  
Dr. Mark Hamer (020 7679 5969)-m.hamer@ucl.ac.uk 
Web-site: www.ucl.ac.uk/psychobiology. 
Email: uclweight.loss@gmail.com 
Thank you for taking the time to read this information sheet! We hope you are able and 
willing to take part in this study. 
 If you have any questions regarding the laboratory testing session please contact Romano 
Endrighi 
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on 020 7679 8328 (voice mail 020 7679 1804) – r.endrighi@ucl.ac.uk 
 For questions regarding the weight loss programme contact Helen Croker on 020 7679 5634 
(voice mail 020 7679 8354) h.croker@ucl.ac.uk or Sarah Young on 020 7679 1614 
s.e.young@ucl.ac.uk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
291 
 
 
Appendix 4: Day-Tracker Study Information Sheet 
 
 
 
UCL PSYCHOBIOLOGY GROUP 
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC 
HEALTH 
 
 
 
The Day-Tracker Study 
The Biology of Everyday Life 
 
PARTICIPANT INFORMATION SHEET (Confidential) 
 
You are being invited to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and discuss it with others if you wish. 
Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
We are trying to understand how our activities and emotions relate to biological function 
in everyday life. We believe that positive wellbeing is associated with good health, while 
more negative emotional states may contribute to ill health. In previous work, we have 
found that different behaviours and emotions have distinct biological profiles. In this 
study, we would like to build on our previous findings with some new measures. This 
research study is part of an international collaboration, funded in part by the National 
Institute on Aging in the USA, and in part by the World Health Organisation.  The study 
is being carried out in UCL by Professors Andrew Steptoe, Jane Wardle and Sir Michael 
Marmot from the Department of Epidemiology and Public Health.  
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Who can take part? 
This study is being carried out with healthy women aged 18 to 65 years old who are 
working full-time. Volunteers should not pregnant, or be on any regular medicines or 
medications except for oral contraceptives or hormone replacement treatment. If you 
have suffered from a serious illness such as heart disease or cancer over the past two 
years, you will not be suitable for the study.  
 
What will happen during the study?  
The study involves taking measurements over two 24 hour periods, one during the week 
and the second on Friday to Saturday. These two study periods will not follow directly 
one after another but should take place within 10 days of each other. After the first 24 
hour study period, you will be asked to complete a questionnaire. This questionnaire 
includes measures of lifestyle factors such as smoking and physical activity, and 
measures of work stress, financial strain and social support. This information will help us 
interpret the biological results we collect. It is completely confidential, and results will not 
be available to anyone outside the study group and will only be used anonymously.  
 
On the first 24-hour study day, you will need to come to the Department of Epidemiology 
and Public Health situated in 1-19 Torrington Place after work (between 4 and 6pm). 
When you arrive in the building, one of our team members will take you to an office on 
the 3
rd
 floor. If you happen to have a cold or flu or have had to take any medicines 
shortly before, please get in touch so that we can reschedule the appointment.  
 
We will first of all measure your height and weight. To do these measurements, you will 
need to be barefoot. Next, we will fit you with a small electronic device that will measure 
your heart rate over the next 24 hours. This involves using two adhesive pads to stick 
electrodes on the left side of your chest, just above the heart. This device is not 
uncomfortable, and once it has been fitted you should not be able to feel it.  
 
We will also ask you to give us some samples of saliva over the next 24 hours, so that 
we can measure levels of stress hormones. The saliva samples are taken by chewing 
gently on a cotton roll for two minutes, then putting the wet cotton roll into a test tube. 
We want to collect two saliva samples in the evening, then 5 more over the next day. 
After you have been shown how to take the saliva samples, you can go off and spend 
the evening, night, and the next day as normal. You will be able to bath or shower as 
normal while you are wearing the heart monitor. 
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We will ask you to return to the Department 24 hours later. At that point, we will collect 
the heart monitor and test tubes from you, and then ask you to complete a computerised 
interview called the ‘Day Reconstruction Interview’. This involves providing details of 
what you were doing over the previous 24 hours, and how you felt at different times of 
the day and evening. It is quite a detailed procedure which will take 30-60 minutes to 
complete. The computerised questionnaire can also be done from your home or other 
personal computer before you come to the office. 
 
The second 24-hour study is exactly the same, except that it will start on Friday after 
work, and go on until the early evening on Saturday. You will not need to come in on 
Saturday, but can take of the chest electrodes yourself and keep the samples until the 
following Monday. After you have finished the measurements on Saturday, we would like 
you to complete the computerised interview as before. If you have a computer at home, 
you can do it there, or else back at UCL on Monday.  
 
What if I change my mind during the study? 
If at any point for any reason you do not want to carry on, then you may stop.  There are 
no consequences of withdrawal from the study, other than forfeiting the honorarium 
payment (see below).   
 
What happens to the information? 
All the information we get from this study about you, including your name, will be 
confidential and will only be used for research purposes.  The data will be collected and 
stored in accordance with the Data Protection Act. The data we collect from all 
volunteers will be combined, and it will not be possible to identify any individual within 
published results.   
 
What happens at the end of the study? 
Provided you have completed all the parts of the study successfully we will give you an 
honorarium of £60.  When the study is complete and all the results are analysed, we will 
send you a summary of our findings. 
 
Can I take part if I am pregnant?  
There are no risks to taking part in the study because you are pregnant. However, 
because pregnancy has effects on some of the hormones that we will be measuring, we 
do not wish pregnant women to participate. 
We hope you are able and willing to take part in our study.  If you have any questions, 
please contact Nina Grant, Psychobiology Unit, Department of Epidemiology and Public 
Health, 1-19 Torrington Place, London WC1E 6BT.  Tel. 020 7679 1702 (internal 
41702). E-mail: nina.grant@ucl.ac.uk 
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